| Date |
Title |
Rating |
| 2011-12-31 |
FDA approves Prevnar 13 pneumococcal conjugate vaccine for adults 50 and older |
None |
| 2011-12-31 |
HimalayaUSA recalls two batches of Organique by Himalaya Nourishing Night Cream |
None |
| 2011-12-31 |
ProStrakan announces FDA approval for Transmucosal Immediate Release Fentanyl REMS Access program |
None |
| 2011-12-31 |
ARCA biopharma extends pharmacogenetic intellectual property protection around bucindolol |
None |
| 2011-12-31 |
FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults |
None |
| 2011-12-31 |
Patented ribose for food, beverage and supplement applications |
None |
| 2011-12-31 |
No Cronobacter detected in Mead Johnson products |
None |
| 2011-12-30 |
New report on CNS, metabolic, immunologic disorders, infection, cardiovascular disease and oncology therapeutic markets |
None |
| 2011-12-30 |
Single shared REMS for TIRF products receives FDA approval |
None |
| 2011-12-29 |
Avastin fails to live up to expectations for extending survival in ovarian cancer |
None |
| 2011-12-29 |
Bevacizumab delays disease progression in ovarian cancer |
None |
| 2011-12-28 |
Powerful painkiller on its way to the market: Experts worry about addiction woes |
4 |
| 2011-12-28 |
Mylan receives final FDA approval for Levetiracetam ER Tablets ANDA |
None |
| 2011-12-28 |
Mylan receives final FDA approval for Eprosartan Mesylate ANDA |
5 |
| 2011-12-27 |
Perrigo receives final approval from FDA for Desloratadine ANDA |
None |
| 2011-12-26 |
Eisai resubmits NDA for perampanel to treat epilepsy-associated seizures |
None |
| 2011-12-26 |
Synthetic drugs treat Crohn's disease in mice |
4 |
| 2011-12-26 |
AJHP examines pharmacists' prescribing medications in current issue |
None |
| 2011-12-26 |
Wolters Kluwer sells pharma-related business to Springer Science+Business Media |
None |
| 2011-12-26 |
FDA accepts Gilead's Quad HIV regimen NDA for review |
None |
| 2011-12-26 |
TheraBiogen launches Social Media campaign |
None |
| 2011-12-26 |
Researchers report how sildenafil can alleviate heart problems |
None |
| 2011-12-26 |
FDA EMDAC schedules to review VIVUS' Qnexa NDA for treatment of obesity |
None |
| 2011-12-23 |
Researchers report how sildenafil can alleviate heart problems |
None |
| 2011-12-23 |
ARV drugs can prevent transmission of HIV |
3 |
| 2011-12-23 |
N.Y. Times review finds misuse of psychotropic drugs in disabled patients |
None |
| 2011-12-23 |
Injected meth users at greater risk of attempting suicide |
None |
| 2011-12-23 |
Veloxis, Athena partner to establish competitive presence for AtorFen in emerging markets |
None |
| 2011-12-23 |
BBC News Magazine examines antiviral drug research |
None |
| 2011-12-23 |
Anti-cancer drugs may also fight antibiotic resistance |
None |
| 2011-12-23 |
Researchers reveal what cells respond to anesthesia in C. elegans |
None |
| 2011-12-23 |
Walgreen expecting sharp drop in prescription business |
None |
| 2011-12-23 |
Religious leaders should come together to ensure access to NTD medicines for world's poorest |
None |
| 2011-12-23 |
First study to explore impact of crowding on children with fracture-related pain |
None |
| 2011-12-23 |
Russia will not use HIV spending to fund needle exchange, methadone therapy, Reuters reports |
None |
| 2011-12-23 |
Momenta, Baxter partner to develop and commercialize biosimilars |
None |
| 2011-12-23 |
Oak Pharmaceuticals acquires three Lundbeck hospital-based injectables |
None |
| 2011-12-23 |
Botox can have unsuspected 'systemic' effects on muscles |
None |
| 2011-12-23 |
ThromboGenics submits ocriplasmin BLA with FDA to treat symptomatic VMA |
3 |
| 2011-12-22 |
New way to awaken paternal Ube3a allele linked with Angelman syndrome |
5 |
| 2011-12-22 |
Effects of allopregnanolone in women with severe pre-menstrual syndrome |
5 |
| 2011-12-22 |
Drugmaker Merck to pay $24M to settle Medicaid case |
None |
| 2011-12-22 |
HPV vaccine support by GAVI example of 'equity in health' |
None |
| 2011-12-22 |
New silk-based microneedle system for controlled-release drug delivery |
None |
| 2011-12-22 |
JAMA commentary argues that vitamin therapy still plays a role in reducing stroke |
None |
| 2011-12-22 |
FDA approves Merck's Isentress to treat HIV-1 infection in children, adolescents |
None |
| 2011-12-22 |
ACTF, Merck announce new HIV initiatives |
None |
| 2011-12-22 |
Impax submits IPX066 NDA to FDA for treatment of Parkinson's |
None |
| 2011-12-22 |
Leishmania parasite develops combined resistance against drug, human immune system |
None |
| 2011-12-21 |
Malaria vaccine shows early success |
None |
| 2011-12-21 |
CutisPharma introduces FIRST - Mouthwash Kits |
None |
| 2011-12-21 |
Actavis enters LOI with QRxPharma to commercialize MoxDuo IR in the U.S. |
None |
| 2011-12-21 |
Optical imaging can visualize cultured cancer cells' response to particular drug |
None |
| 2011-12-21 |
Low-income neighborhoods often misinformed about emergency contraception access |
None |
| 2011-12-21 |
Ranbaxy signs consent decree with U.S. FDA |
None |
| 2011-12-21 |
FDA accepts Pfizer's tofacitinib NDA for review |
None |
| 2011-12-21 |
University of Oxford scientists develop new candidate malaria vaccine |
None |
| 2011-12-21 |
Takeda receives FDA approval for EDARBYCLOR to treat hypertension |
None |
| 2011-12-20 |
Amgen and Watson to collaborate on biosimilar anti-cancer drugs |
None |
| 2011-12-20 |
Drug prices may fall by up to 82 percent in Australia |
None |
| 2011-12-20 |
WHO approves three Mylan ARV therapies to treat HIV/AIDS |
None |
| 2011-12-20 |
MacroGenics to receive milestone payment from Boehringer Ingelheim |
None |
| 2011-12-20 |
Immunosuppressant combination improves survival of human spinal stem cells in ALS rat model |
None |
| 2011-12-20 |
SCYNEXIS, MMV assemble Malaria Box of 400 compounds with antimalarial activity |
None |
| 2011-12-20 |
Pfizer, GlaxoSmithKline to increase sales of pneumococcal vaccines through GAVI |
None |
| 2011-12-20 |
Three-dose artesunate therapy effective in treating children with malaria |
None |
| 2011-12-20 |
Eculizumab protects children from severe Shiga toxin-associated HUS |
None |
| 2011-12-20 |
Lostartan can reduce cigarette smoke-induced lung injury |
None |
| 2011-12-20 |
EETs promote primary tumor growth and metastasis in mouse models of cancer |
None |
| 2011-12-20 |
Routine criminal prosecutions for HIV nondisclosure should be abolished, say experts |
None |
| 2011-12-19 |
Weight loss pill without major side effects coming soon |
None |
| 2011-12-19 |
Yissum introduces novel technology for manufacturing an anti-malaria drug in tobacco |
None |
| 2011-12-19 |
Bloomberg TV to air segment on Antigen Express' immunotherapeutic breast cancer vaccine |
None |
| 2011-12-19 |
EMA CHMP recommends approval for BioMarin's Novato manufacturing facility expansion |
None |
| 2011-12-19 |
Fluoride supplements not found to be safe or effective |
None |
| 2011-12-19 |
HA fillers will see highest growth among facial injectable products in 2013 rebound |
None |
| 2011-12-19 |
Affordable artemisinin using tobacco plants |
None |
| 2011-12-19 |
arGEN-X to advance SIMPLE Antibody platform for treatment of autoimmune disorders |
None |
| 2011-12-17 |
Baxter receives FDA approval for ADVATE to prevent hemophilia A |
None |
| 2011-12-17 |
Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease |
None |
| 2011-12-16 |
Research reveals role of government funding in pharmaceutical R&D |
None |
| 2011-12-16 |
First reliable method to predict whether SSRIs work on depressed patients |
None |
| 2011-12-16 |
Drugmakers get more time to record gifts to doctors |
None |
| 2011-12-16 |
Vaginal progesterone decreases odds of premature delivery in women |
None |
| 2011-12-16 |
Major metropolitan areas show variation in rates of drug-related ED visits |
None |
| 2011-12-16 |
Glucocorticoid inhalation during pregnancy does not increase risk of diseases in offspring |
None |
| 2011-12-16 |
Almost two-thirds of pregnant women in B.C. consume prescription drugs |
None |
| 2011-12-16 |
IQWiG publishes report on Esbriet benefit assessment for treatment of IPF |
None |
| 2011-12-16 |
FDA accepts Vertex KALYDECO NDA for six-month Priority Review |
None |
| 2011-12-16 |
Antimalarial drugs administered during pregnancy safer than contracting malaria, study suggests |
None |
| 2011-12-15 |
Study: Many prescription drugs use phthalates as inactive ingredients |
None |
| 2011-12-15 |
ONC gives gift with vision to reduce blindness and mortality among children |
None |
| 2011-12-15 |
FDA announces PDUFA date for Meda's Dymista |
None |
| 2011-12-15 |
Roundtable discussion about caffeine and physical performance |
None |
| 2011-12-15 |
MTF survey shows large decline in teen smoking |
None |
| 2011-12-15 |
New drug candidate may halt mental decline of Alzheimer's |
None |
| 2011-12-15 |
GeneKey launches personalized medicine service for cancer patients |
None |
| 2011-12-15 |
FDA approves modernized labeling for ViroPharma's Vancocin Capsules |
None |
| 2011-12-15 |
Experts warn expectant moms about dangers of common cold medicines during pregnancy |
None |
| 2011-12-15 |
Scientists evaluate toxicity of Peruvian plant species in traditional medicine |
None |
| 2011-12-15 |
Nitroglycerin can boost body's natural immune response to cancer |
None |
| 2011-12-14 |
Salix submits Crofelemer NDA to FDA for treatment of HIV-associated diarrhea |
None |
| 2011-12-14 |
Hydrogel regenerates healthy, scar-free tissue on skin damaged by severe burns |
None |
| 2011-12-14 |
Researchers discover how statins promote breakdown of plaque in arteries |
None |
| 2011-12-14 |
People in Swaziland protesting shortages of ARVs amid government financial crisis |
None |
| 2011-12-14 |
With federal court action looming, Sebelius says Plan B decision 'not about politics' |
None |
| 2011-12-14 |
Researchers create vaccine that reduces tumors in mice |
None |
| 2011-12-14 |
Study finds underutilization of warfarin among Kentucky women with AF |
None |
| 2011-12-14 |
Study reveals key role of melatonin receptor in sleep regulation |
None |
| 2011-12-14 |
Individuals with mood and anxiety disorders may be more likely to abuse opioids |
None |
| 2011-12-14 |
Statins linked with reduced risk of death among hospitalized flu patients |
None |
| 2011-12-13 |
Research describes advantages of new vaccine adjuvant |
None |
| 2011-12-13 |
Drug users with HIV infection have 74% higher risk of overdose |
None |
| 2011-12-13 |
Plant world has great potential as a source of new medicines, says NYBG scientist |
None |
| 2011-12-13 |
Scientists create antigenic myeloma peptide 'cocktail' |
None |
| 2011-12-13 |
Quintiles launches Kun Tuo to service unique needs of biopharma companies in China |
None |
| 2011-12-13 |
Supply chain map could help improve access to anti-malarial drugs |
None |
| 2011-12-13 |
Consistent asthma medication use could prevent severe attacks |
None |
| 2011-12-13 |
KPT-SINE shows promise against CLL |
None |
| 2011-12-13 |
FDA approves Lannett's ANDA for Triamterene with Hydrochlorothiazide Capsules |
None |
| 2011-12-12 |
ADHD drugs not bad for the heart: Study |
None |
| 2011-12-12 |
Parents blame swine flu vaccine for son’s narcolepsy |
None |
| 2011-12-12 |
Bone drug effective in improving breast cancer survival |
None |
| 2011-12-12 |
Neutra begins to test new proprietary nutrient formulas |
None |
| 2011-12-12 |
Reata, Abbott partner to develop and commercialize AIMs for chronic diseases |
None |
| 2011-12-12 |
Immunomodulators show promise against multiple myeloma |
None |
| 2011-12-12 |
BioInvent announces new BI-505 preclinical data on multiple myeloma |
None |
| 2011-12-12 |
Suppressing STARD9 protein could be a novel strategy to fight cancers |
None |
| 2011-12-12 |
Onyx receives FDA Standard Review designation for carfilzomib NDA to treat RRMM |
None |
| 2011-12-12 |
HER2 proteins do not predict breast cancer patient's outcome after Herceptin treatment |
None |
| 2011-12-12 |
Many postmenopausal women quit breast cancer drugs early because of side effects |
5 |
| 2011-12-12 |
Study describes miR-124 can prevent and treat liver cancer |
None |
| 2011-12-11 |
Positive data from Aeterna Zentaris AEZS-131 preclinical study on TNBC |
None |
| 2011-12-11 |
FDA panel supports birth control Yaz but advises labeling changes |
None |
| 2011-12-09 |
Signal Genetics to launch second generation Myeloma product, MyPRS Plus |
None |
| 2011-12-09 |
Obama defends limit on morning-after pill |
None |
| 2011-12-09 |
New pediatric formula for Chagas disease treatment developed in Brazil |
None |
| 2011-12-09 |
FDA panel: Some birth control pills should carry stronger warning labels |
None |
| 2011-12-09 |
The contraceptive pill could reduce risk of ovarian and uterine cancer in nuns |
None |
| 2011-12-09 |
Trastuzumab improves long-term outcomes in obese patients with HER2-positive breast cancer |
None |
| 2011-12-09 |
ZEN bust-enhancing supplements may increase risk of breast cancer |
None |
| 2011-12-09 |
First Edition: December 9, 2011 |
None |
| 2011-12-09 |
Sebelius overrules FDA on 'morning after' pill's OTC availability |
None |
| 2011-12-09 |
Experimental sublingual vaccine shows promise against influenza infection |
None |
| 2011-12-09 |
Dramatic rise in substance abuse treatment admission rates from 1999-2009 |
None |
| 2011-12-09 |
Paper calls for strong steps to control global crisis of antibiotic-resistant infections |
None |
| 2011-12-09 |
Gilead Sciences to donate $8M in visceral leishmaniasis drug to WHO |
None |
| 2011-12-09 |
caprotec's CCMS technology identifies novel co-targets of three anti-cancer drugs |
None |
| 2011-12-09 |
The Hormone Foundation publishes fact sheet about harmful hCG diet |
None |
| 2011-12-09 |
Menarini, Moberg Derma partner to distribute Emtrix in Italy |
None |
| 2011-12-09 |
Pharmaceutical spam leads patients to seek out online information about prescription drugs |
None |
| 2011-12-09 |
Combination of MEK inhibitors and nilotinib can overcome CML resistance to targeted drug |
5 |
| 2011-12-09 |
USPTO issues Diabetes Patent to Omni Bio |
None |
| 2011-12-09 |
Pharmacyclics, Janssen partner to develop and market PCI-32765 anti-cancer compound |
None |
| 2011-12-08 |
FDA advisory panel OKs anemia drug peginesatide |
None |
| 2011-12-08 |
Zoledronic acid increases bone mineral density, reduces recurrence in postmenopausal breast cancer |
None |
| 2011-12-08 |
Ixabepilone-sunitinib combination holds potential against chemotherapy-resistant ovarian cancer |
None |
| 2011-12-08 |
BCX4945 proves effective at clearing malaria infections |
None |
| 2011-12-08 |
Ecstasy drug associated with chronic changes in human brain |
5 |
| 2011-12-08 |
Euthymics presents EB-1020 preclinical data on ADHD at ACNP annual meeting |
None |
| 2011-12-08 |
Study shows how mothering can strengthen offspring's immune system in brain |
None |
| 2011-12-08 |
Janssen Biotech, Molecular Partners collaborate to develop DARPins for immunological diseases |
None |
| 2011-12-08 |
Watson introduces Amethia Lo and ethinyl estradiol tablets |
None |
| 2011-12-07 |
Vaccine against Ebola developed |
5 |
| 2011-12-07 |
FDA approves changes to REMS for Nplate and Promacta |
None |
| 2011-12-07 |
Antenatal corticosteroids reduce risk of death in extremely preterm infants |
None |
| 2011-12-07 |
AmLactin can help the skin through menopause |
None |
| 2011-12-07 |
Ampio awarded composition of matter patent for Ampion in Europe |
None |
| 2011-12-07 |
Relaxin improves poor blood flow and kidney function in a rat model of PKD |
4 |
| 2011-12-07 |
AFECTAIR may be an effective alternative to SoC for delivery of inhaled nitric oxide |
None |
| 2011-12-07 |
Future of drug discovery and development to be highlighted at 2011 BPS Winter Meeting |
None |
| 2011-12-07 |
Viewpoints: The loss of Berwick; A market for kidneys; Abusing painkillers |
None |
| 2011-12-07 |
Combination of cannabinoids and opiates could help reduce chronic pain |
4.5 |
| 2011-12-07 |
Pretreatment fasting glucose could block breast cancer progression |
None |
| 2011-12-07 |
Health Alliance, Bayer sign outcomes-based contract to support MS patients |
None |
| 2011-12-07 |
Vietnam should shut compulsory rehab centers for drug users, sex workers, U.N. expert says |
None |
| 2011-12-07 |
New method improves accuracy of AF risk assessments |
None |
| 2011-12-07 |
Fake, poor-quality drugs boosting malaria drug resistance in Southeast Asia, U.S. experts say |
None |
| 2011-12-07 |
INT-777 shows promise against metabolic syndrome |
5 |
| 2011-12-06 |
Ranbaxy introduces Atorvastatin-Amlodipine besylate tablets in the U.S. |
None |
| 2011-12-06 |
Combination of metformin and exercise can prevent Type 2 diabetes |
None |
| 2011-12-06 |
FDA assigns CTIs' pixantrone NDA new PDUFA action date |
None |
| 2011-12-06 |
Prenatal exposure to valproate may increase risk of autism in children |
None |
| 2011-12-06 |
Fetal exposure to valproate impairs IQ till age six |
None |
| 2011-12-06 |
MorphoSys unveils next-generation antibody technology Ylanthia |
None |
| 2011-12-06 |
Bold move by Astra Zeneca to share 22 early stage potential drugs with MRC |
None |
| 2011-12-06 |
Aspirin decreases risk of major complications from cardiac surgery |
None |
| 2011-12-05 |
Biogen, Samsung partner to develop and market biosimilars |
None |
| 2011-12-05 |
Converting patients to lamotrigine extended-release for epilepsy treatment found effective and safe |
None |
| 2011-12-05 |
Spectrum seeks FDA IND approval for SPI-014 to treat hyperphosphatemia |
None |
| 2011-12-05 |
CTI seeks license to market Pixuvri in the E.U. for treatment of NHL |
None |
| 2011-12-05 |
Bromide shows promise against SCN1A-associated Dravet syndrome with intractable seizures |
None |
| 2011-12-03 |
Latin American, Caribbean national rotavirus immunization campaigns show success, CDC report says |
None |
| 2011-12-03 |
FDA approves Mylan's Tranexamic Acid Injection ANDA |
None |
| 2011-12-03 |
MK 1775 shows promise against sarcomas |
None |
| 2011-12-02 |
Mylan's NDA for Atazanavir Sulfate and Ritonavir Tablets receives tentative FDA approval through PEPFAR |
None |
| 2011-12-02 |
Assembly Bill 5502-B would raise cost of many prescriptions in NY by 10% |
1 |
| 2011-12-02 |
New insight into why aminoglycoside antibiotics cause deafness |
None |
| 2011-12-02 |
U.S. Marshals seize all Syntec's dietary supplements for false claims |
None |
| 2011-12-02 |
The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications |
None |
| 2011-12-02 |
Mylan confirms generic Generess Fe patent challenge |
None |
| 2011-12-01 |
EGCG may prevent HCV reinfection after liver transplantation |
None |
| 2011-12-01 |
Government inspectors to lawmakers: More must be done to stop prescription of powerful psych drugs to nursing home patients |
None |
| 2011-12-01 |
Botulism toxins could be re-engineered for treating RA, asthma, psoriasis |
None |
| 2011-12-01 |
Lipitor going generic, Pfizer making deals to keep consumers |
None |
| 2011-12-01 |
Treatment cost savings under PEPFAR can be re-invested to increase ARV reach |
None |
| 2011-12-01 |
Taking sleep medication or drinking alcohol does not benefit people with insomnia |
None |
| 2011-12-01 |
Santaris Pharma wins two LNA patent re-examination cases in the U.S. |
None |
| 2011-12-01 |
Harvard SEAS, BASF to co-host symposium on pharmaceutical nanoformulations |
None |
| 2011-12-01 |
Ranbaxy receives FDA approval to manufacture and market generic Lipitor |
None |
| 2011-12-01 |
Neuropharmacology to publish Nutra Pharma's Alpha-Cobratoxin mechanism study on chronic pain |
None |
| 2011-12-01 |
Ranbaxy and Teva announce generic Lipitor agreement |
3 |
| 2011-12-01 |
Oral ingestion of apple polyphenols can prevent colitis in mice |
5 |
| 2011-11-30 |
Watson commences shipping of generic LIPITOR |
None |
| 2011-11-30 |
One-time injection after spinal cord injury can limit pain for 8 months |
None |
| 2011-11-30 |
Ranbaxy receives FDA approval for first generic version of cholesterol-lowering drug Lipitor |
None |
| 2011-11-30 |
Pfizer backs its highest grosser Lipitor |
None |
| 2011-11-30 |
Dramatic nationwide rise in opioid use for chronic abdominal pain |
None |
| 2011-11-30 |
Groups push for legislation to encourage Medicaid programs to use generic drugs |
None |
| 2011-11-30 |
Lapatinib could extend survival in women with Her2-positive breast cancer |
None |
| 2011-11-30 |
Associated Press examines Chinese vaccine makers' entry into international market |
None |
| 2011-11-30 |
Legalization of medical marijuana reduces traffic fatalities, alcohol consumption |
None |
| 2011-11-30 |
DNA gyrase B could rapidly eliminate TB, shorten treatment time |
None |
| 2011-11-29 |
FDA approves Watson's ANDA for generic Yaz oral contraceptive |
None |
| 2011-11-29 |
FDA assigns priority-review designation for ELIQUIS NDA for stroke prevention in atrial fibrillation |
None |
| 2011-11-29 |
EC extends therapeutic indication for Soliris to treat atypical hemolytic uremic syndrome |
None |
| 2011-11-29 |
UIC recruiting volunteers for study on effectiveness of vitamin D in addition to asthma medication |
None |
| 2011-11-29 |
Avita Medical announces acquisition of intellectual property from McComb Foundation |
None |
| 2011-11-29 |
HealthWarehouse.com launches pre-order program for generic Lipitor |
None |
| 2011-11-29 |
Ferrer introduces citicoline oral solution medical food |
None |
| 2011-11-29 |
Seizure drug slows spread of uveal melanoma |
None |
| 2011-11-29 |
Combination of other opioids with methadone therapy can lead to overdose or fatal consequences |
None |
| 2011-11-28 |
FDA approves Mylan's generic Dexrazoxane for Injection ANDA |
None |
| 2011-11-28 |
European Commission approves ONGLYZA as combination therapy with insulin for type 2 diabetes |
None |
| 2011-11-28 |
FDA grants Perrigo final approval for Guaifenesin Extended-Release Tablets ANDA |
None |
| 2011-11-28 |
New creative uses of DNA 'barcoding' |
None |
| 2011-11-27 |
Drug for midnight waking gets FDA approval |
None |
| 2011-11-25 |
Moleac launches NurAiD II in France and Belgium |
5 |
| 2011-11-24 |
Just a few drugs responsible for majority of emergency hospitalizations |
None |
| 2011-11-24 |
Acetaminophen over-use can lead to serious liver damage |
None |
| 2011-11-24 |
Merck agrees to pay $950 million in Vioxx settlement |
None |
| 2011-11-24 |
Obama should announce scale-up of AIDS treatment programs |
None |
| 2011-11-24 |
Study looks at effects of antipsychotic drugs on two brain receptors linked to schizophrenia |
None |
| 2011-11-24 |
Five ways pharmaceutical companies can address NTDs |
None |
| 2011-11-24 |
Combination of radiation treatment and LY2109761 can prevent glioblastoma |
None |
| 2011-11-24 |
Anesthesia drug shortages can have devastating impact on patient care |
None |
| 2011-11-24 |
Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes |
None |
| 2011-11-24 |
Two-drug combination may alleviate radiation sickness in people |
None |
| 2011-11-24 |
Metformin prevents growth of breast cancer cells in human cultures |
None |
| 2011-11-24 |
Bloomberg examines Trans-Pacific Partnership trade initiative and potential impact to U.S. global efforts to tackle HIV |
None |
| 2011-11-24 |
FDA takes legal action against dietary supplement manufacturer in Pennsylvania |
None |
| 2011-11-23 |
Advaxis completes ADXS-HER2 pre-IND meeting with FDA |
None |
| 2011-11-23 |
Transcept receives FDA approval for Intermezzo to treat insomnia |
None |
| 2011-11-23 |
Cancer medicine component could prevent heart attacks |
None |
| 2011-11-23 |
University of Rochester receives U.S. patent for HPV vaccine research |
None |
| 2011-11-23 |
Study reveals principal mechanism of action for paracetamol |
4 |
| 2011-11-23 |
Medicare to cover infusion costs for prostate cancer vaccine, company says |
None |
| 2011-11-23 |
Families with chronically ill member less likely to benefit from employer-sponsored insurance |
None |
| 2011-11-23 |
USPTO issues patent to BioFactura's StableFast platform |
None |
| 2011-11-23 |
L-tyrosine could help treat Nemaline Myopathy in children |
None |
| 2011-11-23 |
Oral antibiotics might treat Buruli ulcer |
None |
| 2011-11-22 |
FDA accepts Regeneron's ARCALYST sBLA for review |
None |
| 2011-11-22 |
Naltrexone for problem gamblers |
None |
| 2011-11-22 |
Merck agrees to pay $950 million in Vioxx safety probe |
None |
| 2011-11-22 |
Essence Healthcare, CompCare sign new multi-service agreement |
None |
| 2011-11-22 |
Eating fish before age of nine months reduces risk of pre-school wheeze in children |
None |
| 2011-11-22 |
New way to exploit expression of BRAF by papillary carcinomas for therapeutic purposes |
None |
| 2011-11-22 |
Medicare will still cover Avastin for breast cancer, despite revocation of FDA approval |
None |
| 2011-11-22 |
Decanoic acid can modulate glucose control |
None |
| 2011-11-22 |
FDA accepts Otsuka's aripiprazole depot formulation NDA for review |
None |
| 2011-11-22 |
New way to enhance effects of anandamide in the body |
None |
| 2011-11-22 |
'WHPA Prague Call to Action' fights against falsified medicines |
None |
| 2011-11-22 |
Researchers identify EGFR protein as therapeutic target for Cushing disease |
None |
| 2011-11-22 |
Oral delivery of PYY hormone can help obese people lose weight |
4 |
| 2011-11-22 |
Older home health care patients are prescribed PIMs three times higher than others |
None |
| 2011-11-21 |
Cisplatin anti-cancer drug binds pervasively to RNA |
None |
| 2011-11-21 |
USPTO to issue patent for CU's DCA to treat cancer |
None |
| 2011-11-21 |
Regeneron’s Eylea for treating age related macular degeneration gets FDA nod |
5 |
| 2011-11-21 |
Breast cancer drug Avastin loses FDA support |
None |
| 2011-11-21 |
Despite market constraints, the drug market for key hospital-treated infections will increase: Report |
None |
| 2011-11-21 |
Viewpoints: Finding savings in Medicare; The Avastin saga; Changes in health care business |
None |
| 2011-11-21 |
The Chinese acute coronary syndrome drug market to grow from $326M in 2010 to $448M in 2015 |
None |
| 2011-11-21 |
ChanRx to evaluate AFIB drug, vanoxerine with closed Series A funding |
None |
| 2011-11-21 |
SAFC commences process validation activities for Oncolytics' REOLYSIN |
None |
| 2011-11-21 |
Australia's TGA grants market authorisation for Pierre Fabre Médicament's milnacipran to treat fibromyalgia |
None |
| 2011-11-21 |
PLoS ONE publishes study on darinaparsin, a multivalent chemotherapeutic |
4 |
| 2011-11-21 |
Impax initiates patent challenge related to Fentora |
None |
| 2011-11-21 |
IGI develops and submits two more ANDAs to the FDA |
None |
| 2011-11-21 |
Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes |
None |
| 2011-11-21 |
Cambridge Theranostics' liquidators set deadline for offers |
None |
| 2011-11-21 |
Mylan settles Vivelle-Dot patent litigation lawsuit with Novartis |
None |
| 2011-11-21 |
ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement |
None |
| 2011-11-21 |
ICON selected as CRO for Tasly's Dantonic pill global Phase III studies for chronic stable angina pectoris |
None |
| 2011-11-21 |
Almac collaborates with Alexion for packaging and distribution of Soliris during German E. coli outbreak |
None |
| 2011-11-21 |
Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea |
None |
| 2011-11-19 |
Switching or adding antidepressants does not exacerbate side effects |
None |
| 2011-11-19 |
Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy |
3.3 |
| 2011-11-19 |
New class of malaria drugs could be used as both prevention, treatment, study shows |
None |
| 2011-11-19 |
Avastin drug not safe and effective for breast cancer patients: FDA Commissioner |
None |
| 2011-11-19 |
FDA approves EUSA's orphan drug ERWINAZE for acute lymphoblastic leukemia |
None |
| 2011-11-19 |
Shire, Shionogi enter agreement to co-develop and co-commercialize ADHD medicines in Japan |
None |
| 2011-11-19 |
FAMEDS founder condemns FDA decision on Avastin for metastatic breast cancer |
None |
| 2011-11-19 |
FDA revokes approval of Avastin for breast cancer |
None |
| 2011-11-19 |
FDA approves EYLEA for treatment of wet Age-related Macular Degeneration |
None |
| 2011-11-18 |
Kremers Urban to resolve Lipitor litigation |
None |
| 2011-11-18 |
Regeneron receives FDA approval for Eylea to treat wet AMD |
None |
| 2011-11-18 |
EUSA Pharma receives FDA approval for Erwinaze to treat ALL |
None |
| 2011-11-18 |
H2S plays a major role in protecting bacteria from effects of different antibiotics |
None |
| 2011-11-18 |
Multi-drug resistant bacteria widespread in Europe, report says |
None |
| 2011-11-18 |
VSL#3 classified as refrigerated medical food for three GI conditions |
5 |
| 2011-11-18 |
IDSA supports 'Get Smart About Antibiotics Week' |
None |
| 2011-11-18 |
South African public health experts urge countries to use TRIPS to produce generic drugs, IPS reports |
None |
| 2011-11-18 |
Norway to focus on unnecessary use of antibiotics for asymptomatic UTI |
None |
| 2011-11-18 |
Two RegeneRx cardiac-related patents receive notice of allowance in Australia, Mexico |
None |
| 2011-11-18 |
Chloroquine-chemotherapy combination holds potential for metastatic breast cancer treatment |
None |
| 2011-11-17 |
Scientists discover family of chemical compounds that could prevent malaria |
None |
| 2011-11-17 |
EC approves Pfizer's Vyndaqel to treat Transthyretin Familial Amyloid Polyneuropathy |
None |
| 2011-11-17 |
Psychiatric medication use soaring among women: Report |
None |
| 2011-11-17 |
Tripling clopidogrel dosage improves platelet reactivity in cardiac patients |
None |
| 2011-11-17 |
Kentucky Circuit Court rules in favor of Watson in drug pricing litigation |
None |
| 2011-11-17 |
20% of U.S. adults take psychiatric drugs |
None |
| 2011-11-17 |
New treatment may be on the horizon for neuroendocrine prostate cancers |
None |
| 2011-11-17 |
Probiotic before radiation therapy can protect intestine from damage |
5 |
| 2011-11-17 |
Male breast cancer patients report tamoxifen side effects |
None |
| 2011-11-17 |
TNF inhibitors may minimally increase risk of serious infections |
None |
| 2011-11-17 |
WSU researchers to study novel antibiotic that may treat VRE infection |
None |
| 2011-11-17 |
Mannosides show promise against urinary tract infections |
5 |
| 2011-11-17 |
Multivitamin use linked to less healthy behaviors |
1 |
| 2011-11-17 |
Malawi government addressing drug, medical supply shortages in wake of aid withdrawals |
None |
| 2011-11-17 |
People with prior stroke or diabetes benefit from thrombolytic therapy |
None |
| 2011-11-17 |
Dipyrone may reduce brain damage after stroke |
None |
| 2011-11-17 |
Incyte receives FDA approval for Jakafi to treat intermediate or high-risk MF |
None |
| 2011-11-16 |
Excessive vitamin D levels can lead to onset of AF |
None |
| 2011-11-16 |
Mirna reports new preclinical data of miRNA-based therapeutic candidate for hepatocellular carcinoma |
None |
| 2011-11-16 |
Cholesterol drugs clash head on |
None |
| 2011-11-16 |
Geron bows out of stem cell research |
None |
| 2011-11-16 |
Atherosclerotic plaques spread downstream in coronary arteries |
None |
| 2011-11-16 |
ZIOPHARM announces new preclinical data from two darinaparsin studies on solid tumors |
None |
| 2011-11-16 |
Amgen receives EC approval to extend therapeutic indications for Vectibix |
None |
| 2011-11-16 |
Advaxis licenses ISG15 tumor antigen from University of Pennsylvania |
None |
| 2011-11-16 |
Niacin not effective in reducing risk of stroke, heart attack in stable CV patients |
None |
| 2011-11-16 |
Combination of antipsychotic and antidepressant drugs may increase risk of CV mortality |
None |
| 2011-11-16 |
International consortium develops first-in-class adiponectin receptor agonist |
None |
| 2011-11-16 |
Evacetrapib drug may increase HDL-C and decrease LDL-C levels |
None |
| 2011-11-16 |
Changing priorities for major generic drug producers could lead to rising drug prices in developing countries |
None |
| 2011-11-16 |
Silibinin stops spread of lung cancer in mice |
None |
| 2011-11-15 |
EPO-secreting engineered vessels could reverse anemia |
None |
| 2011-11-15 |
Pneumococcal vaccine Prevnar13 effective in seniors |
None |
| 2011-11-15 |
Xarelto (rivaroxaban) shows success as blood thinner in acute coronary syndrome |
None |
| 2011-11-15 |
Moberg Derma receives Vinnova grant to develop Limtop for actinic keratosis, genital warts |
None |
| 2011-11-15 |
Scil Proteins completes manufacturing agreement with Lundbeck |
None |
| 2011-11-15 |
Long-term AED therapy may increase risk of atherosclerosis in epilepsy patients |
None |
| 2011-11-15 |
Tigecycline antibiotic shows promise against leukemia |
4.7 |
| 2011-11-15 |
Eliminating drug co-pays improves medication adherence in heart attack patients |
None |
| 2011-11-15 |
CDC launches new antibiotic tracking system |
None |
| 2011-11-15 |
Experts discuss treatment as prevention at USAID-, World Bank-sponsored debate |
None |
| 2011-11-15 |
Multiple medication use may increase severity of erectile dysfunction |
None |
| 2011-11-15 |
PROMETAT no more effective than placebo in reducing methamphetamine use |
None |
| 2011-11-15 |
New technology speeds up 'near real-time' vaccination data collection |
None |
| 2011-11-15 |
Scientists discover promising approaches for treatment of pain |
None |
| 2011-11-14 |
Yissum Research and other investors complete additional investment round of $3 million in Avraham Pharmaceuticals |
None |
| 2011-11-14 |
Stem cell bandage human clinical trial for torn meniscal cartilage |
None |
| 2011-11-14 |
Cancer drug joins list of medicines in short supply |
None |
| 2011-11-14 |
BIDMC researcher says improvement in survival rates best 'since introduction of aspirin' |
None |
| 2011-11-14 |
Dyax and Defiante decide to withdraw KALBITOR MAA filed with EMA |
None |
| 2011-11-14 |
FDA approves Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL |
None |
| 2011-11-14 |
Scientists discover molecular basis for tamoxifen resistance and potential way to defeat it |
None |
| 2011-11-14 |
Scientists create new phenotypic cancer drug screening platform |
None |
| 2011-11-14 |
Next-generation drugs may prevent skin lesions in BRAF mutation-positive melanoma |
None |
| 2011-11-14 |
ZIOPHARM announces darinaparsin preclinical data on prostate cancer |
None |
| 2011-11-14 |
Combination of REGN910 and aflibercept inhibits tumor angiogenesis in animal models |
None |
| 2011-11-14 |
Researchers show how ER-positive breast cancer tumors become resistant to tamoxifen |
None |
| 2011-11-14 |
Low levels of vitamin C associated with worse outcomes for heart failure patients |
None |
| 2011-11-13 |
Older patients less likely to receive pain medication in hospital EDs |
None |
| 2011-11-13 |
IVI receives WHO prequalification for new oral cholera vaccine |
None |
| 2011-11-13 |
Opioid-dependent patients have worse outcomes before knee replacement surgery |
None |
| 2011-11-13 |
Brazilian Ministry of Health, Bristol-Myers Squibb sign technology transfer agreement for Reyataz |
None |
| 2011-11-13 |
NICE refuses AstraZeneca breast cancer drug on NHS |
None |
| 2011-11-11 |
Inflammatory arthritis or autoimmune disease ruled out as cause for joint pain associated with AIs |
None |
| 2011-11-11 |
Actavis begins shipping Morphine Sulfate Extended-Release Capsules |
None |
| 2011-11-11 |
Vaccination dramatically reduces incidence of Hib disease in young children |
None |
| 2011-11-11 |
Worm model to evaluate drugs for Parkinson's disease |
None |
| 2011-11-11 |
New process allows for more rapid and cheaper separation of enantiomers |
None |
| 2011-11-11 |
Pharmaceutical industry should invest more in NTDs |
4 |
| 2011-11-11 |
N-acetylcysteine plus cortisone shows promise against acute alcoholic hepatitis |
None |
| 2011-11-11 |
Watson receives FDA approval for generic Kadian ANDA |
None |
| 2011-11-11 |
Intelligent Fingerprinting launches prototype of hand-held drug testing device |
None |
| 2011-11-11 |
Novartis files suit against Watson over generic Exelon |
None |
| 2011-11-10 |
CCCBD scientist to receive 2011 V Foundation Translational Research Grant |
None |
| 2011-11-10 |
Mylan acquires rights to Pfizer's inhalation technology platform |
None |
| 2011-11-10 |
HFHP now able to offer two stand-alone prescription drug plans statewide |
None |
| 2011-11-10 |
APS supports CDC's call for multifaceted approach to address prescription drug misuse |
None |
| 2011-11-10 |
Aristolochic acid leads to kidney failure, upper urinary tract cancer |
None |
| 2011-11-10 |
Merck's NEXPLANON 68 mg now available in the U.S. |
1 |
| 2011-11-10 |
Study: Omega-3 supplements can decrease inflammation, anxiety |
None |
| 2011-11-10 |
PCMD researcher receives Alzheimer's Association grant to study dementia |
None |
| 2011-11-10 |
Patients with Parkinson's may have increased risk of leg motor restlessness |
None |
| 2011-11-10 |
New epigenetic therapy may treat recurrent metastatic NSCLC |
None |
| 2011-11-09 |
Another tool to fight pharmacy crime through Twitter |
None |
| 2011-11-09 |
Study reveals need for defining optimal amount of iron in infant formula |
None |
| 2011-11-09 |
Salix third quarter total product revenue increases 81% to $146.2 million |
None |
| 2011-11-09 |
Viagra may improve antitumor immunity in people with melanoma |
None |
| 2011-11-09 |
Amylin and Lilly terminate exenatide alliance, resolve litigation |
None |
| 2011-11-09 |
FDA accepts Genentech's vismodegib NDA for review |
None |
| 2011-11-09 |
QRxPharma receives FDA written acceptance for review of MoxDuo IR NDA |
None |
| 2011-11-09 |
Micell announces preliminary data from MiStent Sirolimus DES clinical study |
None |
| 2011-11-09 |
BioSpecifics reports $0.3M net income for third quarter 2011 vs. $0.5M net loss for third quarter 2010 |
None |
| 2011-11-08 |
Lapatinib drug could also treat head and neck cancers |
None |
| 2011-11-08 |
FDA grants Fast Track designation to Opexa's Tovaxin for treatment of SPMS |
None |
| 2011-11-08 |
UM launches campaign on medication adherence in Baltimore |
None |
| 2011-11-08 |
QRxPharma receives date for US pain drug launch, pending approval |
None |
| 2011-11-08 |
Congress examines options to improve availability of prescription drugs |
None |
| 2011-11-08 |
Children's Hospital project to investigate effectiveness of BET antagonists against HIV |
None |
| 2011-11-08 |
Live virus used in polio vaccine can evolve and infect, warns TAU researcher |
None |
| 2011-11-08 |
Georgia Tech/CDC project focuses on microneedle patches for polio vaccination |
5 |
| 2011-11-08 |
Link between heavy methamphetamine use and schizophrenia |
None |
| 2011-11-08 |
Bristol-Myers Squibb receives FDA approval for Erbitux to treat head and neck cancer |
5 |
| 2011-11-07 |
A prescription for prevention |
None |
| 2011-11-07 |
DSM and Svelte Medical Systems enter into license and supply agreement |
None |
| 2011-11-07 |
Perrigo and Synthon commence shipping generic Xyzal Oral Solution |
None |
| 2011-11-07 |
Prostate cancer drug market forecast to grow from $3.6 billion in 2010 to $10.1 billion in 2020 |
None |
| 2011-11-07 |
DuoCort Pharma granted marketing authorization for adrenal insufficiency drug, Plenadren in Europe |
None |
| 2011-11-07 |
MILV subsidiary acquires formula to restore proper kidney function |
None |
| 2011-11-07 |
Study: Young adults in the north west of England consume illegal drugs after mephedrone ban |
None |
| 2011-11-07 |
Scientists achieve major step toward goal of producing synthetic Taxol |
None |
| 2011-11-07 |
Study evaluates JIA disease activity after treatment with etanercept |
None |
| 2011-11-07 |
PKM2 enzyme has important non-metabolic functions in cancer formation |
None |
| 2011-11-07 |
Narcotic analgesics increase risk of falls and fractures among elderly |
None |
| 2011-11-07 |
Anti-TNFs, methotrexate may reduce risk of cardiovascular disease in people with RA |
None |
| 2011-11-07 |
Biologics reduce fatigue in people with RA |
None |
| 2011-11-07 |
IFNa-kinoid shows promise against lupus |
None |
| 2011-11-07 |
Link between use of anti-TNF therapy and malignant melanoma in RA patients |
None |
| 2011-11-06 |
Doctors may stop anti-TNF medications for RA patients before surgery to reduce disease flares |
None |
| 2011-11-05 |
Supplemental dose of pneumonia vaccine recommended for age-eligible patients |
None |
| 2011-11-05 |
APF launches new online educational module on safe use of CAM |
None |
| 2011-11-05 |
Octapharma receives FDA approval for octagam to treat disorders of immune system |
None |
| 2011-11-05 |
Janssen receives FDA approval for Xarelto to prevent stroke in people with AF |
None |
| 2011-11-04 |
Vitamin D levels not related to acute exacerbations of chronic obstructive pulmonary disease |
None |
| 2011-11-04 |
Baxter launches NUMETA emulsion for infusion in Europe |
None |
| 2011-11-04 |
Kenyan company receives WHO prequalification for generic ARV |
None |
| 2011-11-04 |
Avoiding sun may increase risk of vitamin D deficiency in light-skinned people |
None |
| 2011-11-04 |
Financial investment, progress in HIV/AIDS treatment must be protected by international patent law |
None |
| 2011-11-04 |
Cancer drug shortage relates to economics |
None |
| 2011-11-04 |
Glaxo pays $3 billion to settle investigations involving alleged marketing missteps and Medicaid fraud |
None |
| 2011-11-04 |
Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking' |
None |
| 2011-11-04 |
Amphetamine use in adolescence can affect brain chemistry and behaviour |
None |
| 2011-11-04 |
TPI announces formulation expansion program for GMOL |
None |
| 2011-11-04 |
Escitalopram reduces pain severity, interference in opioid-dependent patients |
None |
| 2011-11-04 |
FDA accepts VIVUS' Qnexa NDA for filing and review |
None |
| 2011-11-04 |
Bristol-Myers Squibb, ASLAN partner to develop BMS-777607 for solid tumors |
None |
| 2011-11-04 |
A prescription for prevention |
None |
| 2011-11-03 |
Merck’s cholesterol lowering drug gets FDA panel’s vote |
None |
| 2011-11-03 |
Savient third quarter net loss decreases to $27.4 million |
None |
| 2011-11-03 |
POZEN third quarter revenue increases to $4.9 million |
None |
| 2011-11-03 |
CMS issues J-code for Savient's KRYSTEXXA |
None |
| 2011-11-03 |
FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD |
None |
| 2011-11-03 |
EBV vaccine could prevent mononucleosis and cancers linked to virus |
4 |
| 2011-11-03 |
Exendin-4 drug could prevent later development of diabetes in children |
5 |
| 2011-11-03 |
Synthetic artemisinin discovery could make malaria treatments more affordable, accessible |
None |
| 2011-11-03 |
Benefits of combined therapy for men with high-risk prostate cancer |
None |
| 2011-11-03 |
Exenatide's rapid anti-inflammatory effect may inhibit atherosclerosis |
None |
| 2011-11-03 |
Researchers use diabetes drug to permanently reprogram insulin-producing cells |
None |
| 2011-11-03 |
Allergy shots are cost-effective and deliver relief in weeks |
None |
| 2011-11-03 |
Promedior's Pentraxin-2 effectively suppresses liver fibrosis |
None |
| 2011-11-03 |
UC Merced professor designs powerful chemical inhibitor against HIV |
None |
| 2011-11-03 |
Nicotine might prime the brain to enhance behavioral effects of cocaine |
None |
| 2011-11-03 |
Many spinal fusion surgery patients have low levels of vitamin D |
None |
| 2011-11-03 |
FDA approves Endo Pharmaceuticals' Felodipine Extended-release Tablets |
None |
| 2011-11-02 |
ADHD drugs don’t raise risk for heart attacks or stroke: Study |
None |
| 2011-11-02 |
Americans overdosing on prescription pain killers |
None |
| 2011-11-02 |
Prescription drug shortages: Endocrine Society calls for mandatory reporting by manufacturers |
4 |
| 2011-11-02 |
Scientists identify distinct tobacco transporter for nicotine metabolism |
None |
| 2011-11-02 |
Researchers identify small-molecule drug candidates for many metabolic conditions |
None |
| 2011-11-02 |
Obama takes action to address drug shortages |
None |
| 2011-11-02 |
Prostate cancer patients with bone metastases benefit from repeated 188Re-HEDP therapy |
None |
| 2011-11-02 |
ADHD medications do not increase risk of heart attack in children, young adults |
None |
| 2011-11-02 |
Birth control shot may impair a person's memory |
None |
| 2011-11-02 |
No link between anti-clotting drugs and increased risk of bleeding in GI procedure |
None |
| 2011-11-02 |
SurModics to sell Pharma assets to Evonik for $30 million |
None |
| 2011-11-02 |
SmartTots sets agenda for research on anesthetic safety in children |
None |
| 2011-11-02 |
High dose of vitamin D3 safe and effective for obese adolescents |
None |
| 2011-11-02 |
Takeda receives FDA approval for VELCADE sNDA to treat MM |
None |
| 2011-11-02 |
Glyphosine can prevent development of type 1 diabetes |
None |
| 2011-11-02 |
FDA approves Abbott's XIENCE PRIME Everolimus Eluting Coronary Stent System |
None |
| 2011-11-02 |
Perrigo's partner receives final approval for Epinastine HCl ophthalmic solution |
None |
| 2011-11-01 |
ProPhase Labs introduces new Cold-EEZE Oral Spray |
None |
| 2011-11-01 |
National lupus organizations urge NICE to recommend Benlysta for coverage |
None |
| 2011-11-01 |
Internet-based communication improves teenagers' use of topical acne therapy |
None |
| 2011-11-01 |
LA BioMed's lead investigator hopes to bring PAH awareness this November |
None |
| 2011-11-01 |
Potential role for UV light exposure, vitamin D levels in chronic digestive conditions |
None |
| 2011-11-01 |
Azantis introduces reduced glutathione and vitamin C liposomal products |
None |
| 2011-11-01 |
PerkinElmer launches new NexION ES Software for pharma companies |
None |
| 2011-10-31 |
Panel backs anthrax vaccine testing on children |
None |
| 2011-10-31 |
Cardinal Health launches Protexis Latex Blue surgical gloves with emollient coating |
None |
| 2011-10-31 |
J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain |
None |
| 2011-10-31 |
Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect |
None |
| 2011-10-31 |
New antibiotic regimes may increase infections after specific surgical procedures |
None |
| 2011-10-31 |
PPRT publishes study that evaluates pharmacist provision of clozapine |
None |
| 2011-10-31 |
GC-C agonists have potential to delay progression of colitis into colon cancer |
None |
| 2011-10-31 |
Pacira's third quarter total revenues decrease to $4.0 million |
None |
| 2011-10-31 |
Astex to present data on direct acting antiviral agents against HCV at 62nd AASLD meeting |
None |
| 2011-10-31 |
FDA approves Pacira's EXPAREL for postsurgical pain management |
None |
| 2011-10-31 |
BerGenBio commences preclinical development of BGB324 anti-cancer drug |
None |
| 2011-10-31 |
Hercules Pharma granted rights to license 22nd Century's X-22 smoking cessation aid |
None |
| 2011-10-31 |
Study examines link between hormonal forms of contraception and sexual functioning |
None |
| 2011-10-31 |
Neutralization approach appears to prevent proliferative vitreoretinopathy |
None |
| 2011-10-31 |
Renowned obstetrician receives March of Dimes 2011 Agnes Higgins award |
None |
| 2011-10-31 |
New library for development of targeted cancer drugs |
None |
| 2011-10-30 |
Oral hormonal contraceptives linked to blood clots: Study |
None |
| 2011-10-29 |
VUMC doctors to begin statin drug screening for rare genetic variation |
None |
| 2011-10-29 |
ZIOPHARM reports promising preclinical data with palifosfamide in pediatric sarcoma model |
None |
| 2011-10-29 |
NYUCN to study 'Test and Linkage to Care Among Injecting Drug Users Kenya' |
None |
| 2011-10-29 |
Massachusetts court awards injunction preventing Watson from selling Amphastar's generic LOVENOX |
None |
| 2011-10-29 |
White Smile Global introduces new at-home, foaming teeth whitening product |
None |
| 2011-10-29 |
MEDA files marketing authorization application for Dymista in Europe |
None |
| 2011-10-29 |
Preventive use of ACZ may reduce risk of severe high altitude illness |
None |
| 2011-10-29 |
EC approves Lilly's ALIMTA as continuation maintenance therapy for NSCLC |
None |
| 2011-10-29 |
New drug could combat cardiovascular disease |
None |
| 2011-10-28 |
New vaccine to eradicate meningitis |
None |
| 2011-10-28 |
GAVI Alliance brings life-saving pneumococcal vaccine to Nicaragua |
None |
| 2011-10-28 |
Researchers announce new method to build important heparin drug |
None |
| 2011-10-28 |
Swapping IV medications with oral equivalents may save millions |
None |
| 2011-10-28 |
Virtual platform for intellectual property sharing aims to speed development of drug treatments |
None |
| 2011-10-28 |
Fasudil drug shows promise against cerebral cavernous malformation |
None |
| 2011-10-28 |
RA drug reduces kidney cyst growth in ADPKD mouse model |
4 |
| 2011-10-28 |
Over-the-counter 'thyroid support' supplements could be dangerous |
None |
| 2011-10-28 |
Taking regular aspirin halves risk of hereditary cancers |
None |
| 2011-10-28 |
Enoxaparin can reduce risk of VTE in plastic surgery patients |
None |
| 2011-10-28 |
Gilead submits Quad NDA to FDA for treatment of HIV-1 infection |
None |
| 2011-10-27 |
HDM and SCT increase overall survival for patients with AL amyloidosis |
5 |
| 2011-10-27 |
Mylan receives final FDA approval for Morphine Sulfate ER Tablets ANDA |
None |
| 2011-10-27 |
Nanoparticles could help increase retention of osteoarthritis drugs in knee cavity |
None |
| 2011-10-27 |
EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13 |
None |
| 2011-10-27 |
E. coli asparaginase linked to relapses in ALL patients with special form of ATF5 gene |
None |
| 2011-10-27 |
Gilead, Bristol-Myers Squibb to develop and commercialize fixed-dose combination for HIV |
None |
| 2011-10-27 |
New potential leukemia therapy targets and kills cancer cells |
None |
| 2011-10-27 |
Clinical and genetic risk factors associated with early stent thrombosis |
None |
| 2011-10-27 |
Study: pGJA-P/VAX vaccine shows promise against dental caries |
None |
| 2011-10-27 |
FDA responds to Delcath's request for pre-NDA meeting |
None |
| 2011-10-27 |
WSU researcher to learn more about links between stress and drug use |
None |
| 2011-10-27 |
Medco, Pfizer and UBC collaborate to enhance precision medicine approach |
None |
| 2011-10-27 |
Taking the Pill for 10 years can reduce risk of ovarian cancer by almost half |
None |
| 2011-10-27 |
FDA approves INNOPHARMA's ANDA for olanzapine injection |
None |
| 2011-10-25 |
No link between Chantix and mental health problems says FDA |
None |
| 2011-10-24 |
Viewpoints: Health law curbs savings from OTC meds; Calif. wrestles with managing medical marijuana |
None |
| 2011-10-24 |
Scientists, WHO warn of public health implications of proposed mercury ban due to its use in vaccines |
None |
| 2011-10-24 |
Macular degeneration drug may cause increased IOP |
None |
| 2011-10-24 |
FDA's ODAC to review Affymax peginesatide NDA for treatment of CKD-associated anemia |
None |
| 2011-10-24 |
SafeMinds praises UNEP's draft treaty ban on use of mercury in pharma products |
None |
| 2011-10-24 |
Bioject receives FDA communication on use of jet injectors with flu vaccines |
None |
| 2011-10-24 |
Arrowhead acquires RNA therapeutics assets from Roche |
None |
| 2011-10-24 |
HealthWarehouse.com to provide prescription medications for WhiteGlove |
None |
| 2011-10-24 |
Encap Drug Delivery and Lena Nanoceutics to develop new drug delivery technology |
None |
| 2011-10-24 |
FDA accepts Ironwood and Forest Laboratories' linaclotide NDA for review |
None |
| 2011-10-24 |
Use of bath salts as recreational drugs has greatly escalated in recent years |
None |
| 2011-10-24 |
Potential deadly consequences of silicone injections |
None |
| 2011-10-24 |
Children with PAH may benefit from sildenafil treatment |
None |
| 2011-10-24 |
Playing video games may treat amblyopia in children |
5 |
| 2011-10-24 |
First step in the development of new drug combinations against diseases, conditions |
None |
| 2011-10-24 |
Genetically engineered clotting factor shows promise against hemophilia |
None |
| 2011-10-24 |
DFMO appears to protect against nonmelanoma skin cancers |
None |
| 2011-10-24 |
NSAID may lower risk of death from colorectal cancer among postmenopausal women |
None |
| 2011-10-22 |
Janssen announces FDA label update approval for PREZISTA HIV tablets |
None |
| 2011-10-22 |
Brazil to become world supplier of Chagas disease treatment |
None |
| 2011-10-22 |
Specific dopamine system gene variants linked to ADHD medication response in children |
None |
| 2011-10-22 |
VTT to develop next-generation vaccines against allergy |
None |
| 2011-10-22 |
Blood pressure-lowering medication appears to kick start brain recovery after stroke |
None |
| 2011-10-21 |
Participants invited for DHA-rich fish oil supplement study on mental performance |
None |
| 2011-10-21 |
Watson receives FDA approval for Androderm lower-dose formulations |
None |
| 2011-10-21 |
RSV medication from specialty pharmacies increases likelihood of children receiving recommended doses |
None |
| 2011-10-21 |
Pradaxa for stroke treatment results in higher costs |
None |
| 2011-10-21 |
NPR: The Abbott Lab breakup |
None |
| 2011-10-21 |
Preclinical data from Teva's COPAXONE study on multiple sclerosis |
None |
| 2011-10-21 |
The Guardian interviews GlaxoSmithKline lead researcher about new malaria vaccine |
None |
| 2011-10-21 |
Aid groups, health ministry plan to administer oral cholera vaccine to 100,000 Haitians |
None |
| 2011-10-21 |
No unique link between first-trimester ACE inhibitor use and birth defects |
None |
| 2011-10-21 |
Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show |
None |
| 2011-10-21 |
Gastroenterologist cautions against over-prescription of acid-suppressing drugs in infants |
None |
| 2011-10-21 |
Soy protein can help lower blood lipids in healthy individuals |
None |
| 2011-10-21 |
CERT gene silencing makes breast cancer cells more sensitive to drugs |
None |
| 2011-10-20 |
Byetta combination with insulin glargine gets FDA nod in type 2 diabetes |
None |
| 2011-10-20 |
Study: Women still have hot flushes/night sweats years after menopause |
None |
| 2011-10-20 |
Study examines potential benefits of discordant couple HIV therapy |
None |
| 2011-10-20 |
Three factors appear to correlate with mortality for a patient after surgery |
None |
| 2011-10-20 |
Tenofovir gel shows promise against HSV infection |
None |
| 2011-10-20 |
Ipsen, Syntaxin collaborate to develop new botulinum toxins |
None |
| 2011-10-20 |
Breakthrough in development of effective therapy against Hendra virus |
None |
| 2011-10-19 |
SAIC receives NIAID contract to develop biopharmaceutical products for infectious diseases |
None |
| 2011-10-19 |
Famy Care, Mylan resolve Femcon Fe Chewable Tablets litigation with Warner Chilcott |
None |
| 2011-10-19 |
Multimodal analgesia is used less than 25% of the time prior to surgery |
None |
| 2011-10-19 |
Medication therapy management in interprofessional heath care |
None |
| 2011-10-19 |
Research points to ineffective and incomplete drug education as factor in heroin initiation |
None |
| 2011-10-19 |
Study finds why corticosteroids do not work well for COPD patients |
None |
| 2011-10-19 |
Sam Houston State receives NIJ/FSF grant to investigate BKA designer drugs |
None |
| 2011-10-19 |
King's researchers create traditional Chinese medicine database |
None |
| 2011-10-19 |
JPO issues new patent for Genprex's lead lung cancer candidate |
None |
| 2011-10-18 |
Commercialization strategies for next-generation medicines |
None |
| 2011-10-18 |
HMS launches Initiative in Systems Pharmacology |
None |
| 2011-10-18 |
Older patients drive more safely after surgery and anesthesia care |
None |
| 2011-10-18 |
Hypertension drugs might reduce occurrence of Alzheimer's |
None |
| 2011-10-18 |
Obese children require much smaller doses of anesthetic propofol |
None |
| 2011-10-18 |
Accera identifies genetic profile of AD patients with heightened response to Axona |
None |
| 2011-10-18 |
AHRQ: Asthma drug usage among children doubles |
None |
| 2011-10-18 |
HSV1 drugs could slow progression of Alzheimer's disease |
5 |
| 2011-10-18 |
Nearly 30% of homes with young children have acetaminophen products stored unsafely |
None |
| 2011-10-18 |
VIVUS announces Qnexa NDA resubmission for treatment of obesity |
None |
| 2011-10-18 |
Inhaled anesthetics do not increase incidence of postoperative delirium |
None |
| 2011-10-15 |
MRI scans may become useful tools for assessing cholesterol drugs |
None |
| 2011-10-15 |
New onset tenderness after combo hormone therapy increases risk of breast cancer |
None |
| 2011-10-15 |
Achievement of pre-clinical milestone triggers $4M payment from GSK to Epizyme |
None |
| 2011-10-15 |
Watson confirms patent challenge of generic Daytrana |
None |
| 2011-10-15 |
Brain scans can evaluate new treatments for attention deficit disorder |
None |
| 2011-10-15 |
NextBio predicts mechanisms underlying drug toxicity and identifies new cancer biomarker |
None |
| 2011-10-15 |
ApoPharma receives FDA approval for Ferriprox to treat transfusional iron overload |
None |
| 2011-10-14 |
Penn scientist tracks attitudes and H1N1 vaccination rates on Twitter |
None |
| 2011-10-14 |
IRMS tracks course of designer 'legal high' drugs manufacture |
None |
| 2011-10-14 |
Scientists conclude pesticide contamination as a major problem in Europe |
2 |
| 2011-10-14 |
Survey analyses management of patients suffering from EGFRI toxicities |
None |
| 2011-10-14 |
Insight into how powerful anti-HIV antibody grabs hold of the virus |
None |
| 2011-10-14 |
Researchers control itch without dulling morphine's pain-killing effects |
None |
| 2011-10-14 |
Oncobiologics signs two major pharmaceutical agreements |
None |
| 2011-10-14 |
Cylene advances preclinical development of CX-5461 for treatment of cancer |
None |
| 2011-10-14 |
Noven claims patent infringement over Daytrana, files lawsuit against Watson |
None |
| 2011-10-14 |
New technique stimulates stem cells after liver transplant to prevent rejection |
None |
| 2011-10-13 |
UofL researchers to develop treatments for chlorine-induced lung injuries |
None |
| 2011-10-13 |
Simmons Center to evaluate CGEN-25009 for treatment of idiopathic pulmonary fibrosis |
None |
| 2011-10-13 |
USPTO issues patent to Rexahn's new anti-cancer arylisoquinolinamine compounds |
None |
| 2011-10-13 |
Estrogen may prevent strokes in premature or early menopausal women |
None |
| 2011-10-12 |
Counterfeit drugs risk lives, threaten pharmaceutical industry in India |
None |
| 2011-10-12 |
Study finds experimental vaccine protects monkeys from blinding trachoma |
None |
| 2011-10-12 |
NCCN Oncology Research Program wins two GSK grants |
None |
| 2011-10-12 |
India's Aurobindo Pharma first major generic drugmaker to Join UNITAID's Medicines Patent Pool |
None |
| 2011-10-12 |
Vitamin D plays an essential role in the body's fight against TB |
None |
| 2011-10-12 |
Roundup: Calif. insurer's Avastin decision; Kansas dental care; Gov. Brown vetoes nursing bill |
None |
| 2011-10-12 |
Study: Emerging pharmaceutical platform may produce undesirable effects on eye function |
None |
| 2011-10-12 |
PROLOR receives U.S. patent allowance for CTP-modified interferons |
None |
| 2011-10-12 |
FDA approves NDA for Edgemont's Fluoxetine 60 mg tablet |
None |
| 2011-10-11 |
NovaSterilis awarded patent for sterilization process for pharmaceutical API using supercritical carbon dioxide |
None |
| 2011-10-11 |
Vertex announces availability of INCIVEK to treat hepatitis C in Canada |
None |
| 2011-10-11 |
Aspirin desensitization procedure can benefit patients with sinusitis, asthma and AERD |
None |
| 2011-10-11 |
Diethylstilbestrol in utero affects immune system of the fetus |
None |
| 2011-10-11 |
96% Campaign asks Obama to 'pay attention to science' and scale up global access to ARVs |
None |
| 2011-10-11 |
Gantenerumab appears to reduce brain amyloid levels in patients with AD |
None |
| 2011-10-11 |
Dietary supplements may increase risk of mortality in older women |
None |
| 2011-10-11 |
Statins hold promise against traumatic brain injury |
None |
| 2011-10-11 |
Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men |
None |
| 2011-10-11 |
FDA clears Cardium's new Excellagen topical gel for diabetic foot ulcers |
5 |
| 2011-10-11 |
FDA to review Banner's Bexarotene ANDA for CTCL skin cancer treatment |
None |
| 2011-10-10 |
Merck’s diabetes combo pill gets FDA nod |
None |
| 2011-10-10 |
Cardium's Excellagen topical gel for diabetic foot ulcers receives FDA 510(k) clearance |
None |
| 2011-10-10 |
VGX International, Inovio partner to co-develop SynCon vaccines for hepatitis B and C infections |
None |
| 2011-10-10 |
Novo Nordisk introduces new disposable prefilled insulin pen |
None |
| 2011-10-10 |
Osteoporosis drug protects against bone damaging side effects of breast cancer medications |
None |
| 2011-10-10 |
Researchers examine effects of antirejection drugs in kidney transplant patients |
None |
| 2011-10-10 |
Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD |
None |
| 2011-10-10 |
Merck receives FDA approval for JUVISYNC to treat type 2 diabetes |
None |
| 2011-10-10 |
Caffeine may predict risk of drug abuse |
None |
| 2011-10-10 |
Experts take study on contraceptive use, HIV risk seriously but warn about drawing conclusions prematurely because of study's 'methodological weaknesses' |
None |
| 2011-10-09 |
FDA approves Lilly’s drug Cialis for prostate enlargement |
5 |
| 2011-10-07 |
First combination drug to treat type 2 diabetes and high cholesterol receives FDA approval |
None |
| 2011-10-07 |
MSF calls on Brazilian government to step up production of only drug for Chagas disease |
None |
| 2011-10-07 |
PEPFAR ART cost model data presented to PEPFAR Scientific Advisory Board |
None |
| 2011-10-07 |
CNBC.com examines counterfeit pharmaceuticals in special report |
None |
| 2011-10-07 |
Bedtime consumption of blood pressure medications improves control of hypertension |
2 |
| 2011-10-07 |
Calcium supplementation does not benefit pregnant women, except for hypertension |
None |
| 2011-10-07 |
House lawmaker looks into drug shortages, price markups |
None |
| 2011-10-07 |
Keeping HIV patients on ART will have long-term economic benefits, study shows |
None |
| 2011-10-07 |
Cannabidiol could prevent onset of pain associated with chemotherapy drugs |
None |
| 2011-10-07 |
Tips on how to prevent unnecessary medication/supplement mishaps |
None |
| 2011-10-07 |
Link between marijuana use and crash risk among drivers |
None |
| 2011-10-07 |
Eli Lilly receives FDA approval for Cialis to treat benign prostatic hyperplasia |
None |
| 2011-10-04 |
Blue Shield of California refuses to pay for breast cancer drug Avastin |
None |
| 2011-10-04 |
Merck wins fourth FOSAMAX trial |
None |
| 2011-10-04 |
Canada Supreme Court rules Vancouver's safe drug-injection site can stay open |
None |
| 2011-10-04 |
Quick injection of cortisone can prevent PTSD |
4 |
| 2011-10-04 |
TriLogic, Mission Pharmacal partner to develop new drug delivery system |
1 |
| 2011-10-04 |
Study: Fair-skinned people may need to take vitamin D supplements |
None |
| 2011-10-03 |
Novel drug shows promise for MLL leukemia |
1 |
| 2011-10-03 |
Adaptimmune announces new board appointments as clinical programmes get underway |
None |
| 2011-10-03 |
Drug shortages lead to rationing of critical medicines |
None |
| 2011-10-03 |
Emergent BioSolutions receives $1.25B contract to supply 44.75M doses of BioThrax |
None |
| 2011-10-03 |
New data on long-term use of antidepressant drugs |
4.5 |
| 2011-10-03 |
Health Canada approves Trajenta (linagliptin) for type 2 diabetes |
2 |
| 2011-10-03 |
General anesthesia linked to learning disabilities in children |
None |
| 2011-10-03 |
EMA accepts Inspiration's IB1001 MAA for treatment of hemophilia B |
None |
| 2011-10-03 |
FDA releases new PSA on safe medication use |
None |
| 2011-10-03 |
Marken introduces new global brand and advertising campaign |
None |
| 2011-10-02 |
Prostate cancer medicine deemed too-expensive by NHS |
2 |
| 2011-10-02 |
Multi-million pound fake medicine crackdown in the UK |
None |
| 2011-10-02 |
CSL pays heed to FDA observations on faulty manufacturing processes |
None |
| 2011-10-01 |
AHF protests J&J over AIDS drug prices |
None |
| 2011-10-01 |
Combination therapy improves outcomes for liver cancer patients: Study |
None |
| 2011-10-01 |
Public health officials should determine community storage of anthrax-preventing antibiotics |
None |
| 2011-10-01 |
Tips for seniors to avoid serious complications from prescription meds |
None |
| 2011-10-01 |
Walgreens, Walmart partner with Coventry to offer First Health Value Plus in the U.S. |
None |
| 2011-10-01 |
CorMedix to primarily focus on commercialization of Neutrolin in Europe |
None |
| 2011-10-01 |
ViroPharma licenses worldwide rights from Intellect Neurosciences to OX1 for treatment of FA |
5 |
| 2011-10-01 |
Blueberry powder may control triple negative breast cancer |
None |
| 2011-10-01 |
Express Scripts launches suite of services through HealthBridge Pharma & Biotech |
None |
| 2011-10-01 |
CMA welcomes Supreme Court ruling on Vancouver's supervised injection facility |
None |
| 2011-10-01 |
Poll: 21.4% of Americans believe vaccines can cause autism |
None |
| 2011-10-01 |
UCI study shows promise of metabolic therapy for autoimmune diseases |
None |
| 2011-10-01 |
Circadian subsidiary submits IND application to FDA to initiate VGX-100 study against cancer |
None |
| 2011-10-01 |
ADVENTRX holds Type A meeting with FDA to discuss Exelbine NDA |
None |
| 2011-09-30 |
Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer |
None |
| 2011-09-30 |
FDA, other regulatory and international partners complete International Internet Week of Action |
None |
| 2011-09-30 |
MU researchers examine use of propranolol to improve primary traits linked with autism |
None |
| 2011-09-30 |
Study highlights importance of prior planning before introduction of new vaccines |
None |
| 2011-09-30 |
Patients with chronic hepatitis C less likely to take medications over time |
None |
| 2011-09-30 |
APhA encourages patients to discuss with pharmacist about pain and medications |
None |
| 2011-09-30 |
Survey: 25% of employers have little or no understanding of specialty pharmacy, costs |
None |
| 2011-09-30 |
Resveratrol inhibits proliferation of hormone resistant breast cancer cells |
None |
| 2011-09-30 |
Cocaine use linked to increased risk of open-angle glaucoma |
None |
| 2011-09-30 |
Oral steroid users twice as likely to have severe vitamin D deficiency |
None |
| 2011-09-30 |
Invida, Sinclair IS launch two dermatology products in seven Asia-Pacific markets |
None |
| 2011-09-30 |
AstraZeneca settles SEROQUEL XR patent infringement litigation |
None |
| 2011-09-30 |
Beta-blockers can prevent breast cancer metastasis and improve survival |
None |
| 2011-09-29 |
Circadian files IND with FDA for VGX-100 for the treatment of cancer patients with solid tumors |
None |
| 2011-09-29 |
Bulgaria’s decades old anti-smoking pill could be a cheap and effective answer to smoking cessation |
5 |
| 2011-09-29 |
FDA CDER assigned for pre-market review of CorMedix's Neutrolin |
None |
| 2011-09-29 |
Almirall seeks European approval for linaclotide to treat irritable bowel syndrome with constipation |
None |
| 2011-09-29 |
Oral tenofovir discontinued in HIV clinical trial |
None |
| 2011-09-29 |
Public lecture on children's medicines to be launched on October 5 |
None |
| 2011-09-29 |
SIS becomes an Industry Supporter of ASA |
None |
| 2011-09-29 |
New report finds little evidence to support off-label use of atypical antipsychotics |
None |
| 2011-09-29 |
AASLD publishes updated practice guidelines on hepatitis C |
None |
| 2011-09-29 |
Prototype drug shows promise against chronic lymphocytic leukemia |
5 |
| 2011-09-29 |
Acetyl-L-carnitine likely to improve outcomes and recovery for individuals with SCI |
None |
| 2011-09-29 |
Johns Hopkins researchers discover oxaliplatin-based nerve damage |
None |
| 2011-09-28 |
Valeant's colesevelam New Drug Submission for hypercholesterolemia receives Canadian approval |
None |
| 2011-09-28 |
FDA: Study suggests increased risk of blood clots from drospirenone-containing contraceptives |
None |
| 2011-09-28 |
'Urgent action' needed to prevent resistance to antiretroviral therapy |
None |
| 2011-09-28 |
Americans cutting back on health spending by skipping prescriptions, procedures |
None |
| 2011-09-28 |
Postmenopausal HRT linked with increased risk of asthma hospitalisations in women |
None |
| 2011-09-28 |
UCI professor wins Presidential Early Career Award for Scientists & Engineers |
None |
| 2011-09-28 |
Stimulant prescription use for ADHD has increased steadily from 1996-2008 |
None |
| 2011-09-28 |
Transcept announces resubmission of NDA for Intermezzo to FDA |
None |
| 2011-09-28 |
Benefits and harms vary among atypical antipsychotics for off-label use |
None |
| 2011-09-28 |
DMARDs appear to be more effective for children with arthritis |
None |
| 2011-09-28 |
Asians struggling with alcoholism may benefit from naltrexone |
None |
| 2011-09-28 |
Study sheds light on when to start antiretroviral therapy |
None |
| 2011-09-27 |
Researchers hack genetic code that controls immune response to measles vaccination |
None |
| 2011-09-27 |
Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer |
None |
| 2011-09-27 |
MSU creates new malaria vaccine with immune-stimulating gene |
None |
| 2011-09-26 |
Link between changes in malaria parasite and absorption of pharmaceutical compounds |
None |
| 2011-09-26 |
New insights into actions of NSAIDs |
None |
| 2011-09-26 |
Vaxent, PREVENT sign license agreement to develop and commercialize Strep-A vaccine |
None |
| 2011-09-26 |
Isis files patent infringement lawsuit against Santaris for antisense drugs |
None |
| 2011-09-26 |
Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy |
None |
| 2011-09-26 |
No link between duration or depth of general anesthesia and subsequent cancer risk |
None |
| 2011-09-26 |
Self-reported mental health disability more prevalent among U.S. adults |
None |
| 2011-09-26 |
Sodium Stibogluconate & Paromomycin combination treatment for Kala azar |
1 |
| 2011-09-26 |
Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study |
None |
| 2011-09-26 |
Primatene inhalers to be phased out this December: FDA |
None |
| 2011-09-26 |
EMA CHMP adopts positive opinion for Optimer's DIFICLIR to treat C. difficile infection |
1 |
| 2011-09-26 |
CytoDyn files provisional patent application for humanized version of Cytolin to treat HIV |
None |
| 2011-09-26 |
Janssen Biotech receives FDA approval for Remicade to treat UC in children |
None |
| 2011-09-26 |
Alexion receives FDA approval for Soliris to treat atypical Hemolytic Uremic Syndrome |
None |
| 2011-09-23 |
EMA CHMP adopts positive opinion for Soliris to treat atypical hemolytic uremic syndrome |
None |
| 2011-09-23 |
Gilead announces EMA CHMP positive opinion for HIV-1 drug, Eviplera |
None |
| 2011-09-23 |
Drug shortages fuel increases in cost of care, poor outcomes |
None |
| 2011-09-23 |
FDA denies FOIA regarding Gilead Sciences' Truvada correspondence, AHF sues |
None |
| 2011-09-23 |
Bachmann, Perry wrestle over HPV issue |
None |
| 2011-09-23 |
Momenta, Sandoz file patent suit against Amphastar and Watson over Enoxaparin Sodium Injection |
None |
| 2011-09-23 |
Study identifies genetic mutations that affect immune response to measles vaccination |
None |
| 2011-09-23 |
IU professor to study factors influencing young women's adoption of HPV vaccine |
None |
| 2011-09-23 |
CoPlex, Hawthorn sign license agreement for hawAD14 Alzheimer's drug |
None |
| 2011-09-23 |
Adamis receives patents for APC-200 prostate cancer drug in South Africa, Singapore |
None |
| 2011-09-23 |
Shire announces update on approval status and availability of ProAmatine SOH drug |
None |
| 2011-09-23 |
Bortezomib drug may also treat pulmonary fibrosis or scleroderma |
None |
| 2011-09-23 |
Study: Opioid drugs can increase risk of pneumonia in older adults |
None |
| 2011-09-23 |
USPTO issues patent for Lixte's LB-100 to treat cancer |
None |
| 2011-09-22 |
Anti-obesity drug Contrave may get another chance to prove itself |
None |
| 2011-09-22 |
Jefferson experts review most commonly used CAM practices for mood disorders |
None |
| 2011-09-22 |
New portable test can quickly and economically detect adulterated heparin |
None |
| 2011-09-22 |
Early ART cost effectiveness in resource-poor settings |
None |
| 2011-09-22 |
Humour therapy as effective as antipsychotic drugs in managing agitation in dementia patients |
None |
| 2011-09-22 |
Cannabinoids may block development of PTSD symptoms after traumatic experience |
None |
| 2011-09-22 |
Methylphenidate drug may induce arousal from general anesthesia |
None |
| 2011-09-22 |
Early ART can be cost-effective and decrease mortality in HIV patients |
None |
| 2011-09-22 |
Digna Biotech receives FDA Orphan Drug status for cardiotrophin-1 to treat ALF |
None |
| 2011-09-22 |
Ariel Pharmaceuticals in-licenses AP-1531 from BTG for acute migraine attacks |
None |
| 2011-09-22 |
Hoffman La Roche, Mylan enter settlement and license agreement for XELODA Tablets |
None |
| 2011-09-22 |
Peptide receptor radiolabeled therapy shows promise against neuroendocrine tumors |
None |
| 2011-09-22 |
NIH to honor IGB faculty member with innovator award |
None |
| 2011-09-21 |
Combination of SRIs and cognitive behavior therapy reduces pediatric OCD symptoms |
None |
| 2011-09-21 |
Long-term immunosuppressants improve survival for lupus patients with ESKD |
None |
| 2011-09-21 |
Influential leaders hold high-level discussions on biomedical S&T initiatives |
None |
| 2011-09-21 |
New FDA-approved antiviral drugs offer treatment hope for hepatitis C |
None |
| 2011-09-21 |
St. Jude Medical pledges $100,000 to support SIR Foundation's Discovery Campaign |
None |
| 2011-09-21 |
UNC's new nanoparticle shows potential for cancer chemotherapy |
None |
| 2011-09-21 |
African-American men living in low sunlight areas more likely to have Vitamin D deficiency |
None |
| 2011-09-21 |
Matrix receives FDA's tentative approval for novel co-packaged version of HIV/AIDS therapy |
None |
| 2011-09-21 |
Beta-blocker drugs may improve survival time for melanoma patients |
None |
| 2011-09-20 |
Nuevolution announces collaboration in drug discovery with Boehringer Ingelheim |
None |
| 2011-09-20 |
Whooping cough vaccine may lose protective capacity in 3 years: Study |
None |
| 2011-09-20 |
Qualitest recalls birth control pills citing “packaging error” |
None |
| 2011-09-20 |
Regulatory bias against taking oral anti-cancer medications with food places patients at risk of overdose |
None |
| 2011-09-20 |
Medication non-adherence interventions should be based on personal systems approach |
None |
| 2011-09-20 |
Combination of lunasin and oxaliplatin prevents colon cancer from metastasis |
None |
| 2011-09-20 |
FoxM1 protein plays a critical role in development of medulloblastomas |
None |
| 2011-09-20 |
New UTHealth toll-free helpline for pregnant women to avoid dangerous medications |
None |
| 2011-09-20 |
Powerful new antibiotic treatment for MRSA and C. difficile bugs |
None |
| 2011-09-20 |
FDA approves Amphastar's ANDA for Enoxaparin Sodium Injection |
None |
| 2011-09-19 |
Revolution in drug discovery underway in West Midlands, UK |
None |
| 2011-09-19 |
Too many kids poisoned with prescription drugs: Study |
None |
| 2011-09-19 |
Amgen's Prolia receives FDA approval for new indications to treat cancer patients |
None |
| 2011-09-19 |
Amneal announces availability of generic antiepileptic drug, Felbamate |
None |
| 2011-09-19 |
Meda acquires exclusive licensing rights to Nalox from Moberg Derma |
None |
| 2011-09-19 |
Alkermes establishes business operations in Ireland |
None |
| 2011-09-19 |
Low-dose anticholinergic drugs do not appear to cause cognitive impairment in dementia patients |
None |
| 2011-09-19 |
USPTO issues notice of allowance to Cenestra Health's omega-3 fatty acid formulations |
None |
| 2011-09-19 |
Meda, Moberg Derma enter license agreement for Nalox to treat onychomycosis |
None |
| 2011-09-19 |
Safety tips to prevent unintentional pediatric medication poisonings |
None |
| 2011-09-19 |
Two newer Type 2 diabetes drugs could be linked to increased risk of pancreatic cancer |
None |
| 2011-09-17 |
Bioethicists up the ante in Bachmann's HPV brouhaha |
None |
| 2011-09-17 |
BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine |
None |
| 2011-09-16 |
Anti-nausea drug Zofran being tested for its potential heart rhythm side effects |
None |
| 2011-09-16 |
DryDiapersPlus joins Unique Wellness and BIOTX to provide incontinence products |
None |
| 2011-09-16 |
ONGLYZA used with insulin maintains improvement in glucose control in adults with type 2 diabetes |
None |
| 2011-09-16 |
HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin |
None |
| 2011-09-16 |
Researchers develop polymers that fluoresce in the presence of bacteria |
None |
| 2011-09-16 |
Karolinska Institutet professor earns 2011 ECNP Neuropsychopharmacology Award |
None |
| 2011-09-16 |
Study shows increase in pediatric medication poisoning |
None |
| 2011-09-16 |
Estrogen therapy can reverse progression of pulmonary hypertension |
None |
| 2011-09-16 |
New paper describes unique process that is central to induction of MSRA antibiotic resistance |
None |
| 2011-09-16 |
Teva to invest in CDI for development of novel antiviral drugs |
None |
| 2011-09-16 |
GSA's two forthcoming publications focus on pain relief and medication for seniors |
None |
| 2011-09-16 |
New study aims to reduce number of pediatric pharmaceutical poisoning |
None |
| 2011-09-16 |
Medicated stents lower likelihood of heart attacks in cardiac patients |
5 |
| 2011-09-15 |
Synthon announces European approvals for Eplerenone |
None |
| 2011-09-15 |
VBI Vaccines completes acquisition of Epixis |
None |
| 2011-09-15 |
Positive results from PROLOR Biotech's Factor VIIa-CTP preclinical study on hemophilia |
None |
| 2011-09-15 |
Pfizer awards 2011 fellowship to UH Case Medical Center for pain medicine and epilepsy |
None |
| 2011-09-15 |
JCPT publishes 'The Need for Increased Utilization of Statins After Occlusive Stroke' study |
None |
| 2011-09-15 |
CHK Nutrition, NeuroResearch Clinics sign consent to halt sale of unapproved amino-acid products |
4.5 |
| 2011-09-15 |
ODAC recommends ApoPharma's Ferriprox for FDA approval to treat transfusional iron overload |
None |
| 2011-09-15 |
Scientists report development of three new formulations against methamphetamine abuse |
None |
| 2011-09-15 |
UIC researchers to conduct study on televised drug commercials |
None |
| 2011-09-15 |
Viewpoints: Shredding Bachmann's vaccine argument; 'super' or 'stupor' committee; Bennet on outmoded drug safety rules |
None |
| 2011-09-15 |
Researchers discover several chemical compounds against human prion diseases |
5 |
| 2011-09-14 |
New Zealand biotechnology company moves to US |
None |
| 2011-09-14 |
Lucentis receives Health Canada approval to treat vision loss from DME |
None |
| 2011-09-14 |
Cohera's TissuGlu Surgical Adhesive receives CE Mark approval |
None |
| 2011-09-14 |
Celecoxib inhibits GSK3 enzyme in lung cancer cells |
None |
| 2011-09-14 |
Reminder packaging improves adherence to long-term hypertension medications |
None |
| 2011-09-14 |
FDA grants Orphan Drug Designation for Accentia's Revimmune to prevent GVHD |
None |
| 2011-09-14 |
Biotica, Buck Institute collaborate to investigate polyketides in diseases of aging |
None |
| 2011-09-14 |
Natural S-equol supplement does not increase risk of estrogen-sensitive breast cancer |
None |
| 2011-09-14 |
Merck issues statement on GARDASIL human papillomavirus vaccine |
None |
| 2011-09-14 |
Prescription drugs expensive in Australia and likely to increase |
None |
| 2011-09-14 |
Avedro acquires proprietary and patent pending transepithelial ParaCel riboflavin formulation |
None |
| 2011-09-14 |
Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children |
None |
| 2011-09-14 |
Kremers Urban reaches settlement agreement with ALZA over Concerta patent litigation |
None |
| 2011-09-13 |
FDA’s response to Tobacco company’s allegations on graphic cigarette labels |
None |
| 2011-09-13 |
Older drugs may be better than newly approved ones |
None |
| 2011-09-13 |
FDA announces organizational changes within CDER's Office of Oncology Drug Products |
None |
| 2011-09-13 |
New drug combination may treat two aggressive cancers |
4 |
| 2011-09-13 |
Researchers identify new type of potential anticancer drug |
None |
| 2011-09-13 |
Cardiotrophin 1 has marked effect on fat and glucose metabolism |
5 |
| 2011-09-13 |
Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's |
None |
| 2011-09-13 |
Impax confirms JALYN patent challenge |
3 |
| 2011-09-12 |
Micronutrient powder helps prevent malnutrition in children up to two years old, study review shows |
None |
| 2011-09-12 |
Lantus initiation may help limit weight gain in type 2 diabetes patients |
None |
| 2011-09-12 |
Low-dose aspirin increases risk for GI bleeding |
None |
| 2011-09-12 |
Health Canada approves Merus Labs' advanced wound care product, Collexa |
None |
| 2011-09-12 |
Genentech submits NDA to FDA for vismodegib to treat advanced basal cell carcinoma |
None |
| 2011-09-12 |
InterMune to launch Esbriet for German patients with IPF |
None |
| 2011-09-12 |
Genentech submits vismodegib NDA to FDA for treatment of advanced basal cell carcinoma |
None |
| 2011-09-12 |
Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy |
None |
| 2011-09-12 |
EpiCept announces FDA's feedback on Ceplene clinical development for AML |
None |
| 2011-09-12 |
FDA advisory panel suggests warning for bisphosphonates but does not specify wording |
None |
| 2011-09-12 |
Pew Health Group to ensure safety of U.S. drug supply |
None |
| 2011-09-12 |
General anesthesia can cause cognitive impairment in children |
None |
| 2011-09-12 |
Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy |
None |
| 2011-09-12 |
FDA grants orphan drug designation for Avedro's VibeX to treat Keratoconus |
None |
| 2011-09-12 |
PharmAthene completes 1,500 liter engineering production run for SparVax anthrax vaccine |
None |
| 2011-09-12 |
Candidate malaria vaccine represents 'potentially encouraging anti-malaria strategy,' researchers say |
None |
| 2011-09-12 |
Access to lifesaving generic medicines threatened by U.S. trade pact |
None |
| 2011-09-12 |
Study pinpoints relationship between primary brain tumors and onset of epileptic seizures |
None |
| 2011-09-09 |
FDA panel votes 9-2 in favor of new blood thinner drug |
None |
| 2011-09-09 |
HPV vaccination updates |
None |
| 2011-09-09 |
AstraZeneca Canada introduces new NEXIUM Patient Support program |
None |
| 2011-09-09 |
FDA grants final approval for Mylan's Promethazine HCl Tablets |
None |
| 2011-09-09 |
Astex selects PharmaVentures to assist in divesment of CMC & Formulation Facility |
None |
| 2011-09-09 |
SAMHSA survey finds increase in use of illicit drugs among Americans between 2008-2010 |
None |
| 2011-09-09 |
Elusys receives federal contract to develop prophylactic treatment against anthrax |
None |
| 2011-09-09 |
Possible link between mother's diet and risk of allergies in children |
None |
| 2011-09-08 |
Auxilium reports positive data from XIAFLEX retrospective commercial patient chart review |
None |
| 2011-09-08 |
Naturopathic medicine helps reduce doctors' use of prescription drugs |
None |
| 2011-09-08 |
EC grants orphan drug status for Santen's sirolimus to treat chronic non-infectious uveitis |
None |
| 2011-09-08 |
Researchers uncover new and safe contraceptive pill for women |
None |
| 2011-09-08 |
Scientists discover backup circuits in cetuximab-resistant cancer cells |
None |
| 2011-09-08 |
Inhibition of Sab protein protects liver from acetaminophen toxicity |
None |
| 2011-09-08 |
First-ever comprehensive study of species origins of nature-derived drugs |
None |
| 2011-09-08 |
Beta-glucans can help wounds to heal quickly |
5 |
| 2011-09-07 |
Researchers rethink fenretinide for prevention of oral cancer |
None |
| 2011-09-07 |
BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050 |
None |
| 2011-09-07 |
Cheap medicines could prevent huge number of deaths from heart attacks, strokes |
None |
| 2011-09-07 |
Genetically modified M. smegmatis vaccine shows promise against TB |
None |
| 2011-09-07 |
Use of nonaspirin NSAIDs during early pregnancy raises risk of miscarriage in women |
None |
| 2011-09-07 |
Drugs produced in offshore manufacturing plants more likely to have quality problems |
None |
| 2011-09-07 |
Oxycodone no safer than codeine for breastfed infants: New study |
None |
| 2011-09-06 |
FDA reviews safety issues of bisphosphonates for osteoporosis |
None |
| 2011-09-06 |
FDA stalls the blood-thinner Xarelto’s approval citing inadequate evidence |
None |
| 2011-09-06 |
Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants |
None |
| 2011-09-06 |
NanoViricides selects NV-INF-1 anti-influenza drug for FDA submission |
None |
| 2011-09-06 |
Amakem receives €18m in Series A round of funding |
None |
| 2011-09-06 |
Scale-up Systems establishes new office in India |
None |
| 2011-09-05 |
Study aims to describe and understand current issues on OTC medicine addiction |
None |
| 2011-09-05 |
IKEPLUS immunization completely eliminates TB bacteria from infected tissues |
None |
| 2011-09-05 |
Berlin to market wide range of Acino Pharma's current and future products in Thailand |
None |
| 2011-09-03 |
Researchers discover mechanism of low-dose LDN on cell proliferative-related disorders |
5 |
| 2011-09-03 |
Resveratrol helps prevent metabolic syndrome in offspring |
None |
| 2011-09-03 |
Finland national health institute finds link between H1N1 flu vaccine and children's narcolepsy |
None |
| 2011-09-03 |
Plerixafor drug shows promise against WHIM syndrome |
None |
| 2011-09-02 |
Mayo Clinic and IC-MedTech enter collaborative research agreement with Summa Health System |
None |
| 2011-09-02 |
PTC restructures collaboration with Genzyme |
None |
| 2011-09-02 |
Western, Midwestern states register higher methamphetamine usage |
None |
| 2011-09-02 |
Researchers modify toxic chemical of marine cycyanobacteria to treat colon cancer |
None |
| 2011-09-02 |
Florida steps up efforts against pill mills; Hospital executives under scrutiny |
None |
| 2011-09-02 |
Microtubule stability linked to increased sensitivity to paclitaxel |
None |
| 2011-09-02 |
Contraceptive pill prevents loss of eye sight |
3.5 |
| 2011-09-02 |
Pemetrexed treatment produces better outcomes in ALK-translocated NSCLC patients |
None |
| 2011-09-02 |
Short-term glucocorticoid treatment may prevent osteoarthritis after joint injury |
None |
| 2011-09-02 |
'Sustainable global pharmacovigilance' systems needed to monitor ARVs, other drugs |
None |
| 2011-09-02 |
UC Davis computer model can test effects of anti-arrhythmia medications |
None |
| 2011-09-02 |
FTC presses for more competition on generic drugs |
None |
| 2011-09-02 |
Ancient antibiotic resistance findings leads experts to stress need to use antibiotics sparingly |
None |
| 2011-09-02 |
FDA approves crizotinib for treatment of ALK-positive lung cancer |
None |
| 2011-09-02 |
Dendritic cells play central role in regulation of acetaminophen's toxicity |
None |
| 2011-09-02 |
Stomach acid-reducing drugs appear to cause small intestine damage |
None |
| 2011-09-02 |
LCA applauds FDA approval of Xalkori for ALK positive non-small cell lung cancer |
None |
| 2011-09-02 |
FDA may be allowed an extra 2 months to review new drugs |
None |
| 2011-08-31 |
Study reveals how pharmaceutical managers can maximize the return on marketing investments |
None |
| 2011-08-31 |
SAIC awards Selecta a subcontract to develop synthetic nanoparticle vaccine for malaria |
None |
| 2011-08-31 |
Research shows numerous health benefits of Modified Citrus Pectin |
None |
| 2011-08-31 |
Comprehensive review on non-drug interventions for treatment of high blood pressure |
None |
| 2011-08-31 |
Cost of second-line ARVs a 'huge barrier to care' in resource-poor countries |
None |
| 2011-08-31 |
Insight Pharmaceuticals announces acquisition of MONISTAT business from McNEIL-PPC |
None |
| 2011-08-31 |
Perrigo's ANDA for Ketoconazole Foam, 2% receives final FDA approval to treat seborrheic dermatitis |
None |
| 2011-08-30 |
FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation |
None |
| 2011-08-30 |
AAMPS, ChromaDex sign exclusive marketing agreement for African Herbal Pharmacopoeia |
None |
| 2011-08-30 |
DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry' |
None |
| 2011-08-30 |
Vitamin A supplements could save the lives of 600,000 children a year, researchers say |
None |
| 2011-08-30 |
AstraZeneca: BRILIQUE receives Class I recommendation from ESC |
None |
| 2011-08-30 |
Everolimus-eluting stent reduces incidence of stent thrombosis |
None |
| 2011-08-30 |
Ipsen, Inspiration partner to launch hemophilia product portfolio in Europe |
None |
| 2011-08-30 |
Vitamin C supplementation might benefit children with asthma |
None |
| 2011-08-30 |
High risk of serious complications or death in children with SP-HUS |
None |
| 2011-08-30 |
Study indicates large gap in use of proven therapies for heart attack or stroke |
None |
| 2011-08-30 |
Ivabradine reduces heart volume among patients with cardiac insufficiency |
None |
| 2011-08-29 |
Pfizer receives FDA approval of XALKORI for ALK-positive NSCLC |
None |
| 2011-08-29 |
UCLA-Harvard medication study highlights 3 types of confusing outcome measures |
None |
| 2011-08-29 |
Health Canada approves Bayer's STAXYN for treatment of erectile dysfunction |
2.7 |
| 2011-08-29 |
Infrared Systems completes several internal projects, discusses corporate strategies |
None |
| 2011-08-29 |
Researchers use metformin to effectively starve cancer cells |
5 |
| 2011-08-29 |
Leucine may help people burn fat during periods of food restriction |
None |
| 2011-08-29 |
One in three AF patients at high risk of stroke are not being prescribed VKA therapy |
None |
| 2011-08-29 |
Pfizer's Xalkori receives FDA approval to treat late-stage NSCLC patients with abnormal ALK gene |
None |
| 2011-08-29 |
LUNGevity Foundation applauds FDA's recent approval of XALKORI lung cancer drug |
None |
| 2011-08-29 |
Astellas seeks regulatory approval for mirabegron to treat overactive bladder in the U.S., Europe |
None |
| 2011-08-29 |
Researchers identify molecule that can stop the formation of amyloid fibrils |
None |
| 2011-08-29 |
Pfizer receives FDA approval for XALKORI capsules to treat ALK-positive NSCLC |
5 |
| 2011-08-26 |
Nurofen mix up with Seroquel schizophrenia drug warns MHRA |
None |
| 2011-08-26 |
Autism link to vaccines dispelled by a large review of studies |
5 |
| 2011-08-26 |
Rotavirus vaccine still effective in reducing diarrhea-related deaths in Mexico, researchers say |
None |
| 2011-08-26 |
Viewpoints: Drug shortages = rationing; Changing forces in health marketplace; Birth control mandate |
None |
| 2011-08-26 |
IOM report: Few health problems are clearly associated with vaccines |
None |
| 2011-08-26 |
Yale scientists synthesize huperzine A to combat Alzheimer's |
None |
| 2011-08-26 |
Google pays $500 million settlement in pharmacy ad probe |
None |
| 2011-08-26 |
Neoadjuvant chemotherapy prior to surgery can benefit women with lobular breast cancer |
None |
| 2011-08-26 |
Researchers develop single vaccines to prevent rabies, Ebola infection |
None |
| 2011-08-26 |
IOM issues new report on evidence and causality of vaccine harms |
None |
| 2011-08-26 |
Firazyr receives FDA approval for treatment of HAE acute attacks |
None |
| 2011-08-26 |
Boehringer Ingelheim, Lilly receive EU approval for linagliptin to treat type 2 diabetes |
4 |
| 2011-08-26 |
Shire receives FDA marketing approval for FIRAZYR to treat acute attacks of HAE |
None |
| 2011-08-25 |
Antidepressant alert – Citalopram associated to heart rhythm disturbances |
None |
| 2011-08-25 |
Allergan gets FDA nod for use of Botox in urinary incontinence |
None |
| 2011-08-25 |
Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritis |
None |
| 2011-08-25 |
Removal of OTC drugs for toddlers from the market reduces therapeutic errors |
5 |
| 2011-08-25 |
AHF shares The Lancet's concerns over use of Gilead's Truvada as HIV prevention pill |
None |
| 2011-08-25 |
Redesigned vancomycin can kill deadliest antibiotic-resistant bacteria |
None |
| 2011-08-25 |
Webinar on Prescription Drug Abuse in Workers' Comp |
None |
| 2011-08-25 |
Foreign drug manufacturing, testing raise regulatory and ethical concerns |
None |
| 2011-08-25 |
Researchers discover how antipsychotic drugs manage symptoms of schizophrenia |
5 |
| 2011-08-25 |
Allergan receives FDA approval for Botox to treat specific form of urinary incontinence |
None |
| 2011-08-25 |
NMS Labs develops substance identification tests for nine 'bath salts' compounds |
5 |
| 2011-08-25 |
USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression |
None |
| 2011-08-25 |
FDA approves Allergan's BOTOX to treat specific form of urinary incontinence |
None |
| 2011-08-24 |
Mylan subsidiary to exclusively offer EpiPen 2-Pak and EpiPen Jr 2-Pak Auto-Injector |
None |
| 2011-08-24 |
A pain-free way of tackling dental decay |
None |
| 2011-08-24 |
Call for open challenges in nanomedicine |
None |
| 2011-08-24 |
FDA grants fast track designation for Pharmasset's PSI-938 to treat chronic HCV infection |
None |
| 2011-08-24 |
New invasive procedures may help patients with chronic refractory headache |
1 |
| 2011-08-24 |
New Pressurized Olfactory Device shows direct CNS effect of morphine |
None |
| 2011-08-24 |
First international conference on developmental, translational and clinical pharmacogenomics |
None |
| 2011-08-24 |
Health Canada accepts Sunovion Pharmaceuticals Canada's lurasidone NDS for review |
None |
| 2011-08-24 |
Research may help explain why live attenuated influenza vaccine elicits protection |
None |
| 2011-08-24 |
Daily exercise can work as well as second antidepressant drug |
None |
| 2011-08-24 |
Simvastatin may reduce spinal cord damage from ischemia/reperfusion injury |
None |
| 2011-08-24 |
Only 20.6% of Medicaid-covered Ohio youths complete full six month antidepressant treatment |
None |
| 2011-08-23 |
Trophos awarded US patent covering use of novel cardioprotective compound |
None |
| 2011-08-23 |
Seattle genetics new blood cancer drug Adcetris comes with a hefty price tag |
None |
| 2011-08-23 |
Kerr, Family Health Network partner to reduce medication non-adherence |
None |
| 2011-08-23 |
Prescription drug shortages forcing docs, pharmacists to scramble |
None |
| 2011-08-23 |
Radium-223 chloride granted FDA Fast Track designation for treatment of CRPC |
None |
| 2011-08-23 |
Research into TB medication may shorten treatment regimen |
None |
| 2011-08-23 |
Santarus, Depomed enter new commercialization agreement for GLUMETZA |
None |
| 2011-08-23 |
CTI responds to EMA's Day 120 letter for pixantrone MAA |
None |
| 2011-08-23 |
New report on the immunomodulators market outlook to 2016 |
5 |
| 2011-08-23 |
NovaDel, Rechon enter license and distribution agreement for Zolpimist |
None |
| 2011-08-23 |
Isconova expands Matrix M collaboration with Genocea to treat infectious diseases |
None |
| 2011-08-23 |
AstraZeneca announces availability of BRILINTA tablets in the U.S. pharmacies |
None |
| 2011-08-23 |
Vertex receives Health Canada approval for INCIVEK to treat hepatitis C |
None |
| 2011-08-22 |
Drug co. executive gives pharma a sunny forecast |
None |
| 2011-08-22 |
Modified Ecstasy could be effective against cancer: Study |
5 |
| 2011-08-22 |
New technique can detach sugars from carrier molecule, reattach them to drugs |
None |
| 2011-08-22 |
Decline in HT use could lead to lower mammogram rates among women |
None |
| 2011-08-20 |
AHF: Gilead's campaign for FDA approval of Truvada leads to black marketing in Florida |
None |
| 2011-08-20 |
VOA News examines new drug compound that shows broad-based efficacy in lab tests |
None |
| 2011-08-20 |
FDA accepts Alexza ADASUVE NDA, assigns PDUFA action date |
None |
| 2011-08-20 |
EBD Group, MassBio announce plenary sessions program for BioPharm America 2011 |
None |
| 2011-08-20 |
Statin therapy may not be appropriate for certain patients at risk for stroke |
None |
| 2011-08-20 |
Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication |
None |
| 2011-08-20 |
Combination of exercise and metformin less effective for people with diabetes |
None |
| 2011-08-20 |
FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL |
None |
| 2011-08-20 |
Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL |
None |
| 2011-08-19 |
High levels of calcium in coronary arteries increase risk of stroke, heart attack |
None |
| 2011-08-19 |
Study confirms tamoxifen is superior to fulvestrant in blocking estrogen |
None |
| 2011-08-19 |
Cannabis Science enters distribution agreement with PVM for marijuana dispensing machines |
None |
| 2011-08-19 |
Only 15 U.S. pharmaceutical ads adhere to FDA Prescription Drug Advertising Guidelines |
None |
| 2011-08-19 |
Dissimilar interaction of opioid receptors may explain why men, women experience pain differently |
None |
| 2011-08-19 |
ASA launches new video that highlights need for responsible use of pain medication |
None |
| 2011-08-19 |
H1N1 vaccine safe, effective for hemodialysis and kidney transplant patients |
None |
| 2011-08-19 |
Powerful X-rays help develop new drug treatment for malignant melanoma |
None |
| 2011-08-19 |
High blood phosphate levels can set CKD patients on a rapid path to kidney failure |
None |
| 2011-08-19 |
Study: U.S. health care workers often use complementary and alternative medicine |
None |
| 2011-08-18 |
NPS submits NDA CMC section to FDA for GATTEX |
None |
| 2011-08-18 |
Lucentis receives Health Canada approval for treatment of retinal vein occlusion |
1 |
| 2011-08-18 |
EMA accepts Merck and ARIAD's MAA for ridaforolimus to treat metastatic bone sarcomas |
None |
| 2011-08-18 |
IU scientist to investigate salubrinal drug against osteoporosis |
None |
| 2011-08-18 |
SAMHSA-funded project to develop a Prescriber's Clinical Support System |
None |
| 2011-08-18 |
Winner Medical receives CCI's COTTON USA Mark license |
None |
| 2011-08-18 |
Herbal supplements may weaken the effect of chemotherapy drugs |
None |
| 2011-08-18 |
Positive link between fish oil supplements and cognitive function |
None |
| 2011-08-18 |
ACS honors MIT professor with Priestley Medal for controlled-release drug discovery |
None |
| 2011-08-18 |
Unexplained hospital factors have impact on radioactive iodine use for thyroid cancer: Study |
None |
| 2011-08-18 |
Scientists turn drug-disease match makers |
None |
| 2011-08-18 |
FDA approves Zelboraf (vemurafenib) for advanced skin cancer |
3 |
| 2011-08-18 |
EMA accepts Pfizer's regulatory submissions of two investigational cancer drugs for review |
None |
| 2011-08-18 |
Syndax receives European patent allowance for entinostat to treat metastatic breast cancer |
None |
| 2011-08-18 |
Roche receives FDA approval for Zelboraf to treat BRAF mutation-positive metastatic melanoma |
None |
| 2011-08-17 |
New gout drug may help severely affected: Study |
None |
| 2011-08-17 |
Zelboraf receives FDA approval for treatment of metastatic melanoma |
None |
| 2011-08-17 |
FDA accepts Protalix taliglucerase alfa NDA resubmission for review |
None |
| 2011-08-17 |
Mylan confirms Frova patent challenge |
None |
| 2011-08-17 |
FDA, USP co-sponsors OTC drug products workshop |
None |
| 2011-08-17 |
Comprehensive patent search on Tocilizumab |
None |
| 2011-08-17 |
PAREXEL recognized as Company of the Year for the Pharmaceutical Industry |
None |
| 2011-08-17 |
Bayer Healthcare to provide over 600,000 moxifloxacin tablets to fight MDR-TB in China |
None |
| 2011-08-17 |
Study finds broadest immune response from LAIV nasal spray vaccines for children |
None |
| 2011-08-17 |
FDA approves two new strengths of Lupron Depot-PED for central precocious puberty |
None |
| 2011-08-16 |
Inflammation linked with RA increases patients risk of heart disease |
None |
| 2011-08-16 |
Scientists demonstrate how Modified Citrus Pectin enhances immune function |
None |
| 2011-08-16 |
AHRQ's new Spanish-language guide on heart medications |
None |
| 2011-08-16 |
Combination immunotherapy more effective for patients with Sezary Syndrome |
None |
| 2011-08-16 |
U.S. District Court rules in favor of Pfizer in Viagra patent litigation |
None |
| 2011-08-15 |
Starpharma starts bacterial vaginosis prevention study of VivaGel |
None |
| 2011-08-12 |
NAI reaches settlement with VPX over beta-alanine patent litigation |
None |
| 2011-08-12 |
Thorne acquires global rights to Q-Cell, an advanced formulation Coenzyme Q10 |
None |
| 2011-08-12 |
Fibrate drugs may not prevent heart attacks in diabetes patients with elevated cholesterol |
None |
| 2011-08-12 |
Benefits of nanoparticle sunscreens outweigh risks |
3.7 |
| 2011-08-12 |
Advaxis completes ADXS-PSA prostate cancer construct pre-IND meeting with the FDA |
None |
| 2011-08-12 |
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis |
None |
| 2011-08-12 |
Mylan introduces generic version of Uroxatral for benign prostatic hyperplasia |
None |
| 2011-08-12 |
G-CSF therapy does not induce chromosomal instability in healthy stem cell donors |
2 |
| 2011-08-12 |
NSAIDs like ibuprofen slow the spread of breast cancers |
None |
| 2011-08-12 |
Endothelial progenitor cells may repair leaky blood-brain barrier |
None |
| 2011-08-12 |
Pregnant women lack enough vitamin D despite use of prenatal supplements |
None |
| 2011-08-12 |
Researchers discover key reason why pyrazinamide shortens duration of TB therapy |
1 |
| 2011-08-12 |
FDA assigns PDUFA action date for review of Affymax peginesatide NDA |
None |
| 2011-08-12 |
Nephros submits new 510(k) application with FDA for clearance of hemodiafiltration system |
None |
| 2011-08-11 |
Anticoagulation service improves quality of care for patients treated with warfarin |
None |
| 2011-08-11 |
Higher protein intake helps postmenopausal obese women lose more weight |
None |
| 2011-08-11 |
PUFA intake linked to reduced risk of heart failure, kidney disease and preterm delivery |
None |
| 2011-08-11 |
BCG vaccine can help immune system recognise cancer cells as 'foreign' |
5 |
| 2011-08-11 |
Merck receives Oliver Wight Class A certification |
None |
| 2011-08-11 |
Pharma IQ to launch Compound Management and Integrity Online event |
None |
| 2011-08-11 |
Caffeine can treat postdural puncture headaches |
None |
| 2011-08-11 |
Study: AAKG supplementation has no significant impact on increased blood flow |
2.5 |
| 2011-08-11 |
Paper outlines anticancer drug curaxins' mechanism of action |
None |
| 2011-08-11 |
Herbal remedies fail to provide safety information on labels |
None |
| 2011-08-11 |
FDA approves Gilead's Complera for treatment of HIV-1 infection |
None |
| 2011-08-11 |
Once daily HIV ‘combo’ drug approved in U.S. |
None |
| 2011-08-11 |
Neoprobe seeks FDA marketing approval of Lymphoseek for use in ILM oncology procedure |
None |
| 2011-08-10 |
FDA acceptance of peginesatide NDA triggers $10M milestone payment to Affymax |
None |
| 2011-08-10 |
Patients receive inadequate medical monitoring for prescribed drugs in psychiatric settings |
None |
| 2011-08-10 |
YASOO Health launches grape flavored liquid iron supplement for children |
None |
| 2011-08-10 |
Acorda Therapeutics receives U.S. patent allowance for aminopyridine compositions |
None |
| 2011-08-10 |
Moberg Derma receives first order for Emtrix from Walmart |
None |
| 2011-08-10 |
Erythromycin can prevent and treat aseptic loosening of total joint replacement |
None |
| 2011-08-10 |
Medications can be harmed by excessive heat |
2 |
| 2011-08-09 |
Akela announces new corporate focus on PharmaForm |
None |
| 2011-08-09 |
New preclinical approach can guide more efficient drug development for brain-related conditions |
None |
| 2011-08-09 |
EPO issues European patent for Rexahn's neurotherapeutic compositions |
None |
| 2011-08-08 |
Covalon to showcase latest line of innovative wound care and coating products at FIME Expo |
None |
| 2011-08-08 |
FDA accepts Teva's NDA for BDP Nasal HFA to treat allergic rhinitis |
None |
| 2011-08-08 |
Pre-emptive insulin therapy reduces risk of diabetes mellitus after kidney transplantation |
None |
| 2011-08-08 |
U.S. District Court rules in favor of POZEN in Treximet patent litigation |
None |
| 2011-08-08 |
Medicare prescriptions premiums expected to decrease for seniors |
None |
| 2011-08-06 |
USDA scientists develop new food aid product |
None |
| 2011-08-06 |
Intralipid may protect patients from heart attacks |
None |
| 2011-08-06 |
Simcyp extends application in areas of PD modelling and drug distribution within CNS |
None |
| 2011-08-05 |
Scientists confirm feasibility of new battery-powered skin patch drug delivery system |
None |
| 2011-08-05 |
First anti-venom for scorpion bites approved by FDA |
None |
| 2011-08-05 |
New polymer effectively captures nicotine molecules and analogues |
None |
| 2011-08-05 |
Study stresses importance of broad-spectrum sunscreen to help prevent skin cancer |
None |
| 2011-08-05 |
Health Affairs report describes ground-breaking effort that aims to prevent opioid abuse |
None |
| 2011-08-05 |
Comprehensive patent search on Omega-3-acid ethyl esters |
None |
| 2011-08-05 |
Comprehensive patent search on Hepatitis B Vaccine |
None |
| 2011-08-05 |
Levels of body chemical PCT influence duration of antibiotic use |
None |
| 2011-08-05 |
PharmOut creates online database of Good Manufacturing Practice guidelines |
None |
| 2011-08-05 |
FDA approves first scorpion antivenom |
None |
| 2011-08-04 |
Boston Therapeutics files chewable metformin ANDA with FDA to treat diabetes |
None |
| 2011-08-04 |
Scientists say antibiotic-resistant salmonella strain may spread worldwide |
None |
| 2011-08-04 |
U.S. PTO to reissue two patents for Dey Pharma's Perforomist Inhalation Solution |
None |
| 2011-08-04 |
SynCo Bio commences release of drug products after expansion of Class A zone |
None |
| 2011-08-04 |
Comprehensive patent search on insulin lispro |
None |
| 2011-08-04 |
New research highlights urgent need to develop specific guidelines for HIV-infected children |
None |
| 2011-08-04 |
Avaxia receives BARDA contract to develop new radiation mitigation drug |
None |
| 2011-08-04 |
NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections |
None |
| 2011-08-04 |
ImmunoCellular receives new patent for ICT-69 to treat multiple myeloma, ovarian cancer |
None |
| 2011-08-04 |
ICORE Healthcare receives URAC Accreditation for Specialty Pharmacy |
None |
| 2011-08-04 |
Instituto Bioclon receives FDA approval for Anascorp to treat Centruroides scorpion sting |
None |
| 2011-08-03 |
Incyte announces FDA acceptance of NDA filing for ruxolitinib to treat myelofibrosis |
None |
| 2011-08-03 |
Researchers discover biological mechanism behind sarcopenia |
None |
| 2011-08-03 |
Biomoda to receive European patent for porphyrin-based compound to detect cancer |
None |
| 2011-08-03 |
Biotica acquires full rights to rapamycin analogue program from Pfizer |
5 |
| 2011-08-03 |
New alternative to immunosuppressive treatment after kidney transplants without severe side effects |
None |
| 2011-08-03 |
New generation antidepressants may increase risk of adverse outcomes in elderly |
None |
| 2011-08-03 |
Needle-free nanopatch vaccine delivery system |
4.8 |
| 2011-08-02 |
Lipid nanocarriers in cancer diagnosis and therapy: New book |
None |
| 2011-08-02 |
Smokers taking multivitamins offset their healthy behaviour by smoking more cigarettes |
None |
| 2011-08-02 |
FDA accepts MAP Pharmaceuticals' LEVADEX NDA for filing |
None |
| 2011-08-02 |
Race and the personalized medicine debate |
None |
| 2011-08-02 |
Teva's ZOELY oral contraceptive receives EU Marketing Authorization |
3.7 |
| 2011-08-02 |
Azithromycin may predispose cystic fibrosis patients to mycobacterial infection |
None |
| 2011-08-02 |
Methamphetamine use can fuel HIV infection risk among young MSM |
None |
| 2011-08-02 |
To eliminate germs in contact lens, 'rub and rinse' works best |
None |
| 2011-08-02 |
FDA warns U.S. consumers not to use Evital emergency birth control medicine |
None |
| 2011-08-02 |
Nicotine protects against Parkinson's disease |
5 |
| 2011-08-02 |
Taxoxifen combined with dasatinib reverses chemo-resistance in breast cancer cells |
None |
| 2011-08-02 |
Statins may help protect young people from future strokes |
None |
| 2011-08-02 |
Merrimack receives FDA orphan drug status for MM-398 to treat pancreatic cancer |
None |
| 2011-08-02 |
Ursodeoxycholic acid could help prevent disturbances in heart's normal rhythm |
None |
| 2011-08-02 |
FDA clears Derma Sciences' MEDIHONEY Hydrogel Wound and Burn Dressing |
None |
| 2011-08-01 |
Fera adds four ointments to ophthalmic product portfolio |
None |
| 2011-08-01 |
FDA approves Covidien's morphine sulfate oral solution for chronic pain in opioid-tolerant patients |
None |
| 2011-08-01 |
Vanda, Biotoscana Farma partner to commercialize Fanapt in Argentina |
None |
| 2011-08-01 |
Merck submits ridaforolimus MAA with EMA for treatment of metastatic soft-tissue, bone sarcomas |
None |
| 2011-08-01 |
Fischer retains TransMedia to launch Israel's most popular sunscreen in the U.S. |
None |
| 2011-07-31 |
Universal flu vaccine based on “super antibody” coming soon |
None |
| 2011-07-30 |
Demonstrators in Swaziland express concern over possible antiretroviral shortages |
None |
| 2011-07-30 |
Labopharm, Angelini enter into agreement to reorganize partnership |
None |
| 2011-07-30 |
U.S. appeals court rules in favor of Lilly over Strattera patent case |
None |
| 2011-07-30 |
PPTA applauds introduction of 'Preserving Access to Orphan Drugs Act' |
None |
| 2011-07-30 |
AHRQ: Average annual prescription drug expenses for children with asthma have doubled |
None |
| 2011-07-30 |
LA Times: Robots and pharmacies |
None |
| 2011-07-30 |
Lupin, Lilly partner to promote and distribute Huminsulin products in India and Nepal |
5 |
| 2011-07-30 |
Humira defect lawyers file lawsuit against Abbott in Texas state court |
None |
| 2011-07-30 |
Pharmalucence selects Bosch to provide isolated filling line for Billerica production facility |
2 |
| 2011-07-30 |
FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults |
None |
| 2011-07-30 |
WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events |
None |
| 2011-07-30 |
ORENCIA SC formulation receives FDA approval for treatment of adults with RA |
None |
| 2011-07-30 |
Researchers examine drug that has potential to stop Parkinson's progression |
None |
| 2011-07-30 |
CJ, RaQualia sign license agreement to develop and commercialize RQ-00000010 Partial Agonist |
None |
| 2011-07-29 |
FDA approves Lannett's ANDA for Phentermine Resin Extended-Release Capsules |
None |
| 2011-07-29 |
Cadence confirms FDA dosing recommendations for OFIRMEV |
None |
| 2011-07-29 |
Pew director issues statement on Prescription Drug User Fee Act hearing |
None |
| 2011-07-29 |
New tool can effectively determine likelihood of drugs in the environment |
None |
| 2011-07-29 |
Book examines impact of new racial science |
None |
| 2011-07-29 |
Ivabradine effective in reducing risk of cardiac fibrosis, diastolic heart failure |
None |
| 2011-07-29 |
NIH selects Viamet's novel antifungal compound for inclusion in the TRND program |
None |
| 2011-07-29 |
FDA issues Refusal to File letter for Eisai's perampanel NDA to treat partial-onset seizures |
None |
| 2011-07-29 |
BTI's IPOXYN data on traumatic shock and ischemia to be presented at XIIIth MGH symposium |
None |
| 2011-07-29 |
Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe |
None |
| 2011-07-29 |
Oral chicken interferon-alpha may significantly reduce influenza infection |
None |
| 2011-07-28 |
Yaupon seeks FDA marketing approval of mechlorethamine gel for mycosis fungoides |
None |
| 2011-07-28 |
Amylin, Lilly and Alkermes submit reply to FDA complete response letter for BYDUREON |
None |
| 2011-07-28 |
All Canadian provinces except Quebec announce funding agreement for PNH drug, Soliris |
None |
| 2011-07-28 |
Solazyme launches anti-aging skincare line, Algenist at Space NK stores |
None |
| 2011-07-28 |
Natural recycling system, PPAR agonists can help protect children with heart defects |
None |
| 2011-07-28 |
Pharmaceutical companies' profit protection hurts global AIDS fight |
None |
| 2011-07-28 |
Smokers are misinformed about safety and efficacy of nicotine replacement therapy |
None |
| 2011-07-28 |
Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business |
None |
| 2011-07-28 |
Isis, Genzyme submit European MAA for mipomersen to treat familial hypercholesterolemia |
None |
| 2011-07-28 |
Watson to acquire portfolio of divested generic pharmaceutical products |
None |
| 2011-07-27 |
Britain’s prescription drug use statistics revealed |
None |
| 2011-07-27 |
FDA accepts peginesatide NDA for anemia associated with CKD |
None |
| 2011-07-27 |
Cocaine-free topical anaesthetics can effectively treat pain caused by torn skin |
None |
| 2011-07-27 |
Surge of generics will trigger drop in drug prices |
None |
| 2011-07-27 |
Merck secures worldwide rights to vernakalant i.v. |
None |
| 2011-07-27 |
Nano-emulsion shows promise for Viagra patch |
None |
| 2011-07-27 |
Follow-up dose recommended to defend children against pandemic virus outbreaks |
None |
| 2011-07-27 |
EMA accepts to evaluate Vanda's MAA for oral iloperidone tablets |
4 |
| 2011-07-27 |
High-dose vitamin D reduces musculoskeletal pain in breast cancer patients |
None |
| 2011-07-27 |
Methamphetamine users more likely to develop Parkinson's disease |
None |
| 2011-07-27 |
New preclinical data suggests microRNA-15 inhibits cardiomyogenesis |
None |
| 2011-07-27 |
FDA grants Orphan Drug Designation for Diffusion's TSC to treat glioblastoma multiforme |
None |
| 2011-07-27 |
PACA study: Adrenaline can treat cardiac arrest |
None |
| 2011-07-27 |
Health Canada issues notice of compliance for OCPI's SAMSCA to treat hyponatremia |
5 |
| 2011-07-26 |
Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s |
None |
| 2011-07-26 |
Physician-targeted education campaign reduces outpatient antibiotic use in Quebec |
None |
| 2011-07-26 |
TikoMed receives FDA Orphan Drug Designation for TM-400 to treat hematological cancers |
None |
| 2011-07-26 |
VeganZyme supplement may aid in reducing digestive discomfort and symptoms |
None |
| 2011-07-26 |
'Core-shell' nanoparticles for effective intracellular delivery of RNAi therapeutics |
None |
| 2011-07-26 |
Anesthetic agent isoflurane may treat intracerebral hemorrhage |
None |
| 2011-07-26 |
EMA recommends orphan drug designation for 4SC's resminostat to treat HCC |
None |
| 2011-07-26 |
Takeda resubmits alogliptin and fixed-dose combination therapy NDA to FDA |
5 |
| 2011-07-26 |
Diabetes drug rosiglitazone can reduce development of neuropathic pain |
None |
| 2011-07-25 |
Prasco to market and distribute authorized generic of Shionogi's PONSTEL |
None |
| 2011-07-25 |
Threshold reports initiation of TH-302 and bevacizumab clinical trial for astrocytoma |
None |
| 2011-07-25 |
Ranbaxy announces launch of Letrozole Tablets in UK, Romania and France |
None |
| 2011-07-25 |
Biogen Idec's FAMPYRA receives EU conditional approval for treating functional impairment in MS |
4.5 |
| 2011-07-25 |
Baxter GAMMAGARD LIQUID for PI receives FDA approval for subcutaneous administration |
None |
| 2011-07-25 |
Swaziland government, Vantage plan to construct pharmaceutical manufacturing facility |
None |
| 2011-07-25 |
Better targeting of pharmaceuticals to patient's genetic profile could save around $110B annually |
None |
| 2011-07-25 |
Study: Mail-order pharmacy use linked to improved cardiovascular risk factor outcomes |
None |
| 2011-07-25 |
Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection |
None |
| 2011-07-25 |
Study explores factors for misuse of prescription opioid in young injection drug users |
None |
| 2011-07-25 |
Health Canada approves Valeant's NDA for Sublinox to treat insomnia |
None |
| 2011-07-25 |
Medicines Patent Pool can help many but has potential limitations for AIDS drug access in middle-income countries |
None |
| 2011-07-25 |
PNH patients applaud pan-Canadian approach to providing equitable access to Soliris |
None |
| 2011-07-25 |
Janssen receives FDA Complete Response letter for SIMPONI sBLA to treat RA |
None |
| 2011-07-22 |
CDR recommends reimbursement for schizophrenia drug, ABILIFY |
None |
| 2011-07-22 |
Health Canada approves SPRYCEL as first-line treatment for life-threatening blood cancer |
None |
| 2011-07-22 |
Medicare Part D prescription drug rebates would increase monthly premiums for seniors |
None |
| 2011-07-22 |
FDA approves Merz Aesthetics' XEOMIN for temporary improvement of glabellar lines |
None |
| 2011-07-22 |
Perrigo's coated cinnamon nicotine gum receives FDA marketing approval |
None |
| 2011-07-22 |
Study finds high prevalence of prescription pain medication addiction in chronic patients |
None |
| 2011-07-22 |
Quest receives U.S. patent allowance for cancer combination therapy |
None |
| 2011-07-22 |
GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC |
None |
| 2011-07-22 |
FDA approves Cephalon's REMS for FENTORA, ACTIQ |
None |
| 2011-07-22 |
A*STAR's ETC, Agilent introduce drug screening platform |
None |
| 2011-07-22 |
Adamis receives U.S. patent for APC-100 to treat prostate cancer |
None |
| 2011-07-22 |
FDA approves Boca Pharmacal's Hydrocodone Bitartrate and Acetaminophen Oral Solution ANDA |
None |
| 2011-07-21 |
EMA says link between narcolepsy and Pandemrix 2009 H1N1 vaccine exists |
None |
| 2011-07-21 |
High cost of multiple sclerosis drugs |
None |
| 2011-07-21 |
Australian anti-cancer company completes $2.6 million placement |
None |
| 2011-07-21 |
Randox win Premier Healthcare Alliance contract for Quality Control |
None |
| 2011-07-21 |
Alliqua acquires global license for wound care dressings from Noble Biomaterials |
5 |
| 2011-07-21 |
Excess brain activity in aMCI patients contributes to brain dysfunction underlying memory loss |
None |
| 2011-07-21 |
Caltech, Zcube collaboration will bring painless transdermal drug delivery to patients |
None |
| 2011-07-21 |
Study examines cost-effectiveness of MS drugs in the U.S. |
None |
| 2011-07-21 |
China BCT to launch 21 new retail pharmacy stores in Guangxi |
None |
| 2011-07-21 |
Roche, Merck sign new non-exclusive agreement for HCV triple combination therapy |
None |
| 2011-07-21 |
FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients |
None |
| 2011-07-21 |
USPTO issues patent for Mirna's tumor suppressor microRNAs |
None |
| 2011-07-21 |
Adamis' APC-300 inhibits growth of prostate cancer cells |
None |
| 2011-07-21 |
Novel vaccine for treating heroin addiction |
None |
| 2011-07-21 |
USPTO issues patent for Avila's targeted covalent drugs portfolio |
None |
| 2011-07-21 |
AstraZeneca receives FDA approval for BRILINTA to treat acute coronary syndrome |
None |
| 2011-07-20 |
FDA approves AstraZeneca's anti-clotting drug Brilinta |
None |
| 2011-07-20 |
FDA panel votes against novel diabetes drug citing adverse effects |
None |
| 2011-07-20 |
Purdue Pharma develops new online resource for combating prescription drug abuse |
None |
| 2011-07-20 |
VIVUS to present topiramate exposure, birth defect data at IEC |
None |
| 2011-07-20 |
Capsules: IOM recommends free birth control for all |
None |
| 2011-07-20 |
Birth control pills may reduce woman's bone density |
None |
| 2011-07-20 |
New transgenic mouse could predict toxicity of targeted cancer drugs |
None |
| 2011-07-20 |
Valeant, sanofi-aventis partner to market and distribute Zuacta cream |
None |
| 2011-07-20 |
Patients who use anti-depressants more likely to suffer relapses |
None |
| 2011-07-20 |
CEL-SCI expands licensing agreement with Teva for Multikine cancer drug |
None |
| 2011-07-19 |
DNA vaccine developer Coridon in U.S. collaboration |
None |
| 2011-07-19 |
Natural formula can fight against highly invasive breast cancer |
None |
| 2011-07-19 |
Thalidomide analog shows promise against sickle cell disease |
None |
| 2011-07-19 |
Catylix, Illinois enter license agreement to incorporate fluorine into drugs |
None |
| 2011-07-19 |
Anti-malaria drug provides key insight into potential treatments for autoimmune diseases |
None |
| 2011-07-19 |
U.S. Patent Office issues Notice of Allowance for Kuros' PTH to improve bone healing |
None |
| 2011-07-19 |
International Journal of Cancer publishes Bionovo's Bezielle research |
5 |
| 2011-07-19 |
Optimer introduces DIFICID for treatment of C. difficile-associated diarrhea |
None |
| 2011-07-19 |
U.S. FDA approves 2011-2012 influenza vaccine formulation |
None |
| 2011-07-19 |
FDA approves Lannett's Diethylproprion HCl Tablets ANDA for anti-obesity treatment |
None |
| 2011-07-19 |
Flu vaccine for 2011-12 season approved and ready |
1 |
| 2011-07-19 |
Graceway receives FDA approval for Zyclara Cream to treat actinic keratoses |
None |
| 2011-07-18 |
Shionogi to acquire Victory Pharma's products to treat pain and infectious diseases |
None |
| 2011-07-18 |
CSL Behring supports World Federation of Hemophilia with 1 million IUs of von Willebrand factor/Factor VIII |
None |
| 2011-07-18 |
FDA files MedImmune's sBLA for quadrivalent intranasal nasal influenza vaccine, FluMist |
None |
| 2011-07-18 |
FDA approves Shire's Lialda for maintenance of remission of ulcerative colitis |
None |
| 2011-07-18 |
HER2-positive metastatic breast cancer women benefit from trastuzumab and chemotherapy |
None |
| 2011-07-18 |
Researchers discover unexpected mode of action for vaccine adjuvant alum |
5 |
| 2011-07-18 |
QRxPharma seeks NDA approval for MoxDuo IR |
None |
| 2011-07-16 |
Transcept decreases workforce following FDA news on Intermezzo NDA |
None |
| 2011-07-16 |
Shah congratulates researchers on PrEP findings |
None |
| 2011-07-16 |
New antidepressant prescription linked to increased risk of falls in nursing home residents |
None |
| 2011-07-16 |
Propranolol can block brain from retrieving cocaine-associated memories |
None |
| 2011-07-16 |
Successful strategies for launching fixed dose combination products to market |
None |
| 2011-07-16 |
Teva, Amgen settle G-CSF patent litigation |
None |
| 2011-07-16 |
Zocor, Crestor drugs may cause serious muscle and kidney problems |
1.7 |
| 2011-07-15 |
FDA ODAC recommends approval of Seattle Genetics' ADCETRIS for Hodgkin lymphoma after ASCT |
None |
| 2011-07-15 |
EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related events |
4 |
| 2011-07-15 |
FDA asks Guided Therapeutics to provide additional information on LuViva PMA |
None |
| 2011-07-15 |
Women with current major depression more likely to use crack |
None |
| 2011-07-15 |
Neuralstem receives U.S. patent allowance for three new neurogenic compounds |
None |
| 2011-07-15 |
Transcept receives FDA Complete Response Letter for Intermezzo NDA |
None |
| 2011-07-15 |
Teva commends U.S. Senators for introducing Affordable Medicines Utilization Act of 2011 |
None |
| 2011-07-15 |
Oxytocin does not boost prospects for normal births |
None |
| 2011-07-15 |
Tocotrienol could help reduce stroke damage |
None |
| 2011-07-15 |
Partially hydrolysed whey formula does not prevent allergies in high-risk infants |
None |
| 2011-07-15 |
FDA needs more oversight power to protect increasingly globalized drug supply, Pew report says |
None |
| 2011-07-15 |
CVS Caremark adds Access' MuGard to pharmacy benefit network |
None |
| 2011-07-14 |
Yervoy, a new melanoma drug approved in Australia |
5 |
| 2011-07-14 |
Seattle Genetics lymphoma drug gets FDA panel nod |
None |
| 2011-07-14 |
USPTO awards patent for Convergen LifeSciences' CNVN202 to treat lung cancer |
None |
| 2011-07-14 |
Studies show AIDS drugs can prevent heterosexuals from acquiring HIV |
None |
| 2011-07-14 |
EC grants marketing authorization for BENLYSTA to treat SLE |
None |
| 2011-07-14 |
RXi expands intellectual property portfolio with additional NeuVax patents |
None |
| 2011-07-14 |
EC approves YERVOY for treatment of previously-treated advanced melanoma |
None |
| 2011-07-14 |
Humira's early-line growth threatens Enbrel's future uptake in psoriatic arthritis |
None |
| 2011-07-14 |
New Tamiflu anti-viral flu medication in lower concentration |
None |
| 2011-07-14 |
Scientists discover new mechanism of drug resistance in hospital microbes |
None |
| 2011-07-14 |
Multiple studies find no consensus on kava-induced hepatotoxicity in Western countries |
None |
| 2011-07-14 |
SAS expands Global Certification Program offerings |
1 |
| 2011-07-14 |
Cornell grants ChromaDex worldwide rights to novel manufacturing process for nicotinamide riboside |
None |
| 2011-07-14 |
New approach for producing human-derived gelatin |
None |
| 2011-07-14 |
Pre-exposure prophylaxis reduces risk of HIV infection |
None |
| 2011-07-14 |
Progesterone could fight against neuroblastoma |
None |
| 2011-07-14 |
OncoVista commences OVI-117 additional safety study in a second animal species |
None |
| 2011-07-13 |
AIDS activists and advocates to protest against Gilead's drug pricing at San Francisco federal building |
None |
| 2011-07-13 |
FDA accepts Eisai's DACOGEN sNDA for review to treat acute myeloid leukemia |
None |
| 2011-07-13 |
FDA issues draft guidance to promote development of targeted medicines, diagnostics |
3 |
| 2011-07-13 |
AHF applauds Gilead for licensing AIDS drugs to Medicines Patent Pool |
None |
| 2011-07-13 |
Study about impact of drug shortages on U.S. health systems |
None |
| 2011-07-13 |
Gilead becomes first company to license drugs to Medicines Patent Pool |
None |
| 2011-07-13 |
BRICS health ministers agree to improve access to low-cost medicines |
None |
| 2011-07-13 |
USFDA approves Dr. Reddy's ANDA for Fondaparinux Sodium Injection |
None |
| 2011-07-13 |
U.S. hospitals report severe drug shortages: Survey |
None |
| 2011-07-13 |
Blood cancer drug trial results questioned by FDA |
1 |
| 2011-07-12 |
Gilead, Mylan expand license deal for HIV/AIDS medicines |
None |
| 2011-07-12 |
EPO grants patent for Aeterna Zentaris' perifosine to treat benign, malignant tumours |
None |
| 2011-07-12 |
Rapid method can predict immune responses against flu vaccines |
None |
| 2011-07-12 |
Gilead announces expansion of global access program for HIV medications |
None |
| 2011-07-12 |
Poisonous shrub extract may act as natural painkiller |
None |
| 2011-07-12 |
Study may help explain why antipsychotic drugs can promote overeating, weight gain |
4 |
| 2011-07-12 |
Sunshine completes Adva-27a study in Multidrug Resistant Breast Cancer cell line |
5 |
| 2011-07-12 |
BioAlliance receives European patent for Livatag to treat primary liver cancer |
None |
| 2011-07-11 |
Drug makers seek to block deficit-talk demands for discounts |
None |
| 2011-07-11 |
Ivermectin cream demonstrates activity against head lice eggs |
None |
| 2011-07-11 |
New corticosteroid with cream-like base |
None |
| 2011-07-11 |
FDA-approved Zuplenz oral soluble film now available for licensing to new commercial partners |
None |
| 2011-07-11 |
USANA receives FDA registration to manufacture OTC drugs |
5 |
| 2011-07-11 |
Nevada District Court rules in favor of PDL over Genentech, Roche lawsuit |
None |
| 2011-07-11 |
Antares, Watson enter license deal to commercialize Anturol in the U.S. and Canada |
None |
| 2011-07-11 |
Probiomed, Vanda enter license deal to commercialize Fanapt in Mexico |
None |
| 2011-07-11 |
MSU professor focuses on new formulation for old drug to treat parasitic diseases |
None |
| 2011-07-11 |
GlaxoSmithKline's Boostrix receives FDA approval to prevent tetanus, diphtheria, and pertussis |
None |
| 2011-07-11 |
APP receives FDA approval to market Clonidine Hydrochloride Injection |
None |
| 2011-07-11 |
FDA approves BOOSTRIX to prevent tetanus, diphtheria and pertussis in older people |
None |
| 2011-07-10 |
Flu vaccine against all strains of virus coming soon |
None |
| 2011-07-08 |
Generics as a way to lower health care costs |
None |
| 2011-07-08 |
Mass administration of common anti-parasitic is possible new tool in fight against malaria |
None |
| 2011-07-08 |
Onconova, SymBio enter commercialization collaboration for rigosertib in Japan and Korea |
None |
| 2011-07-08 |
Shire files lawsuit against Watson over generic Vyvanse |
None |
| 2011-07-08 |
Study finds higher rate of switching from Byetta to Victoza in treatment of type 2 diabetes |
None |
| 2011-07-08 |
LFB receives U.S. patent titled 'Monoclonal Antibodies with Enhanced ADCC Function' |
None |
| 2011-07-08 |
AMT files request for re-examination of Glybera marketing application with EMA |
None |
| 2011-07-08 |
U.S. District Court rules in favor of Watson over Mucinex patent suit |
None |
| 2011-07-07 |
Heartworm medication Ivermectin prevents malaria transmission in Africa |
None |
| 2011-07-07 |
Low temperature vacuum drying process for production of probiotics |
None |
| 2011-07-07 |
Study finds link between genetic variation and cetuximab rectal cancer therapy |
None |
| 2011-07-07 |
Improved global safety monitoring of HIV drugs is needed |
None |
| 2011-07-07 |
Simpler antibiotic combination could help prevent TB in patients with and without HIV |
None |
| 2011-07-07 |
Hydrogel capsule could simultaneously deliver different types of drugs |
None |
| 2011-07-06 |
AIDS vaccine may be far off, but path to it is getting clearer |
None |
| 2011-07-06 |
Drug companies' desires to maintain status quo are 'lethal' |
None |
| 2011-07-06 |
Treating migraines with behavioral approaches can make financial sense |
None |
| 2011-07-06 |
New biological insights into fat tissue |
None |
| 2011-07-06 |
Infants treated with certain HIV medication more likely to experience adrenal dysfunction |
None |
| 2011-07-05 |
PET imaging technique may identify TKI-responsive lung cancer |
None |
| 2011-07-05 |
Antidepressants during first trimester linked to increased risk of autism |
None |
| 2011-07-05 |
Anti-depressants during early pregnancy linked to increased risk of autism |
None |
| 2011-07-05 |
New study reaffirms safety of seasonal flu and H1N1 vaccines |
5 |
| 2011-07-05 |
Anti-inflammatory drugs may increase risk of atrial fibrillation |
None |
| 2011-07-05 |
Varenicline may increase risk of adverse cardiovascular events among smokers |
None |
| 2011-07-02 |
Obama administration turns bright spotlight on prescription painkiller abuse |
None |
| 2011-07-02 |
Medicare to cover 2 expensive cancer drugs |
None |
| 2011-07-01 |
Thai health authorities plan to screen residents of northeast region for deadly fluke worms |
None |
| 2011-07-01 |
NPR examines controversial drug being used to save women's lives |
None |
| 2011-07-01 |
Pill for rare ageing disease on the horizon |
None |
| 2011-07-01 |
Bone fusion drug comes under scrutiny due to researchers’ vested interests |
None |
| 2011-07-01 |
Avastin for breast cancer still covered by Medicare despite FDA indecision |
None |
| 2011-07-01 |
New clot busting drug approved in UK |
1.5 |
| 2011-07-01 |
Panel advises FDA to reject Avastin as breast cancer drug |
None |
| 2011-07-01 |
Multinational drug companies' scam |
None |
| 2011-06-30 |
Some generic anti-epilepsy drugs may not be effective |
None |
| 2011-06-30 |
VIVUS submits avanafil NDA to FDA for treatment of erectile dysfunction |
None |
| 2011-06-30 |
Research raises questions about some generic epilepsy drugs |
None |
| 2011-06-30 |
Valeant to acquire rights relating to Elidel and Xerese from Meda |
None |
| 2011-06-30 |
Swaziland's supply of antiretroviral drugs running low |
1 |
| 2011-06-30 |
Study provides novel information about clinical potential of anti-cancer antibiotics |
None |
| 2011-06-30 |
Obstetricians/gynecologists rank Pfizer as No. 1 pharmaceutical company: SDI |
None |
| 2011-06-30 |
Drug companies collaborate with DNDi support to develop drug for African sleeping sickness |
None |
| 2011-06-30 |
Valeant, Meda partner for life cycle opportunities for Elidel and Xerese |
None |
| 2011-06-30 |
Almirall, Forest Labs submit aclidinium bromide NDA to FDA for treatment of COPD |
None |
| 2011-06-30 |
Recombinant attenuated Salmonella vaccines hold promise against infectious diseases |
4 |
| 2011-06-30 |
Physicians urge FDA not to approve Truvada as an HIV prevention pill |
None |
| 2011-06-30 |
Early metformin treatment may prevent adolescent polycystic ovary syndrome |
None |
| 2011-06-30 |
FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer |
None |
| 2011-06-30 |
Dendreon receives FDA approval for Los Angeles cancer immunotherapy manufacturing facility |
None |
| 2011-06-30 |
Viewpoints: Calif.'s budget, Supreme Court drug rulings, the Avastin debate |
None |
| 2011-06-29 |
Supreme Court rules in favor of ‘pharma’ data mining |
None |
| 2011-06-29 |
Vaccines may be given in food in the near future |
None |
| 2011-06-29 |
FDA looks at Avastin risks |
None |
| 2011-06-29 |
Patients, scientists in different corners for cancer drug fight |
None |
| 2011-06-29 |
Exciton enters distribution agreement with Marathon Medical |
None |
| 2011-06-29 |
Cipher grants Vertical exclusive U.S. distribution rights to CIP-TRAMADOL ER |
None |
| 2011-06-29 |
Suneva Medical receives Health Canada marketing approval for Bellafill |
None |
| 2011-06-29 |
Hi-Tech Pharmacal pays $3.6M for rights to Atley's branded pain treatment products |
None |
| 2011-06-29 |
Medivir, Meda renegotiate agreement for cold sores medicine, Xerese |
None |
| 2011-06-29 |
Study proves efficacy of cellulose powder, without any adverse effects, in treatment of hay fever for children |
None |
| 2011-06-29 |
Bayer Yakuhin seeks marketing authorization in Japan for EYLEA for treatment of wet AMD |
None |
| 2011-06-29 |
Bristol-Myers Squibb and Mylan expand access to HIV drug Reyataz in sub-Saharan Africa and India |
None |
| 2011-06-28 |
Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy |
None |
| 2011-06-28 |
Tibotec, Gilead Sciences enter license agreement for new combination product of PREZISTA and cobicistat |
None |
| 2011-06-28 |
Merck, UPS extend logistics and distribution agreement |
None |
| 2011-06-28 |
Drug labels sometimes lack key safety warnings: Consumer Reports Health |
None |
| 2011-06-28 |
NUROMOL non-prescription painkiller now available in pharmacies across the UK |
None |
| 2011-06-28 |
DSM introduces Kremer Method for rapid, cost effective production of biopharmaceuticals |
None |
| 2011-06-28 |
Drug shortages have tripled during the last six years |
None |
| 2011-06-28 |
FDA hearing on breast cancer drug set for this week |
None |
| 2011-06-28 |
Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancer |
None |
| 2011-06-28 |
Accelerated hepatitis B vaccination schedule effective for high-risk pregnant women |
None |
| 2011-06-27 |
Australian Nobel Prize winner closer to delivering vaccines in food after positive first study in humans |
None |
| 2011-06-27 |
New and effective diabetes drug seeking approval |
5 |
| 2011-06-27 |
FDA directive on anemia drug in kidney disease patients |
None |
| 2011-06-27 |
EMA acceptance of brentuximab vedotin MAA triggers $5M milestone payment to Seattle Genetics |
None |
| 2011-06-27 |
Endo recalls two lots of Endocet Tablets |
None |
| 2011-06-27 |
Health Canada approves Tasigna for newly diagnosed Philadelphia chromosome-positive CML |
None |
| 2011-06-27 |
FDA accepts for filing Columbia's PROCHIEVE progesterone gel NDA |
None |
| 2011-06-27 |
FDA issues Complete Response Letter for Pfizer's REMOXY NDA |
None |
| 2011-06-27 |
Anticholinergic medications linked to risk of cognitive impairment, death in older population |
2 |
| 2011-06-27 |
Study finds no adverse effects of vitamin D supplements in pregnant women, newborns |
None |
| 2011-06-27 |
EMA accepts Millennium's MAA for ADCETRIS to treat lymphoma |
None |
| 2011-06-27 |
FDA recommends conservative dosing guidelines for ESAs to treat anemia in patients with CKD |
None |
| 2011-06-27 |
New anti-inflammatory drug improves kidney function in patients with type 2 diabetes |
None |
| 2011-06-27 |
Matrix honors EP Vantage with European Mediscience 2011 Commentator of the Year award |
1 |
| 2011-06-27 |
Vaccination against rotavirus decreases hospitalization rates among infants |
None |
| 2011-06-27 |
Intravenous diclofenac holds promise against severe pain following oral surgery |
None |
| 2011-06-27 |
Some HIV drugs can cause premature ageing |
None |
| 2011-06-24 |
Isotechnika's partner Lux to appeal EMA CHMP decision against Luveniq |
None |
| 2011-06-24 |
EMA approves Shire's new REPLAGAL manufacturing facility in Lexington |
None |
| 2011-06-24 |
EMA CHMP recommends approval of linagliptin for type 2 diabetes |
None |
| 2011-06-24 |
Supreme Court sides with drug makers in two decisions |
None |
| 2011-06-24 |
Nutrastar opens Harbin specialty store in central Nangang District |
None |
| 2011-06-24 |
FDA approves second anti-HIV drug from Rutgers-Janssen collaboration |
5 |
| 2011-06-24 |
FDA approves Lannett's NDA for Morphine Sulfate Oral Solution |
None |
| 2011-06-24 |
EMA CHMP issues positive opinion for Baxter's IVIG therapy for multifocal motor neuropathy |
None |
| 2011-06-24 |
Unavailability of Avastin more dangerous risk for breast cancer patients, says FAMEDS founder |
None |
| 2011-06-24 |
Fera launches Garamycin Ophthalmic Solution |
None |
| 2011-06-24 |
Pfizer and Pain Therapeutics receive FDA Complete Response Letter for resubmission of REMOXY NDA |
None |
| 2011-06-24 |
Automated screening system helps identify cases of unexpected drug diversions |
None |
| 2011-06-24 |
ViroPharma receives positive European CHMP opinion for Buccolam to treat acute seizures |
None |
| 2011-06-24 |
Cocaine contaminated with livestock de-worming drug causes painful purpura |
None |
| 2011-06-24 |
Scientists develop new NO delivery system to fortify effects of Viagra in the body |
None |
| 2011-06-24 |
Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA |
None |
| 2011-06-24 |
Inhaled corticosteroids linked to increased risk of fractures in patients with COPD |
None |
| 2011-06-24 |
Mylan introduces generic Entocort EC capsules for treatment of Crohn's disease |
None |
| 2011-06-24 |
USPTO issues Notice of Allowance for Neurocrine's NBI-98854 to treat tardive dyskinesia |
None |
| 2011-06-24 |
AMT receives CHMP opinion on Glybera Marketing Authorisation Application |
None |
| 2011-06-24 |
Anticholinergic drugs might increase risk of cognitive impairment, death in older people |
None |
| 2011-06-24 |
Health Canada grants market authorization for Sanofi-aventis Jevtana to treat prostate cancer |
None |
| 2011-06-24 |
FDA grants Orphan Drug Designation for Accentia's Revimmune to treat two autoimmune diseases |
None |
| 2011-06-23 |
U.S. Supreme Court ruling on generic drugs |
None |
| 2011-06-23 |
Some drug mixtures may be fatal for elderly: study |
None |
| 2011-06-23 |
Scil Technology receives public research grant for novel rheumatoid arthritis treatments |
None |
| 2011-06-23 |
Health Canada approves PURE Hard Surface disinfectant |
None |
| 2011-06-23 |
GAD vaccine DIAPREV-IT study in high-risk children continues as planned |
4 |
| 2011-06-23 |
PNP Pharmaceuticals contracted as exclusive global manufacturer of Fero Industries' Sucanon |
None |
| 2011-06-23 |
FDA grants Fast Track designation for Repligen's RG3039 to treat Spinal Muscular Atrophy |
None |
| 2011-06-23 |
Watson Pharmaceuticals expands Salt Lake City R&D and manufacturing facility |
None |
| 2011-06-23 |
The role of pharmaceutical companies in global health |
None |
| 2011-06-23 |
Insight into future development of global pharmaceutical industry |
None |
| 2011-06-23 |
AP: Walgreens, Express Scripts at odds in contract negotiations |
None |
| 2011-06-23 |
MEDA seeks marketing authorization for Zyclara in Europe |
None |
| 2011-06-23 |
Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong |
None |
| 2011-06-23 |
Axxam receives ADDF grant to develop new therapeutics for Alzheimer's |
None |
| 2011-06-23 |
AstraZeneca, Jubilant announce delivery outcomes and early success in Pain therapeutic area |
None |
| 2011-06-23 |
Incivek-combination therapy increases chances of HCV patients achieving viral cure |
None |
| 2011-06-23 |
Mothers receiving influenza vaccination during pregnancy also protect infants |
None |
| 2011-06-23 |
India looking to supply generic drugs to Japan |
None |
| 2011-06-23 |
Sanofi Pasteur establishes new vaccine research and development facility in Canada |
None |
| 2011-06-23 |
Rush scientist receives NIH grant to evaluate whether cinnamon may treat MS |
None |
| 2011-06-23 |
LPI receives final FDA approval for generic version of Levaquin tablets |
None |
| 2011-06-22 |
FDA approves ProStrakan's Rectiv for pain associated with anal fissures |
None |
| 2011-06-22 |
VENENUM opens new medicinal chemistry facility in Hamilton, NJ |
1 |
| 2011-06-22 |
Pharmasset receives U.S. patent titled 'Nucleoside Phosphoramidate Prodrugs' |
None |
| 2011-06-22 |
Homosexual men with prostate cancer more likely to report problems with bicalutamide drug |
4 |
| 2011-06-22 |
Supreme Court accepts case that could shape field of personalized medicine |
None |
| 2011-06-22 |
Scientists apply math model to HIV to discover targets for vaccines or drugs |
None |
| 2011-06-22 |
Dr. Reddy's Labs launches generic version of LEVAQUIN tablets in the U.S. |
None |
| 2011-06-22 |
Use public-private partnerships to improve access to essential health products |
None |
| 2011-06-22 |
Disease-modifying antirheumatic drugs reduce risk of diabetes from RA, psoriasis |
None |
| 2011-06-22 |
Frankincense may help treat painful arthritis |
None |
| 2011-06-22 |
Research focuses on how marijuana affects decision-making process |
None |
| 2011-06-22 |
New-onset diabetes risk increases with intensive-dose statin therapy |
None |
| 2011-06-22 |
Biotest, Abbott partner to develop and commercialize BT-061 for autoimmune diseases |
None |
| 2011-06-22 |
Palatin receives U.S. patent titled ‘Amino Acid Surrogates for Peptidic Constructs' |
None |
| 2011-06-21 |
AusBiotech supports ‘Raising the Bar’ |
None |
| 2011-06-21 |
CSL Biotherapies statement on FDA warning letter |
None |
| 2011-06-21 |
Respira reports results of DPI drug engine clinical study against COPD, asthma |
None |
| 2011-06-21 |
EC grants marketing authorization to BYDUREON for treatment of type 2 diabetes |
None |
| 2011-06-21 |
IPS examines access to treatment for drug-resistant TB |
None |
| 2011-06-21 |
FDA confirms printed prescription drug ads affect consumer understanding of medications |
None |
| 2011-06-21 |
New anti-abuse formulation of painkiller Oxycodone |
None |
| 2011-06-21 |
Government and private sector must work together on HIV vaccine |
None |
| 2011-06-21 |
U.S. FDA approves generic Levaquin for treatment of bacterial infections |
None |
| 2011-06-21 |
Rheonix, Mayo Clinic partner for genotyping test to assist warfarin sensitivity |
None |
| 2011-06-20 |
Mayo Clinic announces collaboration on genotyping test for Warfarin sensitivity |
None |
| 2011-06-20 |
Benitec’s pain program validated by independent study |
None |
| 2011-06-20 |
Contaminated cocaine may lead to public health epidemic |
None |
| 2011-06-20 |
Photocure launches Photodynamic Cosmetic for improving skin appearance |
None |
| 2011-06-20 |
NanoViricides plans to lease new cGMP manufacturing and lab space |
None |
| 2011-06-20 |
Supreme Court ruling would affect around 10,000 Reglan-metoclopramide lawsuits |
None |
| 2011-06-20 |
Pulmatrix introduces novel iSPERSE inhaled dry powder drug delivery platform |
None |
| 2011-06-20 |
Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain |
None |
| 2011-06-20 |
Endo Pharmaceuticals, Jubilant achieve milestone in cancer drug development program |
None |
| 2011-06-20 |
Concert earns $4M milestone payment from GSK collaboration |
None |
| 2011-06-20 |
Ground breaking treatment for Cystic Fibrosis |
None |
| 2011-06-20 |
One in ten Europe's middle-aged citizens took antidepressants during 2010 |
None |
| 2011-06-20 |
Chengdu Tianyin files renewal application for High Tech Enterprise Status |
None |
| 2011-06-20 |
Pharma IQ publishes results of Industry-wide distribution survey |
None |
| 2011-06-19 |
Risperidone recall by J&J |
None |
| 2011-06-18 |
FDA approves NULOJIX |
None |
| 2011-06-18 |
Watson Pharmaceuticals confirms SEASONIQUE patent challenge |
None |
| 2011-06-18 |
HPV vaccine shows success in young Australian women, study says |
1 |
| 2011-06-18 |
Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings |
None |
| 2011-06-18 |
Economist examines decade of changes in vaccine field |
None |
| 2011-06-18 |
Niclosamide drug effective against colon cancer metastasis |
None |
| 2011-06-17 |
RHEI receives Chinese SFDA acceptance letter for MuGard |
None |
| 2011-06-17 |
FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA |
None |
| 2011-06-17 |
Joint venture to manufacture and distribute tenofovir gel in Africa |
None |
| 2011-06-17 |
Fast-acting antidepressant effect of ketamine |
None |
| 2011-06-17 |
Medical societies urge diabetes patients to remain on their prescribed medications |
None |
| 2011-06-17 |
PEG hydrogel sealant effectively encloses surgical wounds after spinal procedures |
None |
| 2011-06-17 |
Menafrivac more effective, less expensive than older meningitis vaccines, studies say |
None |
| 2011-06-16 |
New Australian drug shows positive response in patients with multiple myeloma blood cancer |
2.4 |
| 2011-06-16 |
CEVEC and Catalent Pharma Solutions offer joint cell line development service |
None |
| 2011-06-16 |
Potent reagent for reliable stem cell differentiation |
None |
| 2011-06-16 |
Researchers reveal why anti-androgen therapy may fail in men with prostate cancer |
None |
| 2011-06-16 |
Geisinger uses mandatory approach to improve healthcare worker influenza vaccination rates |
None |
| 2011-06-16 |
'Cell membrane capsules' made from real living cells improve functional drug delivery |
None |
| 2011-06-16 |
Antibiotics overprescribed for in home-care patients |
None |
| 2011-06-16 |
InNexus files patent protection for new Age-related Macular Degeneration therapeutic |
None |
| 2011-06-16 |
Liraglutide medication can help treat type 1 diabetes |
5 |
| 2011-06-16 |
Potential new drug therapies targeting genetic mutations benefit lung-cancer patients |
None |
| 2011-06-16 |
ViroPharma receives European Centralized Marketing Authorization for Cinryze for treatment of HAE |
None |
| 2011-06-16 |
Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant |
None |
| 2011-06-15 |
Cholesterol-lowering statins reduce rate of mortality and cardiovascular events |
None |
| 2011-06-15 |
Cardinal Health renews pharmaceutical distribution agreement with Prime Therapeutics |
None |
| 2011-06-15 |
Galectin strengthens cancer drug patent portfolio in Europe |
None |
| 2011-06-15 |
FDA issues final rulemaking on testing and labeling of sunscreen products |
None |
| 2011-06-15 |
Leukothera effectively treats psoriasis in humanized mouse xenograft transplantation model |
None |
| 2011-06-15 |
GlycoVaxyn's Second Annual Science Day to highlight challenges of vaccine industry |
2 |
| 2011-06-15 |
Botox injections can reduce wrinkles with half as many sessions after 20 months |
None |
| 2011-06-15 |
Editorial, opinion pieces respond to GAVI pledging conference |
None |
| 2011-06-15 |
APP announces $38 million expansion of New York manufacturing facility |
None |
| 2011-06-15 |
Researchers reveal how anti-arrhythmic drugs control irregular heartbeats |
None |
| 2011-06-15 |
Meningitis vaccine showing success in West Africa |
None |
| 2011-06-15 |
Study investigates effects of dopamine replacement therapy on cognition in patients with Parkinson's |
None |
| 2011-06-15 |
Large donations help GAVI raise $4.3B, exceeding goal |
None |
| 2011-06-15 |
Jamieson introduces UC-II undenatured collagen to relieve osteoarthritis pain |
None |
| 2011-06-15 |
OCuSOFT, Ardeo partner to distribute novel dry eye therapy in the U.S. and Canada |
None |
| 2011-06-15 |
TIA, CONRAD enter license agreement to manufacture and distribute Tenofovir1% gel in Africa |
None |
| 2011-06-15 |
PDR launches new online network to collect, distribute adverse drug events in the U.S. |
None |
| 2011-06-15 |
GSK, Arecor enter license agreement to develop advanced formulations of vaccines |
None |
| 2011-06-15 |
New FDA rules for sunscreen labels |
3 |
| 2011-06-15 |
FDA approves Abbott's CREON capsules for treatment of EPI due to cystic fibrosis |
None |
| 2011-06-14 |
Abbott’s CREON receives FDA approval for infant-specific dose |
None |
| 2011-06-14 |
Boiron launches new natural and non-steroidal products for athletes to treat muscle pain |
None |
| 2011-06-14 |
FDA extends Pacira's EXPAREL PDUFA goal date by three months |
None |
| 2011-06-14 |
Humira defect lawyers file suit against Abbott Laboratories in federal court |
1 |
| 2011-06-14 |
Universal influenza vaccination may reduce health care costs in the U.S. |
None |
| 2011-06-14 |
C-Path, IMI sign MoU to accelerate development of safer, more effective medicines for patients |
None |
| 2011-06-14 |
B. Braun receives FDA approval to use 1g and 2g Ceftazidime in DUPLEX Drug Delivery System |
None |
| 2011-06-14 |
CTI completes pixantrone NDA resubmission meeting with FDA's Division of Oncology Drug Products |
None |
| 2011-06-14 |
Dengue vaccine could be available in four years |
None |
| 2011-06-14 |
Cypress receives FDA approval for ZUTRIPRO, REZIRA NDA to treat cough and common cold |
None |
| 2011-06-13 |
Nose spray vaccine for type 1 diabetes could be a reality soon |
None |
| 2011-06-13 |
Formaldehyde & other chemicals declared carcinogenic: Report |
None |
| 2011-06-13 |
New drug more effective than standard treatment to prevent heart-attack deaths |
None |
| 2011-06-13 |
Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines |
None |
| 2011-06-13 |
Servier, Cortex sign new option agreement for AMPAKINE technology |
None |
| 2011-06-13 |
Mystic's key manufacturing technology for drug, biologic delivery systems receives U.S. patent |
None |
| 2011-06-13 |
New decade of vaccines |
None |
| 2011-06-13 |
Risky behavior, psychiatric disorders and substance abuse contribute to opioid overdose |
None |
| 2011-06-13 |
New swine flu variant shows some resistance to drugs, report says |
None |
| 2011-06-13 |
FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures |
None |
| 2011-06-13 |
Low-cost meningitis vaccine cuts cases in African countries, data show |
None |
| 2011-06-13 |
Hanwha, Merck partner to develop and commercialize HD203 |
None |
| 2011-06-13 |
Valeant Pharmaceuticals receives FDA approval for Potiga |
None |
| 2011-06-13 |
LA/hypnosis combination during surgery can aid healing process, reduce drug use and hospital stay time |
None |
| 2011-06-13 |
Breckenridge receives final FDA approval for Letrozole ANDA |
None |
| 2011-06-13 |
Merck receives FDA approval for redesigned drug container labels |
None |
| 2011-06-10 |
Larger trial study needed to decide fate of niacin |
None |
| 2011-06-10 |
Experts discuss impact of new vaccines on global health |
None |
| 2011-06-10 |
Researchers and advocates form new vaccine foundation |
None |
| 2011-06-10 |
Amylin disappointed with U.S. District Court's ruling in BYETTA preliminary injunction |
None |
| 2011-06-10 |
Mothers' B vitamin intake protects children against intestinal tumors |
None |
| 2011-06-10 |
LGL to host third annual pharmacogenetic conference on 8-9th November 2011 |
None |
| 2011-06-10 |
FDA grants Fast Track Designation for Emergent BioSolutions' NuThrax vaccine |
None |
| 2011-06-09 |
Drugs for enlarged prostate raise cancer risk |
None |
| 2011-06-09 |
New vaccines on the horizon |
None |
| 2011-06-09 |
Respira introduces breakthrough Dry Powder Inhaler |
None |
| 2011-06-09 |
New vaccine leads to dramatic fall in meningitis A cases |
None |
| 2011-06-09 |
University of Mississippi grants ChromaDex global rights to pterostilbene |
None |
| 2011-06-09 |
Merck announces changes to high-dose simvastatin prescribing information in the U.S. |
1 |
| 2011-06-09 |
JDRF, Selecta Biosciences partner to develop type 1 diabetes vaccine |
None |
| 2011-06-09 |
Ameritox launches Rx Guardian CD, next-generation pain-medication monitoring solution |
None |
| 2011-06-09 |
U.S. FDA announces safety label changes for cholesterol-lowering medication, simvastatin |
None |
| 2011-06-09 |
Agensys, Seattle Genetics to co-develop second antibody-drug conjugate for multiple solid tumors |
None |
| 2011-06-09 |
IPS examines negotiations over intellectual property laws affecting generic AIDS drugs |
None |
| 2011-06-08 |
Paladin to commercialize Silenor for treatment of insomnia in Canada, South America and Africa |
None |
| 2011-06-08 |
Therapeutic equivalent to replace penicillin |
None |
| 2011-06-08 |
Adoption of premium-priced sclerotherapy agents will contribute to growth of US sclerotherapy market |
None |
| 2011-06-08 |
Novation recognizes APP with NOVAPLUS Pharmacy Manufacturer of the Year |
None |
| 2011-06-08 |
GSK, Crucell to test second-generation malaria vaccine |
None |
| 2011-06-08 |
GAVI appeals for $3.7B ahead of pledging conference despite lower vaccine prices |
None |
| 2011-06-08 |
OzHealth Pharma, Moberg Derma partner to distribute Emtrix in Australia and New Zealand |
None |
| 2011-06-08 |
Bio-Nucleonics resumes production of metastatic cancer drug, Strontium-89 |
None |
| 2011-06-08 |
FDA grants orphan drug designation for Edison's EPI-743 to treat inherited mitochondrial diseases |
None |
| 2011-06-08 |
Combined contraceptive pill does not cause weight gain in young women |
None |
| 2011-06-08 |
FDA approves Mylan's ANDA for Donepezil HCl Tablets to treat dementia linked with Alzheimer's |
None |
| 2011-06-07 |
Thermo Fisher Scientific launches new triple quadrupole gas chromatography-mass spectrometry system |
None |
| 2011-06-07 |
Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis |
5 |
| 2011-06-07 |
FDA accepts Topaz's ivermectin NDA for treatment for head lice infestations |
None |
| 2011-06-07 |
Zoledronate at lower dose effective in reducing risk of osteoporotic fractures |
None |
| 2011-06-07 |
Intrexon, Halozyme partner to develop subcutaneous alpha 1-antitrypsin for A1AT deficiency |
2 |
| 2011-06-07 |
Bayer HealthCare seeks EU marketing authorization of VEGF Trap-Eye for treatment of wet AMD |
None |
| 2011-06-07 |
EC approves Biogen Idec's AVONEX PEN to treat multiple sclerosis |
None |
| 2011-06-07 |
Increases in VEGF-family markers in metastatic colorectal cancer patients associated with Avastin resistance |
None |
| 2011-06-07 |
APP to commence marketing Letrozole Tablets for breast cancer in the U.S. |
None |
| 2011-06-07 |
Female cancer survivors benefit from natural nutritional supplement |
None |
| 2011-06-07 |
FDA issues revised PDUFA date for Lannett's Morphine Sulfate Oral Solution NDA |
None |
| 2011-06-07 |
Testosterone spray may slow cognitive decline in post-menopausal women |
None |
| 2011-06-07 |
Women with low bone density more likely to benefit from bisphosphonate drug |
None |
| 2011-06-07 |
Actavis receives final FDA approval for Zolpidem ER Tablets |
None |
| 2011-06-07 |
Focus on getting more people on antiretroviral therapy as AIDS turns 30 |
None |
| 2011-06-06 |
PATH malaria vaccine initiative to collaborate with GSK and Crucell in development of 2nd-generation malaria vaccine |
4 |
| 2011-06-06 |
Several drug makers plan to lower prices of vaccines for GAVI purchase |
None |
| 2011-06-06 |
Dr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US |
None |
| 2011-06-06 |
Ganeden Biotech sells Sustenex and Digestive Advantage to Schiff for $40 million |
None |
| 2011-06-06 |
TenX BioPharma grants Emergent BioSolutions rights to zanolimumab |
2 |
| 2011-06-06 |
FDA grants orphan drug designation for Aradigm's ciprofloxacin to manage bronchiectasis |
None |
| 2011-06-06 |
FDA accepts Sunovion ciclesonide HFA nasal aerosol NDA for review |
None |
| 2011-06-06 |
Topiramate drug can help people lose weight |
None |
| 2011-06-06 |
Formoterol medication shows promise for improving fat and protein metabolism in men |
None |
| 2011-06-06 |
Bharat Biotech announces the pricing for ROTAVAC vaccine |
None |
| 2011-06-06 |
Formoterol drug improves fat burning and protein metabolism in men |
None |
| 2011-06-06 |
Anti-ghrelin vaccine decreases food intake and increases calorie burning in mice |
None |
| 2011-06-05 |
New skin cancer drug brings hope |
None |
| 2011-06-05 |
GAVI welcomes lower pentavalent vaccine price |
None |
| 2011-06-05 |
Safety of birth control pills under scrutiny |
None |
| 2011-06-04 |
Scientists find way to protect kidney from cancer drug toxicity |
None |
| 2011-06-04 |
HRT reduces risk of breast cancer in women with BRCA mutations after ovary removal |
5 |
| 2011-06-04 |
Recommendations on new cancer drug review process fall short in several ways: CCAC |
None |
| 2011-06-04 |
International drug policy panel calls for legalization of some drugs, de-criminalizing drug use |
None |
| 2011-06-04 |
Department of Health urges caregivers, parents to update students' immunizations |
None |
| 2011-06-04 |
Enzyme Research journal publishes new peer-reviewed article involving Protandim |
None |
| 2011-06-04 |
PTEN does not reduce effectiveness of breast cancer drug, Herceptin: Study |
None |
| 2011-06-04 |
Study assesses public's willingness to consider pre-exposure prophylaxis for HIV prevention |
None |
| 2011-06-04 |
Gabapentin medication induces anorgasmia in older and elderly patients |
3.5 |
| 2011-06-04 |
Decreasing iron-storing protein expression can enhance action of brain cancer therapy: Researchers |
None |
| 2011-06-04 |
Patent infringement suit filed against Impax Laboratories in connection with Detrol |
None |
| 2011-06-04 |
Research in progress for novel protein kinase inhibitors: GEN |
None |
| 2011-06-04 |
Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer |
None |
| 2011-06-03 |
Bexarotene and erlotinib drugs effective in treating advanced lung cancer |
None |
| 2011-06-03 |
Preclinical study: Combination therapy of SPX-106 and D-tagatose reduces triglycerides and cholesterol |
None |
| 2011-06-03 |
Watson seeks FDA approval to market generic version of Pfizer's Viagra |
None |
| 2011-06-03 |
Longer looks: Is American medicine destroying itself? |
None |
| 2011-06-03 |
Orexigen meets FDA to gain clarity on approval for Contrave NDA to treat obesity |
None |
| 2011-06-03 |
Insight into beneficial epilepsy treatments for children with autism |
None |
| 2011-06-03 |
UC review finds rate of rtPA treatment for ischemic stroke in the U.S. doubled since 2005 |
None |
| 2011-06-03 |
Syndax receives U.S. patent for entinostat to treat metastatic cancers |
None |
| 2011-06-03 |
PQA honors Kaiser Permanente for outstanding performance in medication safety |
None |
| 2011-06-03 |
FDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat depressive, anxiety disorder |
None |
| 2011-06-02 |
Repligen announces completion of RG1068 pre-New Drug Application meeting with U.S. FDA |
None |
| 2011-06-02 |
Teva receives FDA approval to market Eisai's Alzheimer's treatment Aricept Tablets in the U.S. |
None |
| 2011-06-02 |
XTL receives FDA Orphan-drug designation for rHuEPO drug to treat Multiple Myeloma |
None |
| 2011-06-01 |
China's SFDA grants production license to TPI anti-diabetic drug Gliclazide |
None |
| 2011-06-01 |
EMA accepts Pfizer's filing of axitinib for regulatory review to treat advanced renal cell carcinoma |
None |
| 2011-06-01 |
Alexion's sBLA for Soliris receives FDA Priority Review designation to treat aHUS |
None |
| 2011-06-01 |
Spanish Medicines Agency grants IMP License to Midatech's clinical grade nanoparticles |
None |
| 2011-06-01 |
UNICEF publishes vaccine costs in an effort to promote price competition |
None |
| 2011-06-01 |
Lymphoma vaccine extends disease-free survival by 14 months |
None |
| 2011-06-01 |
FDA approves Actavis’ Donepezil Hydrochloride 5mg and 10mg tablets |
None |
| 2011-06-01 |
FDA approves APP Pharmaceuticals' Piperacillin and Tazobactam for Injection |
None |
| 2011-06-01 |
E64d reduces Aβ levels and improves memory function in brains of Alzheimer's disease mice |
None |
| 2011-06-01 |
Suberoylanilide hydroxamic acid holds promise against familial frontotemporal dementia |
None |
| 2011-06-01 |
MorphoSys to start share buy-back |
None |
| 2011-06-01 |
European Commission grants Orphan Drug Designation for CSL Behring's rVIIa-FP to treat hemophilia |
None |
| 2011-06-01 |
Eculizumab effective for treating hemolytic-uremic syndrome from EHEC |
None |
| 2011-06-01 |
Type II diabetes drug may slow or stop breast cancer tumor metastasis |
1 |
| 2011-06-01 |
Centocor Ortho Biotech, AVEO sign license deal to develop, commercialize RON-targeted antibodies |
None |
| 2011-06-01 |
Birth control pill safety issues raised |
None |
| 2011-05-31 |
FDA approves Oceana's Solesta for treatment of fecal incontinence |
None |
| 2011-05-31 |
Defiante, Dyax expand KALBITOR partnership to treat hereditary angioedema |
None |
| 2011-05-31 |
YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation |
None |
| 2011-05-31 |
Takeda, Affymax submit peginesatide NDA to FDA for treatment of anemia linked with chronic renal failure |
None |
| 2011-05-31 |
BioAlliance's appeals in SpePharm litigation rejected |
None |
| 2011-05-31 |
Scientists develop carbohydrate-based vaccine against C. difficile infection |
None |
| 2011-05-31 |
Cancer drug helps prevent hypertensive heart disease |
None |
| 2011-05-30 |
National Pharmacovigilance Programme to increase awareness about benefits of adverse event reporting |
None |
| 2011-05-30 |
Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence |
None |
| 2011-05-30 |
Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrhea |
None |
| 2011-05-29 |
Cholesterol drug Niaspan fails to protect heart: Study |
None |
| 2011-05-29 |
Flu vaccines at the ready this season |
None |
| 2011-05-29 |
Efficacy of Abbott cholesterol drug in question |
4 |
| 2011-05-27 |
Emergent in active discussions with U.S. government for multi-year supply of BioThrax to the SNS |
None |
| 2011-05-27 |
Blue Cross and Blue Shield FEP pharmacy benefit management program awarded to CVS Caremark |
None |
| 2011-05-27 |
Nature special issue focuses on vaccines |
None |
| 2011-05-27 |
Study: Cardiovascular disease may be under treated in rheumatoid arthritis patients |
None |
| 2011-05-27 |
IDF applauds Representatives for Medicare IVIG Access Act |
None |
| 2011-05-27 |
Sanofi-Aventis, Medtronic under scrutiny in press reports |
None |
| 2011-05-27 |
Two new hepatitis C drugs effectively improve cure rates of African Americans |
1 |
| 2011-05-27 |
Mylan plans to change name of Matrix Laboratories |
None |
| 2011-05-27 |
Leukemia, psoriasis drugs may treat vascular diseases |
None |
| 2011-05-27 |
Research sheds light on how painkillers could prevent or slow down cancer growth |
None |
| 2011-05-27 |
Abiraterone acetate effective for men with advanced prostate cancer |
None |
| 2011-05-27 |
Omega-3 fatty acids reduce risk of heart attack in stent patients |
None |
| 2011-05-27 |
Long-term exposure to estrogen increases high blood pressure in women |
5 |
| 2011-05-27 |
Pro-Pharmaceuticals announces name change to Galectin Therapeutics |
None |
| 2011-05-27 |
MAP Pharmaceuticals submits LEVADEX NDA to FDA for treatment of migraine in adults |
None |
| 2011-05-26 |
Invida announces launch of novel atopic dermatitis symptomatic treatment |
None |
| 2011-05-26 |
Gerber Products receives first qualified health claim from FDA for infant formulas |
None |
| 2011-05-26 |
HPV vaccination does not affect rate of disease flares in patients with SLE, study finds |
None |
| 2011-05-26 |
IPS examines access to medicine in Malawi |
None |
| 2011-05-26 |
Studies find antibiotics overused for children with asthma, urinary tract infections |
None |
| 2011-05-26 |
Nurses can play vital role in increasing patients' adherence to cancer-fighting medication |
None |
| 2011-05-26 |
U.S. District Court grants temporary restraining order in Amylin's litigation against Lilly |
None |
| 2011-05-26 |
Paxil and Pravachol in combination cause unexpected increase in blood glucose levels |
None |
| 2011-05-26 |
Metyrapone reduces brain's ability to re-record negative emotions associated with recalling painful memories |
None |
| 2011-05-26 |
Study shows positive link between percentage of motile sperm and serum vitamin D levels |
None |
| 2011-05-26 |
Lx Therapies, BioCis partner to form Laurantis Pharma |
None |
| 2011-05-25 |
Scarcity of resources calls for equitable distribution system for novel HCV treatment |
1 |
| 2011-05-25 |
Comtex SmarTrend ranks POZEN as second most efficient pharmaceutical company |
None |
| 2011-05-25 |
Pharmaceutical Executive's Ad Stars, DTC Perspectives recognize Auxilium and Heartbeat work |
None |
| 2011-05-25 |
AFP examines expansion of Indian drug companies in South Africa |
None |
| 2011-05-25 |
Study provides insight into effective treatments for autism spectrum disorder, seizures |
None |
| 2011-05-25 |
BPD expands existing bioprocess and scale-up laboratory in Poway, CA |
1 |
| 2011-05-25 |
New combination therapy eradicates acute lymphoblastic leukemia in children, older adults |
None |
| 2011-05-25 |
3M Skin and Wound Care introduces Tegaderm Diamond Dressing with Comfort Adhesive Technology |
2.5 |
| 2011-05-24 |
Study offers hope for reducing incidence of AIDS with potential preventive vaccine |
None |
| 2011-05-24 |
Provepharm obtains European marketing authorization for its Methylthioninium Chloride Proveblue |
None |
| 2011-05-24 |
New study finds drug's side effect labeling have ballooned in size |
None |
| 2011-05-24 |
Scientific evidence supports benefits of sunscreen usage to prevent skin cancer |
None |
| 2011-05-24 |
Fluorinated glucosamine blocks synthesis of key sugar linked to skin inflammation, cancer progression |
None |
| 2011-05-24 |
Exosome Diagnostics announces expansion of scientific advisory board |
None |
| 2011-05-24 |
IPS examines subsidized malaria drugs in Kenya |
None |
| 2011-05-24 |
Long-term, regular acetaminophen use may be associated with lower prostate cancer risk |
None |
| 2011-05-24 |
Vertex Incivek receives FDA approval for treatment of chronic hepatitis C |
None |
| 2011-05-24 |
FDA approves Taro's ANDA for Cetirizine Hydrochloride Oral Solution |
None |
| 2011-05-23 |
Key U.S. patents increase commercial rights and clinical indications |
None |
| 2011-05-23 |
FDA approves Amneal's generic Furadantin |
None |
| 2011-05-23 |
Vertex receives FDA approval for INCIVEK to treat hepatitis C |
3 |
| 2011-05-23 |
Nano-complex pre-meal dietary supplement can reduce fat and sugar absorption in the body |
3 |
| 2011-05-23 |
Mylan introduces Divalproex Sodium Capsules for treatment of seizures |
None |
| 2011-05-23 |
Novel compound could become an effective alternative to common narcotic analgesics |
None |
| 2011-05-23 |
Sosei to introduce NorLevo oral emergency contraceptive in Japan |
None |
| 2011-05-22 |
Verizon Wireless and Medco unveil mobile medication app with real-time patient-specific drug safety |
None |
| 2011-05-22 |
Avandia withdrawal from shelves by November: FDA |
None |
| 2011-05-21 |
FDA approves SUTENT for treatment of pancreatic NET |
None |
| 2011-05-21 |
Many 'legal high' drugs sold on the internet do not contain ingredients they claim |
None |
| 2011-05-21 |
Some cancer patients go without drugs because of high cost |
None |
| 2011-05-21 |
U.S. District Court grants Cephalon Temporary Restraining Order for generic AMRIX |
None |
| 2011-05-21 |
New study raises doubts about benefits of ezetimibe in patients suffering from high LDL cholesterol |
5 |
| 2011-05-21 |
Edurant receives FDA approval for treatment of HIV-1 infection |
None |
| 2011-05-21 |
Local production of pharmaceuticals could improve access in developing countries, U.N. report says |
None |
| 2011-05-21 |
Feeding SimplyThick to premature infants may cause NEC, warns FDA |
None |
| 2011-05-21 |
FDA approves Sutent for patients with progressive neuroendocrine cancerous tumors in pancreas |
None |
| 2011-05-20 |
Most paediatric paracetamol prescriptions fails to comply with BNFc recommendations |
None |
| 2011-05-20 |
EMA CHMP recommends conditional marketing authorization of FAMPYRA |
None |
| 2011-05-20 |
EMA CHMP recommends positive opinion for marketing authorization of Amgen's XGEVA |
None |
| 2011-05-20 |
Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection |
None |
| 2011-05-20 |
EMA CHMP issues positive opinion for marketing approval of BENLYSTA |
None |
| 2011-05-20 |
Cholesterol drug may help treat mitochondrial diseases |
1 |
| 2011-05-20 |
'No magic pill' for HIV prevention |
None |
| 2011-05-20 |
Abbott appreciates FDA Advisory Committee recommendations to retain Trilipix indication for mixed dyslipidemia |
None |
| 2011-05-20 |
Naltrexone improves clinical, inflammatory activity in Crohn's disease patients |
None |
| 2011-05-20 |
Study: Costs get in way of cancer patients refilling their prescriptions |
None |
| 2011-05-19 |
Medical food resolves metabolic syndrome and cardiovascular risk factors |
None |
| 2011-05-19 |
Viagra helps reduce clinical signs of multiple sclerosis |
None |
| 2011-05-19 |
AVAC calls on donors, policy makers to strengthen support for AIDS vaccine research |
None |
| 2011-05-19 |
USPTO grants four key patents for Alvine's proteases to detect celiac disease |
None |
| 2011-05-19 |
Study: 10% of cancer patients fail to fill initial oral oncolytic prescriptions |
None |
| 2011-05-19 |
Modified vitamin A drug may help prevent age-related macular degeneration |
None |
| 2011-05-19 |
Generic drugs to rule the market in the near future: Experts |
None |
| 2011-05-19 |
Panel votes 20-0 for reformed labeling of kids’ pain & fever relieving medication |
None |
| 2011-05-19 |
Aspirin, simvastatin not effective in combating pulmonary artery hypertension |
4 |
| 2011-05-19 |
APP receives FDA approval to market Gemcitabine HCI for Injection, USP in 2 g dosage |
None |
| 2011-05-19 |
Alemtuzumab as effective as other more expensive immune suppressants for kidney transplants |
2 |
| 2011-05-19 |
New breast cancer biomarker may help identify women's response to tamoxifen |
None |
| 2011-05-19 |
Global health partnership announces first-, second-line AIDS drugs price reductions in developing world |
None |
| 2011-05-18 |
Study reveals weakness of pharmacies' clinical decision support software in evaluating drug-drug interactions |
None |
| 2011-05-18 |
Haiti presents plan to immunize 90 percent of newborns |
None |
| 2011-05-18 |
Silodosin helps reduce chronic prostatitis in men |
2.5 |
| 2011-05-18 |
Study: 80% of U.S. physicians use Herceptin for HER2-positive metastatic gastric cancer treatment |
None |
| 2011-05-18 |
UW C4C, Pharmigene execute licensing agreement for warfarin personalized medicine technology |
None |
| 2011-05-18 |
Bill Gates calls for greater immunization efforts in World Health Assembly address |
None |
| 2011-05-18 |
Two drug makers will disclose prices they charge UNICEF for vaccines |
None |
| 2011-05-18 |
Study finds three-month TB treatment regimen just as effective as standard longer course |
None |
| 2011-05-18 |
Teva, ERYtech Pharma sign long term distribution agreement for Graspa in Israel |
None |
| 2011-05-18 |
Opinion: Study will unite HIV advocates, add funding pressure to Obama administration |
None |
| 2011-05-17 |
Daiichi Sankyo, Regency Therapeutics launch SPRIX Nasal Spray for severe pain |
None |
| 2011-05-17 |
Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds |
None |
| 2011-05-17 |
Pfizer seeks U.S. FDA, Japanese MHLW approval for crizotinib NDA to treat ALK-positive advanced NSCLC |
None |
| 2011-05-17 |
Nordic Naturals' dietary supplements earn NSF certification |
1 |
| 2011-05-17 |
Antiretrovirals important to protect HIV-positive children from measles |
None |
| 2011-05-17 |
World Health Assembly begins in Geneva |
None |
| 2011-05-17 |
Novel topically-applied molecular microbicide protects women against HIV infection |
None |
| 2011-05-17 |
Eli Lilly responds to Amylin's exenatide lawsuit |
None |
| 2011-05-17 |
Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide |
None |
| 2011-05-17 |
Epichem signs exclusive distributor agreement with AR Brown |
None |
| 2011-05-17 |
Benitec raises AU$8 million for gene silencing therapeutics |
None |
| 2011-05-17 |
Abcc10 might help counter resistance and extend effectiveness of anticancer drugs |
None |
| 2011-05-17 |
GPSA, Sanofi partner to develop and commercialize GBR 500 for inflammatory disease treatment |
None |
| 2011-05-17 |
Perrigo's ANDA for generic Zantac 150 receives FDA final approval to treat heartburn |
None |
| 2011-05-17 |
FDA nod for hepatitis C drug |
None |
| 2011-05-17 |
Opinion: New HIV infections more expensive than providing antiretroviral drugs to existing patients |
None |
| 2011-05-16 |
FDA warns consumers about look like antimicrobial dietary supplements |
None |
| 2011-05-16 |
Mylan introduces Bromfenac Ophthalmic Solution for cataract postoperative inflammation treatment |
None |
| 2011-05-16 |
Amylin files lawsuit against Eli Lilly for improper commercialization of exenatide |
None |
| 2011-05-16 |
Study finds no potential cardiovascular risks of ADHD medications in children, adolescents |
None |
| 2011-05-16 |
Study: HIV treatment drugs slash transmission risk |
None |
| 2011-05-16 |
Formoline L112 effectively aids weight loss |
4.5 |
| 2011-05-16 |
Counterfeit medicines posing increasing risk to patients worldwide, U.N. agency says |
None |
| 2011-05-16 |
Karo Bio symposium to discuss research on ER-beta and therapeutic applications |
None |
| 2011-05-16 |
Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS |
None |
| 2011-05-16 |
pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment |
None |
| 2011-05-16 |
Vitamin D may improve exercise capacity, respiratory muscle strength in COPD patients |
4 |
| 2011-05-16 |
Obese men may face high risk of prostate cancer progression |
None |
| 2011-05-16 |
Mylan introduces Cyclobenzaprine HCl ER Capsules, a muscle relaxant |
None |
| 2011-05-16 |
Merck receives FDA approval for Victrelis to treat chronic hepatitis C |
None |
| 2011-05-13 |
Scientists 'tinker' with HIV drug chemistry hoping to reduce costs |
None |
| 2011-05-13 |
China's SFDA approves TPI anti-diabetic drug Gliclazide |
None |
| 2011-05-13 |
Mylan introduces Risperidone Orally Disintegrating Tablets for schizophrenia treatment |
None |
| 2011-05-13 |
Patients with sickle cell disease may require higher, frequent doses of morphine |
None |
| 2011-05-13 |
Rethink praises Ontario's decision to provide breast cancer patients with access to Herceptin |
None |
| 2011-05-13 |
Majority of high-risk heart disease patients have poor adherence to statin treatment |
None |
| 2011-05-13 |
Hydroxyurea safe and effective for infants, toddlers with sickle-cell disease |
None |
| 2011-05-12 |
Researchers help explain why smart drugs are not effective in some cancer patients |
None |
| 2011-05-12 |
ETI finalizes proprietary progesterone formulations for Traumatic Brain Injury |
None |
| 2011-05-12 |
Linguamatics releases I2E. Version 3.2 software for pharmaceutical companies |
None |
| 2011-05-12 |
New organocatalyst now available for drug development industry |
None |
| 2011-05-12 |
Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomiting |
None |
| 2011-05-12 |
Antiretroviral therapy can reduce risk of HIV transmission in couples |
None |
| 2011-05-12 |
Losartan therapy improves muscle injury regeneration and prevents disuse atrophy |
None |
| 2011-05-12 |
Scientists develop promising vaccine formulations to treat methamphetamine addiction |
None |
| 2011-05-12 |
VGTI, OHSU's new vaccine candidate may fight against HIV |
None |
| 2011-05-12 |
Researchers look for surrogate endpoints to predict early benefit of cancer drugs |
None |
| 2011-05-12 |
FDA accepts EffRx NDA for EX101 to treat osteoporosis |
None |
| 2011-05-12 |
Neogenix Oncology to receive European Patent for NEO-301 antibody for treatment of pancreatic cancer |
None |
| 2011-05-12 |
FDA accepts Insys NDA for Fentanyl SL Spray to treat breakthrough cancer pain |
None |
| 2011-05-12 |
ViroPharma, Halozyme sign license deal to develop Cinryze against hereditary angioedema |
None |
| 2011-05-11 |
Injecting botox in 'trigger points' of pericraneal and neck muscles reduces migraine frequency |
None |
| 2011-05-11 |
SAFC, Oncolytics Biotech sign commercial supply agreement for REOLYSIN |
None |
| 2011-05-11 |
AspirinWorks Test now available in greater Boston and surrounding area |
None |
| 2011-05-11 |
Baylor has now patented new polarimeter that could prove useful in pharmaceuticals |
None |
| 2011-05-11 |
Amylin, JDRF collaborate to investigate combination therapy for type 1 diabetes treatment |
None |
| 2011-05-11 |
NAA calls for immediate Congressional hearings and scientific investigation into autism-vaccine link |
5 |
| 2011-05-11 |
U.S. biopharmaceutical companies to benefit from Almac's European Product Launch workshop |
None |
| 2011-05-11 |
EMD Millipore inaugurates new Shanghai Biopharmaceutical Technical Center |
None |
| 2011-05-11 |
Adherence to disease-modifying drugs is low in patients with multiple sclerosis |
None |
| 2011-05-11 |
Genentech submits vemurafenib NDA for BRAF V600 mutation-positive metastatic melanoma |
None |
| 2011-05-11 |
BioAlliance Pharma enters license deal with Sosei to commercialize Loramyc in Japan |
None |
| 2011-05-11 |
Sosei acquires rights to Loramyc in Japan from BioAlliance Pharma |
None |
| 2011-05-11 |
Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis |
None |
| 2011-05-11 |
Govt. audit finds antipsychotic drugs often overused in nursing homes |
None |
| 2011-05-11 |
Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment |
None |
| 2011-05-11 |
NCL launches new public education campaign on medication adherence |
None |
| 2011-05-11 |
Major European conference on Nanomedicine to take place in Basel, Switzerland |
None |
| 2011-05-11 |
Allos, Mundipharma enter strategic collaboration to co-develop FOLOTYN |
None |
| 2011-05-10 |
AOBO's ZD Pill and CWJ Tablet receive Chinese approval for sales in Hong Kong |
None |
| 2011-05-10 |
HIV drugs can be used to target malaria and other parasitic diseases |
None |
| 2011-05-10 |
Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis |
None |
| 2011-05-10 |
Geron comments on recent European telomerase peptide cancer vaccine patents |
None |
| 2011-05-10 |
Study: Personality impacts medication adherence behaviour |
None |
| 2011-05-10 |
Pepscan, Phylogica collaborate for Phylomer peptide lead optimisation |
None |
| 2011-05-10 |
biocrea and Pfizer jointly presented details on novel PDE10 inhibitors |
None |
| 2011-05-10 |
ASA survey shows more than 90% of respondents experience anesthesia drug shortage |
None |
| 2011-05-10 |
Mathematical approach can make combination vaccines more affordable for developing countries |
None |
| 2011-05-10 |
Forest subpoenaed over hypertension medications |
None |
| 2011-05-10 |
Research finds 'no safe window' for painkiller use among heart attack survivors |
None |
| 2011-05-09 |
KAEL-GemVax wins European telomerase patent challenge |
None |
| 2011-05-09 |
OncoSec's tumor-destroying, tissue-sparing drug/device system profiled in Medical Device Daily |
None |
| 2011-05-09 |
Ideal psychotropic drug may cause physical dependence |
2.2 |
| 2011-05-09 |
Merrimack, PharmaEngine collaborate to develop and commercialize PEP02 in Asia and Europe |
None |
| 2011-05-09 |
Heptares, Shire sign deal to develop novel A2A antagonist for CNS disease treatment |
None |
| 2011-05-09 |
Merrimack acquires development and commercialization rights to MM-398 in Europe, Asia |
None |
| 2011-05-09 |
Elan Drug Technologies, Alkermes merge to form new company in Ireland |
None |
| 2011-05-09 |
Best Practices' report provides marketing, branding strategies for expanding multi-drug portfolio |
None |
| 2011-05-09 |
Adalimumab remains in newborn's bloodstream for at least three months |
None |
| 2011-05-09 |
Mithridion's MCD-386CR receives Orphan Drug designation from FDA for PSP treatment |
None |
| 2011-05-07 |
Cegedim Relationship Management's co-pay savings card programs presented at PMSA conference |
None |
| 2011-05-07 |
Current Opinion in Immunology journal publishes Inovio's article on DNA vaccines |
None |
| 2011-05-07 |
Medical societies still 'welcome' drug company support |
None |
| 2011-05-07 |
Study finds 4.5 million outpatient visits yearly due to adverse drug effects |
None |
| 2011-05-07 |
Alza files patent infringement suit against Impax in connection with Concerta |
None |
| 2011-05-07 |
Caisse des Dépôts, sanofi-aventis sign memorandum of understanding for Caisse des Dépôts Investment in Biocitech life science technology park |
None |
| 2011-05-07 |
FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas |
None |
| 2011-05-07 |
Novartis receives FDA approval for Afinitor to treat pancreatic neuroendocrine tumors |
None |
| 2011-05-06 |
Inhalation therapy might halt and reverse progression of pulmonary arterial hypertension |
None |
| 2011-05-06 |
SaveRxCanada.com reveals top reasons why U.S. customers select Canadian pharmacy |
None |
| 2011-05-06 |
Springer author earns ESCMID recognition for work in clinical microbiology and infectious diseases |
None |
| 2011-05-06 |
SAS Health Care & Life Sciences Executive Conference to discuss clinical research best practices |
None |
| 2011-05-06 |
TB medication variations in private markets could harm treatment efforts, study says |
None |
| 2011-05-06 |
Patent expiries, generic pricing policies may be factors in slow drug spending growth |
None |
| 2011-05-06 |
Savings projected from 'emerging' generic drugs |
None |
| 2011-05-06 |
FDA approves Novartis' Afinitor tablets for pancreatic NET treatment |
None |
| 2011-05-05 |
New drugs need to provide more data on how they compare with existing ones: Study |
None |
| 2011-05-05 |
Asthma ‘pill-a-day’ shows similar effectiveness as inhalers: Study |
None |
| 2011-05-05 |
Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension |
None |
| 2011-05-05 |
PhotoMedex introduces DNA Damage Control sunscreens |
None |
| 2011-05-05 |
Mylan launches Oxycodone and Aspirin Tablets for treatment of severe pain |
None |
| 2011-05-05 |
FDA releases final guidance to firms that market OTC drug products |
None |
| 2011-05-05 |
Devrom is effective for eliminating flatulence, stool odor issues |
4.6 |
| 2011-05-05 |
S*BIO regains North American, European rights to novel JAK2 inhibitors from Onyx |
None |
| 2011-05-05 |
NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign |
None |
| 2011-05-05 |
UCF to develop safe, inexpensive and effective polio vaccine |
None |
| 2011-05-05 |
Study: Bisphosphonates can cause fatigue fractures |
None |
| 2011-05-05 |
Leukotriene antagonists can serve as effective alternative to conventional asthma treatment |
None |
| 2011-05-05 |
Rockland produces new Anti-NF-κB monoclonal antibody |
None |
| 2011-05-05 |
TGen licenses ONCO-101 cancer drug to Syracuse |
None |
| 2011-05-04 |
Durata receives positive EMA Scientific Advice on dalbavancin clinical development plan |
None |
| 2011-05-04 |
Affitech, Cancer Research Technology sign deal to advance therapeutic antibodies |
None |
| 2011-05-04 |
Cocaine and nicotine employ similar mechanisms to induce synaptic plasticity in brain |
None |
| 2011-05-04 |
Study measures cost-effectiveness of trauma drug published in PLoS One |
None |
| 2011-05-04 |
Yale, Debiopharm partner to develop and commercialize Debio 1036 for inflammatory diseases |
None |
| 2011-05-04 |
NCPA explains how PBM tools can reduce costs in Texas, other states |
None |
| 2011-05-04 |
FTC, FDA take action on unproven STD drug products |
None |
| 2011-05-04 |
Ecstasy may cause long-term brain damage |
None |
| 2011-05-04 |
AHF cautions against fast track FDA-approval for expanded use of Gilead’s Truvada |
None |
| 2011-05-03 |
Merial, GenVec extend deal to develop and commercialize foot-and-mouth disease vaccine |
None |
| 2011-05-03 |
Study: Dual medications do not hasten recovery from depression |
None |
| 2011-05-03 |
NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals |
None |
| 2011-05-03 |
Lopinavir can combat HPV-related cervical cancer |
2.7 |
| 2011-05-03 |
New study: Text-heavy labels can reduce acetaminophen overdose |
None |
| 2011-05-03 |
Calcium and vitamin D intake before bone density test can reduce risk of osteoporosis |
None |
| 2011-05-03 |
AHA recommends Omega-3 EPA/DHA intake for individuals with elevated triglyceride levels |
None |
| 2011-05-03 |
CTI to re-submit pixantrone NDA to FDA's Office of New Drugs for re-review |
None |
| 2011-05-03 |
Desirudin more effective for VTE prevention in patients with renal impairment |
None |
| 2011-05-03 |
Althea enters commercial drug supply agreement with Biotest |
None |
| 2011-05-03 |
Winner Medical's PurCotton products introduced at MICF 2011 |
None |
| 2011-05-03 |
JPO issues patent to Silence Therapeutics' RNAi technology |
None |
| 2011-05-03 |
Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes |
None |
| 2011-05-03 |
HIV drugs may also combat parasitic diseases: Study |
None |
| 2011-05-03 |
More HIV infections linked to injection drug use in East Africa, report finds |
None |
| 2011-05-03 |
Statins can help reduce lung damage in severe abdominal sepsis |
5 |
| 2011-05-03 |
FDA approves Perrigo's Minoxidil Foam, a generic version of Men's Rogaine Foam |
None |
| 2011-05-03 |
Oragenics announces availability of oral care probiotics for children and adults |
None |
| 2011-05-03 |
AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis |
3.7 |
| 2011-05-03 |
Sanofi Pasteur, EnGen Bio and Dyadic Nederland sign research deal for vaccine development |
None |
| 2011-05-03 |
Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film |
None |
| 2011-05-03 |
Boehringer Ingelheim, Eli Lilly receive FDA approval for Tradjenta to treat type 2 diabetes |
None |
| 2011-05-02 |
Watson introduces generic version of Concerta |
None |
| 2011-05-02 |
Watson launches Generess Fe low-dose oral contraceptives in the U.S. |
None |
| 2011-05-02 |
FDA accepts SGEN's brentuximab vedotin BLAs for Hodgkin lymphoma, ALCL treatment |
None |
| 2011-05-02 |
Assessment tool may help identify newborn exposure to methamphetamine |
None |
| 2011-05-02 |
Talecris, Grifols enter 'Consent Agreement' with FTC Staff |
None |
| 2011-05-02 |
Temsirolimus with chemotherapy may serve as promising therapy for mesothelioma |
None |
| 2011-05-01 |
Many herbal medicines banned under EU directives |
None |
| 2011-04-30 |
Extensive folic acid fortification of foods prevents neural tube defects in neonates |
None |
| 2011-04-30 |
Bioniche Life Sciences opens new livestock vaccine manufacturing facility |
None |
| 2011-04-30 |
Prescriptions for narcotic-containing drugs often contain too much medication per dose |
None |
| 2011-04-30 |
AHF advocates to attend drug giant Abbott Laboratories' Annual General Meeting |
None |
| 2011-04-30 |
Centocor Ortho Biotech Products withdraws NDA for trabectedin for treatment of women with ROC |
None |
| 2011-04-30 |
Missouri American Water supports DEA's prescription drug collection program |
None |
| 2011-04-30 |
Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment |
None |
| 2011-04-30 |
FDA approves Abbott's AndroGel for hypogonadism treatment in men |
None |
| 2011-04-30 |
Spectrum receives FDA approval for FUSILEV to treat colorectal cancer |
None |
| 2011-04-29 |
New study identifies less invasive therapy for ACE inhibitor side-effects |
None |
| 2011-04-29 |
Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C |
None |
| 2011-04-29 |
Avastin, Lucentis are equally effective for age-related macular degeneration treatment |
None |
| 2011-04-29 |
Flu vaccination lowers kidney transplant recipients' risk of organ loss and death |
None |
| 2011-04-29 |
CTSN focuses on new prairie vole model for autism treatment |
None |
| 2011-04-29 |
Study finds low pediatric flu vaccination acceptance rates in Atlanta |
None |
| 2011-04-29 |
Bayer expands sponsorship agreement with World Federation of Hemophilia |
None |
| 2011-04-29 |
UMMS, RXi receive MLSC grant to develop RNAi therapeutics for ALS |
None |
| 2011-04-29 |
Researchers report Avastin is effective as Lucentis for AMD treatment |
2 |
| 2011-04-29 |
MorphoSys reaches second clinical milestone with OncoMed Pharmaceuticals |
None |
| 2011-04-29 |
Antibiotics may serve as effective treatment for appendicitis than surgery |
None |
| 2011-04-29 |
Longer looks: Autism researcher's legacy; methadone for prisoners |
None |
| 2011-04-29 |
Drug subsidy issues out of PBS’ hands - almost |
None |
| 2011-04-29 |
Celanese EVA Performance Polymers, PSI partner to develop drug-eluting devices |
None |
| 2011-04-29 |
Ramipril can effectively reduce risk of ESRD in obese patients |
None |
| 2011-04-28 |
UIC receives federal contract to develop antibiotics against three bacterial infections |
None |
| 2011-04-28 |
LEO Pharma introduces new Taclonex website for plaque psoriasis treatment |
5 |
| 2011-04-28 |
Centocor Ortho Biotech receives FDA approval for Zytiga to treat prostate cancer |
2 |
| 2011-04-28 |
Justices question Vermont's effort to restrict drug data mining |
None |
| 2011-04-28 |
Anesthetia does not appear to influence children's brain |
1 |
| 2011-04-28 |
AstraZeneca introduces new CRESTOR and NEXIUM customer service websites |
None |
| 2011-04-28 |
Novo Nordisk first quarter net profit increases 23% to DKK 4,073 million |
None |
| 2011-04-28 |
Study focuses on calcium intake among U.S. population |
None |
| 2011-04-28 |
Cotinine can reduce plaques linked with dementia and prevent memory loss |
None |
| 2011-04-28 |
Researchers begin approved drugs screening for clinical use against rare diseases |
None |
| 2011-04-28 |
Pfizer announces global launch of new child nutrition products |
None |
| 2011-04-28 |
Seattle BioMed study to identify biomarkers for malaria vaccine design |
None |
| 2011-04-28 |
NIH awards UH with $361,000 grant for chikungunya vaccine study |
None |
| 2011-04-28 |
Janssen, Beactica enter drug discovery agreement |
5 |
| 2011-04-28 |
FOIA request on Avastin filed with the FDA |
None |
| 2011-04-28 |
Study clarifies ginkgo's pain-reducing effects |
None |
| 2011-04-27 |
Promising pain medication may decrease ability to fight off sepsis |
None |
| 2011-04-27 |
CMAJ: Canada needs national pharmacare program |
None |
| 2011-04-27 |
Clinical study: Plant extract can fight effectively against hay fever |
None |
| 2011-04-27 |
Rwanda launches Africa's first nationwide cervical cancer vaccination, detection program |
None |
| 2011-04-27 |
Socioeconomic status linked to medication non-adherence in children with epilepsy |
None |
| 2011-04-27 |
MSF letter criticizes Johnson & Johnson for not joining Medicines Patent Pool |
None |
| 2011-04-27 |
High Court hears arguments regarding access to docs' prescribing data |
None |
| 2011-04-27 |
RegenceRx supports DEA program to raise awareness on unused prescription drugs |
None |
| 2011-04-27 |
EPO grants patent to Microbix' VIRUSMAX vaccine enhancement technology |
None |
| 2011-04-27 |
Rxi secures SBIR grants to develop novel RNAi therapeutics for ALS |
None |
| 2011-04-27 |
ISC-4 topical compound may prevent skin cancer lesion formation |
None |
| 2011-04-27 |
Azithromycin holds promise for preventing BPD in Ureaplasma-infected preterm infants |
None |
| 2011-04-27 |
Columbia requests FDA Priority Review for PROCHIEVE progesterone gel NDA |
None |
| 2011-04-27 |
FDA grants orphan drug status to Provectus' PV-10 for liver cancer treatment |
None |
| 2011-04-26 |
Lilly and Medtronic’s joint venture in Parkinson’s disease therapy |
None |
| 2011-04-26 |
Newer birth control pill raises risk of blood clots |
None |
| 2011-04-26 |
Durata attains global rights for dalbavancin to treat abSSSI |
None |
| 2011-04-26 |
Anti-inflammatory drugs reduce effectiveness of widely used antidepressant medications |
None |
| 2011-04-26 |
Collins, Orszag criticize Ryan plan; Santorum rues Medicare prescription benefit vote |
None |
| 2011-04-26 |
Ohio State Roundtable to discuss about cancer drug development |
None |
| 2011-04-26 |
Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45 |
None |
| 2011-04-26 |
Caliber opens world's largest plant-made pharmaceutical facility in Bryan |
None |
| 2011-04-26 |
Colorectal cancer patients with genetic mutation can benefit from new class of drugs |
None |
| 2011-04-26 |
Study: Women use more medications during pregnancy |
None |
| 2011-04-26 |
Survey: Pharmacists top OTC product picks in more than 77 total categories |
None |
| 2011-04-26 |
Unintentional prescription opioid overdose deaths have reached epidemic proportions in the U.S. |
None |
| 2011-04-26 |
Men with high DHA levels may face risk of developing aggressive prostate cancer |
None |
| 2011-04-26 |
FDA approves Bayer's new Kogenate FS storage option for hemophilia A treatment |
None |
| 2011-04-26 |
KemPharm to formulate and develop KP106 as oral film dosage for ADHD treatment |
None |
| 2011-04-26 |
Alkem, Karo Bio partner to license eprotirome |
None |
| 2011-04-26 |
Aquilent launches new vaccine government site to help citizens stay healthy |
None |
| 2011-04-26 |
Infants with bronchopulmonary dysplasia can benefit from azithromycin therapy |
None |
| 2011-04-26 |
GSK receives FDA approval for Lamictal XR to treat partial seizures |
None |
| 2011-04-26 |
Aetna achieves full pharmacy benefit management accreditation from URAC |
None |
| 2011-04-25 |
Kadmon Pharmaceuticals and Nano Terra announce worldwide licensing agreement |
None |
| 2011-04-25 |
NovaSterilis novel vaccine patent |
None |
| 2011-04-25 |
AstraZeneca selects Biologics as U.S. channel partner for vandetanib |
None |
| 2011-04-25 |
CryoLife's BioGlue Surgical Adhesive launched in Japan |
None |
| 2011-04-25 |
Mylan launches Letrozole Tablets for hormone receptor-positive early stage breast cancer |
None |
| 2011-04-25 |
Pro-Pharmaceuticals receives method patent regarding DAVANAT in Japan |
None |
| 2011-04-25 |
POZEN, AstraZeneca file lawsuit against Dr. Reddy's for patent infringement relating to VIMOVO |
None |
| 2011-04-25 |
AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer |
None |
| 2011-04-25 |
Supreme Court to weigh drug confidentiality laws |
None |
| 2011-04-25 |
Bayer's oral contraceptives may increase risk of blood clots, stroke or heart attack |
None |
| 2011-04-25 |
U.S. Court of Appeals rules in favour of Perrigo in PBM infant formula lawsuit |
5 |
| 2011-04-25 |
New study reports national survey results of physicians who deliver childhood vaccinations |
1 |
| 2011-04-25 |
Ahead of Immunization Week, WHO calls for countries to come together to control measles outbreak in Europe |
None |
| 2011-04-25 |
SAMHSA develops Metro Briefs on drug-related statistics across the nation |
None |
| 2011-04-25 |
U.N. Secretary-General calls for scale up of global malaria efforts ahead of World Malaria Day |
None |
| 2011-04-25 |
Research sheds light on molecular movements of neural transporters |
None |
| 2011-04-25 |
FDA approves Sanofi Pasteur's meningococcal vaccine |
None |
| 2011-04-25 |
AP reports on Global Fund malaria drug thefts, issues correction |
None |
| 2011-04-25 |
Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment |
None |
| 2011-04-25 |
Nano Terra, Kadmon sign deal to license novel product candidates |
None |
| 2011-04-25 |
Creative approach can tackle bacterial infections in patients with cystic fibrosis |
None |
| 2011-04-25 |
Californians for Patient Care reminds parents about affordable infants' immunizations |
None |
| 2011-04-25 |
Bayer's birth control pills may increase risk of venous thromboembolism |
None |
| 2011-04-24 |
Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease |
None |
| 2011-04-22 |
Rite Aid reduces price of whooping cough vaccine for children in California |
None |
| 2011-04-22 |
Daiichi Sankyo's LIXIANA receives Japanese marketing approval |
None |
| 2011-04-22 |
Luitpold temporarily suspends distribution of drug products manufactured at Shirley, New York facility |
None |
| 2011-04-22 |
United Water and NCPA embark on an effort to encourage safe disposal of unused medications |
None |
| 2011-04-22 |
Decision Resources: 63% of neurologists select Tysabri as effective MS treatment |
None |
| 2011-04-22 |
NPR: 3 in 4 prescriptions are for generic drugs |
None |
| 2011-04-22 |
Fleming ramps up production of ThyroShield to meet increased domestic and international demand |
None |
| 2011-04-22 |
Researchers discover new compound to fight against shingles |
None |
| 2011-04-22 |
FDA approves Spectrum's FUSILEV Injection to treat metastatic colorectal cancer |
None |
| 2011-04-22 |
GM-SCF therapy can reduce flu symptoms and prevent death |
None |
| 2011-04-22 |
EPO doping drug can reduce cerebral malaria related deaths |
1 |
| 2011-04-22 |
USPTO issues patent to Oragenics ProBiora3 for oral care |
None |
| 2011-04-21 |
WSU researcher develops potential vaccine for Chlamydia |
None |
| 2011-04-21 |
FDA warns four firms to stop making unproven MRSA prevention claims |
None |
| 2011-04-21 |
Watson Laboratories seeks FDA approval to market Colesevelam HCI tablets |
None |
| 2011-04-21 |
Salix Pharmaceuticals receives three U.S. patents relating to rifaximin |
None |
| 2011-04-21 |
Report: Prescription drug spending growth slows |
None |
| 2011-04-21 |
Neurelis completes dosing in intranasal diazepam formulation study |
None |
| 2011-04-21 |
Feds announce comprehensive plan to combat painkiller abuse |
None |
| 2011-04-21 |
Shanghai Pharmaceutical and Pfizer enter MOU to pursue potential business opportunities |
None |
| 2011-04-20 |
America’s best loved drugs: Report |
None |
| 2011-04-20 |
Stepped up measures to tack rising painkiller abuse |
None |
| 2011-04-20 |
Prism Pharmaceuticals to be acquired by Baxter |
None |
| 2011-04-20 |
Treatment for Bipolar Disorder now available in Nova Scotia Formulary |
None |
| 2011-04-20 |
Mylan launches Famciclovir Tablets |
None |
| 2011-04-20 |
Adeona, TG United enter commercial-scale manufacturing agreement for reaZin |
None |
| 2011-04-20 |
Forest acquires worldwide rights to novel antiarrhythmic agent azimilide |
None |
| 2011-04-20 |
Study demonstrates clinical effectiveness of Systagenix ADAPTIC TOUCH as a primary wound contact layer |
None |
| 2011-04-20 |
Covidien supports FDA’s REMS for important class of pain medications |
None |
| 2011-04-20 |
Rituxan receives FDA approval for treating two rare diseases |
None |
| 2011-04-20 |
TCI forecasts cancer vaccine market to approach $3 billion in 2015 |
None |
| 2011-04-20 |
Breakdown products of thalidomide cause birth defects: New study |
None |
| 2011-04-20 |
FDA approves Rituxan-corticosteroid combination for Wegener's Granulomatosis and Microscopic Polyangiitis |
5 |
| 2011-04-19 |
Plans to combat painkiller abuse |
None |
| 2011-04-19 |
EMA CHMP grants positive opinion for Biogen Idec's AVONEX PEN |
None |
| 2011-04-19 |
SafeMinds calls for immediate vaccine safety studies in autistic children |
None |
| 2011-04-19 |
Cumberland acquires Vanderbilt's ifetroban rights |
None |
| 2011-04-19 |
AADSM event to discuss latest advances in sleep-disordered breathing research |
None |
| 2011-04-19 |
Canada needs to modernize its pharmaceutical laws to ensure drug safety: CMAJ |
None |
| 2011-04-19 |
Seattle enters second ADC research collaboration agreement with Genmab |
None |
| 2011-04-19 |
BioSante, Aduro BioTech enter license agreement for GVAX cancer vaccines |
None |
| 2011-04-19 |
BioSante licenses Pancreas and Prostate cancer vaccines to Aduro BioTech |
None |
| 2011-04-19 |
Bedford Labs launches cancer drug Topotecan Hydrochloride for Injection |
None |
| 2011-04-19 |
Drospirenone doesn't carry any risk of gall bladder disease |
None |
| 2011-04-19 |
FDA approves Taro's Imiquimod Cream ANDA |
None |
| 2011-04-18 |
Pharma Tech expands agreement for Shasta Genstrip |
None |
| 2011-04-18 |
Baxter enters definitive agreement to acquire Prism |
None |
| 2011-04-18 |
Tibet Pharmaceuticals' updated online Investor Fact Sheet is now available in China |
None |
| 2011-04-18 |
FDA accepts Regeneron's VEGF Trap-Eye BLA for review |
None |
| 2011-04-18 |
iOWH's semisynthetic ART enters production, distribution phase to combat malaria |
None |
| 2011-04-18 |
Biotech Synergy concludes EP-2101 asset transfer, cancer epitopes related portfolio |
None |
| 2011-04-18 |
True 2 Beauty launches new sexual enhancement supplements |
None |
| 2011-04-18 |
CHMP adopts EU positive opinion for TYSABRI labeling with anti-JCV antibody status |
None |
| 2011-04-18 |
Ipsen, Active Biotech sign deal to co-develop and commercialize TASQ |
None |
| 2011-04-18 |
Scientists develop new compound for multiple sclerosis treatment |
None |
| 2011-04-18 |
Eye physicians need to include low-cost molecular medicine in their tool box |
None |
| 2011-04-18 |
Pharmatek receives U.S. DEA approval for Schedule I-V controlled substance analysis |
None |
| 2011-04-18 |
Patients with schizophrenia can benefit from L-lysine treatment |
4 |
| 2011-04-16 |
Scientists discover new clues about mechanism behind losartan drug's protective effects |
3 |
| 2011-04-16 |
Kakadu Complex can protect against high insulin levels |
2.5 |
| 2011-04-16 |
AHF commends U.S. Congress for strong bipartisan commitment to AIDS |
None |
| 2011-04-16 |
NVP-BEZ235 inhibits growth of ovarian cancer cells, increases survival: Study |
None |
| 2011-04-16 |
Probiotic may reduce rate of recurrent urinary tract infections in women |
None |
| 2011-04-16 |
Johnson & Johnson provides further details regarding distribution rights for REMICADE, SIMPONI |
None |
| 2011-04-16 |
Eli Lilly receives FDA complete response letter for liprotamase NDA |
None |
| 2011-04-16 |
Boehringer Ingelheim's dabigatran etexilate receives positive opinion from EMA committee |
None |
| 2011-04-15 |
U.S. District Court grants preliminary injunction to POZEN's Treximet patent lawsuit |
None |
| 2011-04-15 |
JNJ, Merck sign distribution agreement for REMICADE and SIMPONI |
None |
| 2011-04-15 |
Patients with COPD can benefit from ICS use |
None |
| 2011-04-15 |
Genentech receives FDA approval for Actemra to treat juvenile idiopathic arthritis |
None |
| 2011-04-15 |
EMA recommends lifting of suspension of marketing authorization for Octapharma's octagam |
None |
| 2011-04-15 |
New JAMA issue focuses on infectious diseases and immunology |
None |
| 2011-04-15 |
New mixed-carb plus protein formulation more effective for female athletes |
None |
| 2011-04-15 |
GSK announces safety profile of orlistat and alli |
None |
| 2011-04-15 |
Serotonin can help promote human intimacy and romantic feelings |
None |
| 2011-04-15 |
African genital herpes strains are more infectious than the U.S. virus |
None |
| 2011-04-15 |
AHRQ finds 52% increase in medication side effects, injuries between 2004 and 2008 |
None |
| 2011-04-15 |
Pharmaceuticals stored on space flights may have shorter shelf-life |
None |
| 2011-04-15 |
Takeda announces EDARBI availability in U.S. pharmacies for hypertension treatment |
None |
| 2011-04-15 |
Women consume more non-prescribed drugs than men |
None |
| 2011-04-15 |
Novartis, Duke sign deal to develop pandemic flu vaccine |
None |
| 2011-04-15 |
NRC, NCKU partner to develop cancer diagnostic and treatment technologies |
None |
| 2011-04-15 |
Consumer group calls for ban on weight loss drugs Alli and Xenical |
None |
| 2011-04-15 |
FDA accepts Teva's NDA filing of Bio-T-Gel for male hypogonadism |
None |
| 2011-04-15 |
Topamax recall by Johnson & Johnson |
None |
| 2011-04-15 |
Major pharmaceutical company, Access sign deal for RNAi therapeutics |
None |
| 2011-04-15 |
Ortho-McNeil Neurologics announces voluntary recall of TOPAMAX 100mg Tablets |
None |
| 2011-04-15 |
Scientists develop new test for premature babies |
None |
| 2011-04-15 |
Botox may offer new hope for patients with low cerebrospinal fluid headaches |
None |
| 2011-04-15 |
EPO grants patent to OncoGenex OGX-427 for prostate cancer treatment |
None |
| 2011-04-15 |
The Wistar Institute, Advaxis enter research collaboration |
None |
| 2011-04-12 |
FDA panel votes in favour of Sunitib (Sutent) for pancreatic tumors |
None |
| 2011-04-12 |
Breast cancer patients can benefit from new nanobodies |
None |
| 2011-04-12 |
Scientists discover how anti-depressants make new brain cells |
4 |
| 2011-04-12 |
Hypericin may treat recurrent malignant brain tumors |
None |
| 2011-04-12 |
Statin prior to major elective surgery can reduce serious kidney injury |
None |
| 2011-04-11 |
Alzheimer’s drug – a failure of sorts: Study |
None |
| 2011-04-11 |
GeoVax Labs expands its HIV/AIDS vaccine program with NIAID, NIH and HVTN |
None |
| 2011-04-11 |
Auxilium to receive $30 million from Pfizer following XIAPEX sale in EU market |
None |
| 2011-04-11 |
PAREXEL's QbD approaches can help pharma companies maximize product quality, safety |
None |
| 2011-04-11 |
Study shows how specific nutritional combination may help maintain healthy breast tissue |
None |
| 2011-04-11 |
AHF praises CA Treasurer for urging AIDS drug companies to reduce medication costs |
None |
| 2011-04-11 |
CINJ experts to comment on vaccine therapy and biomedical informatics |
None |
| 2011-04-11 |
Takeda, Heptares collaborate to develop new drugs against CNS disorders |
None |
| 2011-04-11 |
Researchers discover new avenue for hypertension, cardiovascular disease treatment |
None |
| 2011-04-11 |
Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment |
None |
| 2011-04-11 |
Immunization does not increase emergency room visit in children with inherited disorders |
None |
| 2011-04-11 |
Florida Society of Pain Management Providers applauds Senate President for supporting PDMP |
None |
| 2011-04-11 |
Scientists identify new treatment to combat PFAPA syndrome in children |
3.6 |
| 2011-04-11 |
IDSA, U.S. health officials describe ways to respond to global threat of antimicrobial resistance |
None |
| 2011-04-11 |
Opinions: Budget talks, foreign aid; making drugs more accessible to poor |
None |
| 2011-04-10 |
New weight loss pill - combination of two existing drugs |
None |
| 2011-04-08 |
HealthWarehouse.com implements Google Commerce Search for prescription medications |
None |
| 2011-04-08 |
Watson confirms patent challenge by Alcon for generic Vigamox |
None |
| 2011-04-08 |
Impax, Banner Pharmacaps collaborate for commercialization of softgel capsule products |
None |
| 2011-04-08 |
FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date |
None |
| 2011-04-08 |
Researchers test plants used in traditional African medicine against malaria |
None |
| 2011-04-08 |
FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model |
None |
| 2011-04-08 |
Lecture to explain science behind modern pharmaceutical products |
None |
| 2011-04-08 |
Strathclyde establishes new EPSRC Centre to improve chemical manufacturing |
None |
| 2011-04-08 |
How the pharmaceutical industry is confronting a changing landscape |
None |
| 2011-04-08 |
Frailty in older patients not linked to high risk of adverse drug reactions |
None |
| 2011-04-08 |
New substance to tackle drug resistant tuberculosis |
None |
| 2011-04-08 |
GeoVax Labs to update its HIV/AIDS vaccine status at World Vaccine Conference |
None |
| 2011-04-08 |
GlaxoSmithKline, XenoPort receive FDA approval for Horizant to treat RLS |
None |
| 2011-04-08 |
Study suggests depression treatment may have long-term benefits |
None |
| 2011-04-08 |
CFFT, Vertex collaborate to develop new medicines for cystic fibrosis |
4.5 |
| 2011-04-08 |
Study: DBS surgery allows 77% of patients to stop anti-tremor medication use |
None |
| 2011-04-08 |
Opinions: Support antibiotic R&D; foreign aid budget cuts |
None |
| 2011-04-08 |
IDSA develops plans to combat deadly antibiotic-resistant 'super bugs' |
None |
| 2011-04-08 |
Patients with stroke can benefit from antidepressants |
None |
| 2011-04-07 |
Shionogi launches CUVPOSA for pediatric chronic severe drooling |
None |
| 2011-04-07 |
FDA issues Approvable Letter for Oceana's Solesta in treatment for bowel incontinence |
None |
| 2011-04-07 |
CoMeD urges UN to ban mercury use in pharmaceuticals |
None |
| 2011-04-07 |
Alnylam to extend RNAi therapeutics research collaboration with AlCana and UBC |
None |
| 2011-04-07 |
Alexion submits Soliris marketing applications to FDA, EMA for aHUS treatment |
None |
| 2011-04-07 |
Vismodegib is an effective treatment for patients with basal cell carcinomas |
None |
| 2011-04-07 |
Powerful natural formula is an effective treatment for men with prostate cancer |
2 |
| 2011-04-07 |
DSP, BBI sign license agreement for BBI608 |
None |
| 2011-04-07 |
Patients with type 2 diabetes can benefit from metformin than other drugs |
1 |
| 2011-04-07 |
AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer |
None |
| 2011-04-07 |
Cliffside encourages patients to continue antidepressant use despite health risks |
None |
| 2011-04-07 |
Top 10 global pharmaceutical company, Medicago sign deal to develop non-influenza vaccine |
3 |
| 2011-04-07 |
Fish oil can serve as beneficial booster for tamoxifen breast cancer therapy |
None |
| 2011-04-07 |
Study: Naproxen can reduce colon cancer formation |
None |
| 2011-04-07 |
NIH awards HemoShear with Phase I SBIR grant to develop rodent liver system |
None |
| 2011-04-07 |
USPTO issues notice of allowance to Mirna's mir34a patent application |
None |
| 2011-04-07 |
FDA approves Horizant Extended-Release Tablets for Restless Legs Syndrome |
4 |
| 2011-04-07 |
U.S. Marshals, FDA seize $6 million worth Triad antiseptic products |
None |
| 2011-04-07 |
Progesterone gel can reduce preterm birth in women with short cervix |
None |
| 2011-04-07 |
Brazil's Ministry of Health, PharmaPraxis sign deal to manufacture biologic drugs |
5 |
| 2011-04-07 |
Study: New cancer drug shrinks tumors in mouse model with few side effects |
5 |
| 2011-04-07 |
AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer |
None |
| 2011-04-07 |
Nuron Biotech announces acquisition of Wyeth's HibTITER vaccine assets |
None |
| 2011-04-06 |
Lupin grants Salix exclusive worldwide rights to rifaximin |
None |
| 2011-04-06 |
BioWa, OBT enter license agreement to advance ADCC programs |
None |
| 2011-04-06 |
Optimer, Cubist sign deal to market DIFICID for CDI treatment in the U.S. |
None |
| 2011-04-06 |
FDA reports dramatic increase in adverse drug events |
None |
| 2011-04-06 |
WSPA, BAWA partner for anti-rabies campaign in Bali |
None |
| 2011-04-06 |
Experts welcome World Health Day on antibiotic resistance as timely |
None |
| 2011-04-06 |
Novartis' TOBI Podhaler receives Health Canada NOC for Pa treatment in CF patients |
None |
| 2011-04-06 |
Shire files lawsuit against Watson over ADDERALL XR patent infringement |
None |
| 2011-04-06 |
TZDs might serve as new agents for addiction treatment |
4 |
| 2011-04-06 |
Two reports show drastic increase in opioid prescriptions in America |
None |
| 2011-04-06 |
PQM program launches new public medicine database |
None |
| 2011-04-06 |
NIAID awards Aragen Bioscience with three subcontracts to advance preclinical studies |
None |
| 2011-04-05 |
R&D Directions names Novavax VLP influenza vaccine as one of top '100 great investigational drugs in development' |
4.5 |
| 2011-04-05 |
La Jolla acquires GliaMed's novel class of compounds |
None |
| 2011-04-05 |
Majority of customers highly satisfied with neighborhood independent drugstores |
None |
| 2011-04-05 |
Metformin therapy may protect PCOS women against endometrial cancer |
None |
| 2011-04-05 |
Ranolazine is an effective treatment for patients with refractory angina |
None |
| 2011-04-05 |
Artemisinin or high-pressure oxygen can boost natural cancer remedy |
1 |
| 2011-04-05 |
Acamprosate can help treat patients with autism, Fragile X syndrome |
5 |
| 2011-04-05 |
Nicotine has no effect on lung cancer tumor incidence, frequency or size |
None |
| 2011-04-05 |
Researchers develop new cancer treatment |
None |
| 2011-04-05 |
Cubist enters license agreement with Teva to dismiss CUBICIN patent lawsuit |
None |
| 2011-04-05 |
Statins can help prevent risk of death from pneumonia |
None |
| 2011-04-05 |
Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia |
None |
| 2011-04-05 |
Exercise may decrease blood flow and oxygen in hypertensive people |
None |
| 2011-04-05 |
ETI develops extended release SC depot formulation of NSAID drug meloxicam |
None |
| 2011-04-05 |
Gilead's increase of HIV drugs price unreasonable, says AHF |
None |
| 2011-04-05 |
Scientists discover new compounds that may help fight against parasitic diseases |
None |
| 2011-04-05 |
Boehringer Ingelheim receives FDA approval for Viramune XR to treat HIV-1 infection |
None |
| 2011-04-04 |
Pfizer receives FDA Refusal to File letter for tafamidis to treat Transthyretin Familial Amyloid Polyneuropathy |
None |
| 2011-04-04 |
KKR affiliate to acquire Pfizer's Capsugel business |
None |
| 2011-04-04 |
Orexo partner ProStrakan launches Abstral in the US |
None |
| 2011-04-04 |
Mylan receives FDA approval for generic Xalatan Ophthalmic Solution |
None |
| 2011-04-04 |
Aspirin usage associated with decrease in pancreatic cancer risk |
None |
| 2011-04-04 |
BUSPH, The Partnership at Drugfree.org collaborate to increase 'Join Together' resource utilization |
None |
| 2011-04-04 |
Researchers pinpoint effects of enhanced adult neurogenesis in hippocampus |
5 |
| 2011-04-04 |
Men who consume digoxin have 24% reduced risk of prostate cancer |
None |
| 2011-04-04 |
MEDA submits Dymista NDA to FDA for seasonal allergic rhinitis treatment |
None |
| 2011-04-04 |
Study finds increased carbapenem use in VA acute care health facilities over the last 5 years |
None |
| 2011-04-04 |
New research reveals potential treatment for HO in children, soldiers |
None |
| 2011-04-04 |
Scientists identify new treatment target for squamous cell lung cancer |
None |
| 2011-04-04 |
Study: Antidepressants can thicken arteries and lead to heart disease |
None |
| 2011-04-04 |
Scientists identify digoxin as possible therapy for prostate cancer |
None |
| 2011-04-02 |
Entry inhibitors can provide first new hepatitis B & D treatments for many years |
None |
| 2011-04-02 |
Experts must monitor new antiviral compounds for HCV treatment |
None |
| 2011-04-02 |
Sunshine Biopharma to present new Adva-27a data against cancer at AACR meeting |
5 |
| 2011-04-02 |
The Economist examines factors contributing to antimicrobial resistance |
None |
| 2011-04-02 |
Array BioPharma to unveil new findings about its anti-cancer programs at AACR Annual Meeting |
None |
| 2011-04-02 |
Thalidomide provides new hope for patients with difficult to treat liver cancer |
None |
| 2011-04-02 |
Three abstracts from SuperGen PIM kinase inhibitor program to be presented at AACR |
None |
| 2011-04-02 |
National survey: 76% of parents trust child's doctor for vaccine-safety information |
None |
| 2011-04-02 |
Champions enters exclusive license agreement with BCCA for Irinophore C |
None |
| 2011-04-02 |
Willingboro pharmacy dispenses 500 millionth prescription |
None |
| 2011-04-01 |
Ther-Rx Corporation announces important initiative to reduce cost of Makena |
None |
| 2011-04-01 |
ACADIA extends collaboration agreement with Allergan for drug discovery platform |
None |
| 2011-04-01 |
Lilly's Axiron testosterone replacement therapy now available in US pharmacies |
1.3 |
| 2011-04-01 |
Rx Partnership receives Amerigroup grant to provide Virginians with medication access |
None |
| 2011-04-01 |
Valeant, Promius sign deal to market Cloderm Cream |
None |
| 2011-04-01 |
Biota receives US$231 million BARDA contract to advance laninamivir development |
None |
| 2011-04-01 |
Invida, Roche partner to commercialize primary care products |
None |
| 2011-04-01 |
California State Controller urges Merck, Tibotec and ViiV to reduce AIDS drug prices |
None |
| 2011-04-01 |
LIFE Biosystems to present MASE data at AACR annual meeting |
None |
| 2011-04-01 |
New research finds HIV virus's V3 loop as attractive vaccine target |
None |
| 2011-04-01 |
Study confirms D-penicillamine and trientine effective against Wilson disease |
None |
| 2011-04-01 |
New data confirms antiviral activity of fluvastatin in patients with HCV |
None |
| 2011-04-01 |
Biota Scientific receives BARDA contract to develop single-dose antiviral drug |
None |
| 2011-04-01 |
Medicare moves to pay for Provenge |
None |
| 2011-04-01 |
Treatment for HBV infection with entecavir followed by lamivudine results in virologic rebound |
None |
| 2011-04-01 |
Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemia |
None |
| 2011-03-31 |
Biota wins U.S. drug development contract for Laninamivir |
None |
| 2011-03-31 |
First Edition: March 31, 2011 |
None |
| 2011-03-31 |
Aetna commends FDA's decision on hydroxyprogesterone caproate |
None |
| 2011-03-31 |
SMFM praises FDA's announcement on Makena drug |
None |
| 2011-03-31 |
Health advocates file petition with U.N. over proposed trade agreement among several countries |
None |
| 2011-03-31 |
Researchers identify drug candidate that can treat prostate cancer |
None |
| 2011-03-31 |
Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases |
None |
| 2011-03-31 |
HHS unveils new website on vaccine and immunization for consumers |
None |
| 2011-03-30 |
AA Pharma launches Lithium Carbonate SR 300mg for Bipolar Disorder in Canada |
None |
| 2011-03-30 |
Traditional Chinese herbal medicine is an effective skin whitening cream |
None |
| 2011-03-30 |
McNeil takes voluntary action against certain OTC products in the U.S. |
None |
| 2011-03-30 |
DSP, Intercept enter license agreement for OCA |
None |
| 2011-03-30 |
Dr. Reddy’s acquires GSK's US penicillin facility and products |
None |
| 2011-03-30 |
FDA grants orphan drug status to America Stem Cell's ASC-101 |
None |
| 2011-03-30 |
Prostate cancer drug and a new drug to prevent preterm births cause cost concerns, controversy |
None |
| 2011-03-30 |
WHO Director-General responds to draft report on agency's handling of H1N1 pandemic |
None |
| 2011-03-30 |
Unilife initiates Unifill syringe production for pharmaceutical companies |
None |
| 2011-03-30 |
Merck submits Erbitux indication extension to EMA for NSCLC treatment |
None |
| 2011-03-30 |
Valeant receives European Commission marketing authorization for Trobalt |
None |
| 2011-03-30 |
ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI |
None |
| 2011-03-30 |
Orthopedic surgeons prefer Genzyme's 3-cycle hyaluronic-acid in the U.S., Europe |
None |
| 2011-03-30 |
Drugs' cost deters patients from taking heart medicine |
None |
| 2011-03-30 |
USPTO grants composition-of-matter patent to Zalicus 'Synavive' product |
None |
| 2011-03-30 |
Non-generic drugs increase Medicaid costs |
None |
| 2011-03-30 |
USPTO issues patent to Somaxon's Silenor food effect |
None |
| 2011-03-30 |
Researchers develop new drug for multiple cancer treatment |
None |
| 2011-03-30 |
EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy |
None |
| 2011-03-30 |
Oral antioxidant formulation before medical imaging may minimize cell damage |
None |
| 2011-03-29 |
Reports of H1N1 outbreaks in Venezuela, Mexico prompt quick preventive action by health authorities |
None |
| 2011-03-29 |
AstraZeneca, AmeriCares partner to deliver medicines for people with chronic conditions |
None |
| 2011-03-29 |
PerkinElmer expands epigenetic detection reagents portfolio for drug discovery |
None |
| 2011-03-29 |
Nycomed submits teduglutide MAA to EMA for SBS treatment |
None |
| 2011-03-29 |
Cardinal Health, APhA partner to prevent prescription medication abuse |
None |
| 2011-03-29 |
Atypical antipsychotics is a safe mental health medication for nursing home residents |
None |
| 2011-03-29 |
Scientists develop new model that can predict early adverse drug reactions |
None |
| 2011-03-29 |
USPTO issues Notice of Allowance to Modular's green surfactant patent application |
None |
| 2011-03-28 |
New pill may protect DNA from radiation damage |
None |
| 2011-03-28 |
Cancer drug Gleevec may hold promise against scleroderma: Study |
5 |
| 2011-03-28 |
Metagenics announces 2011 schedule for educational programs in lifestyle medicine |
None |
| 2011-03-28 |
Drugs can prevent risk of breast cancer in women, experts say |
None |
| 2011-03-28 |
RDY introduces Levocetirizine tablets in the U.S. market |
None |
| 2011-03-28 |
DAW prescriptions can increase annual health system costs to $7.7 billion |
None |
| 2011-03-28 |
MRF: FDA's decision on Yervoy offers new treatment options for patients with melanoma |
None |
| 2011-03-28 |
U.S. FDA approves Yervoy to treat patients with late-stage melanoma |
4 |
| 2011-03-28 |
University of Aberdeen, TPP enter agreement to develop novel future medicines |
None |
| 2011-03-28 |
Study establishes strong link between nicotine and diabetes complications |
None |
| 2011-03-28 |
CHPA issues statement in response to anti-consumer law on cold and allergy drugs |
None |
| 2011-03-28 |
FDA approves ipilimumab for metastatic melanoma treatment |
None |
| 2011-03-28 |
Anergis SA closes funding round for allergy vaccines |
None |
| 2011-03-28 |
U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit |
None |
| 2011-03-28 |
Panax ginseng, saffron and yohimbine can boost human sexual function |
None |
| 2011-03-28 |
Geriatrician provides latest Alzheimer drug research developments at International conference |
None |
| 2011-03-28 |
BMY receives FDA approval for YERVOY to treat metastatic melanoma |
4 |
| 2011-03-28 |
APP voluntarily recalls Irinotecan Hydrochloride Injection for precautionary measure |
None |
| 2011-03-28 |
NeoProteomics secures exclusive option agreement with Case Western Reserve University |
None |
| 2011-03-28 |
Scientists receive AACR Team Science Award for HPV research |
None |
| 2011-03-28 |
Zileuton can help reduce amyloid plaque formation and Alzheimer's development |
None |
| 2011-03-28 |
FDA approves ipilimumab to treat metastatic melanoma |
None |
| 2011-03-25 |
German company steps up production of Radiogardase following Japan nuclear crisis |
None |
| 2011-03-25 |
Study finds increased risk of VTE during first year of combination oral contraceptive usage |
None |
| 2011-03-25 |
'Dispense as written' prescriptions cost the health care system $7.7 billion annually |
None |
| 2011-03-25 |
US District Court rules against Watson in generic Fentora patent suit |
None |
| 2011-03-25 |
Merck to return rights for betrixaban to Portola |
None |
| 2011-03-25 |
Graceway receives FDA approval for Zyclara Cream to treat genital warts |
None |
| 2011-03-25 |
New study finds 74.8% increase in hospital emergency visits due to Ecstasy use |
None |
| 2011-03-25 |
Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates |
None |
| 2011-03-25 |
Antibiotic treatment does not benefit patients with discoloured phlegm |
None |
| 2011-03-25 |
Almac extends Pharma Services business unit to increase demand for storage capacity |
None |
| 2011-03-25 |
Parkinson's disease drugs may lead to impulse control disorders |
None |
| 2011-03-25 |
Althea extends labeling, packaging of biological product services through Sherpa |
None |
| 2011-03-25 |
New findings may make morphine a safer, more effective drug for chronic pain control |
None |
| 2011-03-25 |
Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF |
4 |
| 2011-03-25 |
Columbia University, Sanofi-aventis collaborate to develop innovative diabetes medicines |
None |
| 2011-03-25 |
USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate |
None |
| 2011-03-25 |
AACP selects Maryland professor for Pharmacy Educator Award |
None |
| 2011-03-25 |
Agilent opens new lab facility in Bangalore, India |
None |
| 2011-03-25 |
Researchers identify gene that can predict hypersensitivity to epilepsy drug |
None |
| 2011-03-25 |
APC-300 drug significantly inhibits pancreatic cancer cell growth: Adamis |
None |
| 2011-03-25 |
Sitagliptin drug can slow onset of diabetes |
5 |
| 2011-03-25 |
Merck & Co receives FDA approval for Zostavax vaccine to treat shingles |
None |
| 2011-03-24 |
Perceptive Informatics announces eClinical Product Suite survey results |
None |
| 2011-03-24 |
Pharmacists seek delay of rule limiting amount of dispensed drugs |
None |
| 2011-03-24 |
ASAM issues white paper to halt medical marijuana use |
2 |
| 2011-03-24 |
Colorcon announces specific details on its patent positions for enteric coatings |
None |
| 2011-03-24 |
Star Scientific's Ariva-BDL and Stonewall-BDL modified risk tobacco products not subject to FDC Act Chapter IX |
None |
| 2011-03-24 |
Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis |
None |
| 2011-03-24 |
WHO report urges countries to step up fight against drug-resistant TB |
None |
| 2011-03-24 |
Resveratrol can provide resistance before and after hazardous radiation exposure |
1 |
| 2011-03-24 |
Xirrus deploys high performance Wi-Fi Arrays at EMA |
None |
| 2011-03-24 |
FTC: Granting pharmacists authority over PBMs may increase drug prices, reduce competition |
None |
| 2011-03-24 |
House bill proposes immunity for negligent drug manufacturers |
5 |
| 2011-03-24 |
Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment |
None |
| 2011-03-24 |
Oral contraceptive use before pregnancy does not pose respiratory problems in children |
None |
| 2011-03-24 |
New report shows 2% decrease in anxiolytic and hypnotic sales in Norway |
None |
| 2011-03-24 |
NephRx receives new U.S. patent for NX002 to treat IBD |
None |
| 2011-03-24 |
Actavis receives FDA marketing approval for generic Valtrex |
None |
| 2011-03-24 |
New research: Methadone can affect brain and impair intellectual functions |
None |
| 2011-03-24 |
USPTO grants patent to ULURU's Altrazeal product |
None |
| 2011-03-23 |
Ansell announces substantial price increase for NRL medical gloves |
None |
| 2011-03-23 |
Cilag, POZEN enter license agreement to develop and commercialize MT 400 |
None |
| 2011-03-23 |
NephRx receives new U.S. patent for NX002 to treat oral mucositis |
None |
| 2011-03-23 |
PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia |
None |
| 2011-03-23 |
SGEN, Abbott enter collaboration agreement for ADC products |
None |
| 2011-03-23 |
POZEN files motion for Treximet patent litigation against Par |
None |
| 2011-03-23 |
SMR, RTU enter license agreement for RESCULA eye drops |
None |
| 2011-03-22 |
Milk allergy successfully treated with Xolair |
4 |
| 2011-03-22 |
Multivitamin supplements can optimize body's metabolic performance |
None |
| 2011-03-22 |
USP teams up with FDA, CHPA to update quality standards for common medications |
None |
| 2011-03-22 |
Researchers launch free online Atlas of TB vaccination policies around the world |
None |
| 2011-03-22 |
AACP to honor UW professor with Volwiler Research Achievement Award |
None |
| 2011-03-22 |
Oral desensitization with omalizumab may treat milk allergy in children |
None |
| 2011-03-22 |
ACE, ARB combination therapy may increase risk of kidney failure, death |
None |
| 2011-03-22 |
FDA accepts Arisaph's ARI-3037MO IND for phase I human clinical trial |
None |
| 2011-03-22 |
BDSI's BEMA drug delivery technology receives Canada patent |
None |
| 2011-03-22 |
Researchers to develop house dust mite allergy vaccine that can cure asthma |
None |
| 2011-03-22 |
Watson introduces Famciclovir tablets to treat cold sores, genital herpes |
None |
| 2011-03-21 |
Hi-Tech Pharmacal acquires rights to Nystatin Oral suspension ANDA from Bausch + Lomb |
None |
| 2011-03-19 |
CHMP recommends approval of Centralized Marketing Authorization for Cinryze |
None |
| 2011-03-19 |
Government of Canada commits to contribute towards global effort to combat malaria |
None |
| 2011-03-19 |
BioMarin announces preliminary results from ADAPT in patients suffering from PKU |
None |
| 2011-03-19 |
Research roundup: Successful medical homes; shortage of HIV doctors; boosting use of $4 generic drugs |
None |
| 2011-03-19 |
Researchers identify protein that triggers immune response in TB-infected people |
None |
| 2011-03-18 |
EMA CHMP adopts negative opinion for Amgen's Vectibix in treatment of wild-type KRAS metastatic colorectal cancer |
None |
| 2011-03-18 |
EMA CHMP adopts positive opinion for Teva's NOMAC-E2 contraceptive pill |
None |
| 2011-03-18 |
Avid, Eli Lilly receive FDA complete response letter for Amyvid NDA |
None |
| 2011-03-18 |
MHA hosts two-day Long Term Care Business Summit at ARIA |
None |
| 2011-03-18 |
Medicare officials signal no payment changes on anemia drugs |
None |
| 2011-03-18 |
SCRIP to launch new pharma Lifecycle Management microsite |
None |
| 2011-03-18 |
Nature's Health announces record sales of 145% for Australian Dream pain relief cream |
None |
| 2011-03-18 |
Anacor Pharma, MMV enter agreement to develop AN3661 for malaria treatment |
None |
| 2011-03-18 |
New study: Men who consume hair loss drug may report sexual dysfunction |
1 |
| 2011-03-18 |
New drug can aid in smoking reduction therapy |
None |
| 2011-03-18 |
Brand name drug prices go up |
None |
| 2011-03-18 |
Positron to introduce its radiopharmaceutical system at American College of Cardiology |
None |
| 2011-03-17 |
GenSpera strengthens intellectual property for second prostate cancer drug |
None |
| 2011-03-17 |
Highmark forces patients with PIDD to switch over to specific IgG therapy |
None |
| 2011-03-17 |
pIMAGO nanopolymer can test cancer drug efficacy against biochemical processes |
None |
| 2011-03-17 |
Inovio signs agreement with OncoSec to sell non-DNA cancer vaccine technology |
None |
| 2011-03-17 |
Scientist suggests breaking tangled mucus barrier can help treat cancer |
None |
| 2011-03-17 |
ACEP, Poison Control Centers raise awareness about drug poisoning dangers |
None |
| 2011-03-17 |
New omalizumab medication may reduce seasonal asthma attacks in children |
None |
| 2011-03-17 |
Naltrexone may be effective in women with specific genetic variation |
None |
| 2011-03-17 |
Scientists to develop new universal vaccine against various flu viruses |
3 |
| 2011-03-17 |
Pharmaron signs agreement to provide Isis with nucleoside phosphoramidites up to 100 kg |
None |
| 2011-03-16 |
MorphoSys inks manufacturing agreement with Boehringer Ingelheim |
None |
| 2011-03-16 |
Nukepills.com donates 50,000 potassium iodide tablets to Tokushukai Hospital in Tokyo |
5 |
| 2011-03-16 |
Shanghai ChemPartner signs outsource research service agreement with Shenogen Pharma |
None |
| 2011-03-16 |
Researchers discover 3-D structure of key biological receptor |
None |
| 2011-03-16 |
Optimer receives U.S. patent for fidaxomicin to treat CDI |
None |
| 2011-03-16 |
Artesunate more effective against severe malaria |
2 |
| 2011-03-16 |
Study investigates physiological changes within brain due to Prozac treatment |
3 |
| 2011-03-16 |
Millennium, SGEN expand ADC collaboration |
None |
| 2011-03-16 |
Gadavist approved by FDA for use in central nervous system MRI scans |
None |
| 2011-03-16 |
NMS announces license agreement with Novartis |
None |
| 2011-03-15 |
Apeiron in antitumor substances deal with Cleveland Clinic |
None |
| 2011-03-15 |
Anavex to commence phase I clinical trial in Alzheimer’s disease |
None |
| 2011-03-15 |
Raymond Associates, BioNeutral enter global sales and distribution agreement for Ygiene antimicrobial technology |
None |
| 2011-03-15 |
Chelsea uses PHT's LogPad, SitePad Tablet for clinical study to treat Parkinson's patients with NOH |
None |
| 2011-03-15 |
InhibOx and COSMIC discoveries align to deliver full service drug discovery offering |
None |
| 2011-03-15 |
OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology |
None |
| 2011-03-15 |
Type 2 diabetes drug less likely to cause weight gain, raise cholesterol levels |
2 |
| 2011-03-15 |
Argentum responds to recent decision in patent lawsuit against Noble Biomaterials |
None |
| 2011-03-15 |
Study evaluates potential national savings from discount generic medication programs |
None |
| 2011-03-15 |
New study: Two peptide agent combination might block tumor growth |
None |
| 2011-03-15 |
USPTO grants second patent to Angiochem's EPiC drugs |
None |
| 2011-03-15 |
New findings may open doors for vaccine development against HIV, tuberculosis |
None |
| 2011-03-15 |
EC grants marketing authorization for Taiho's Teysuno to treat gastric cancer |
None |
| 2011-03-15 |
Study: Statin use may reduce risk of high-grade prostate cancer |
None |
| 2011-03-14 |
Bayer receives FDA approval for Gadavist Injection |
None |
| 2011-03-14 |
Indium oxine in development at Positron's Crown Point facility |
None |
| 2011-03-14 |
EvaluatePharma data shows poor R&D productivity measures both in quality, quantity |
None |
| 2011-03-14 |
AbCheck licenses CELEXION yeast display technology for an industry first |
None |
| 2011-03-14 |
SOM Biotech closes first financing round and files patent application |
None |
| 2011-03-14 |
SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA |
None |
| 2011-03-14 |
CTI, Chroma enter agreement to co-develop and license tosedostat |
None |
| 2011-03-14 |
External panel issues draft report saying WHO response to H1N1 lacked cohesion, clarity |
None |
| 2011-03-14 |
Nanotechnology might provide greater efficacy of medicines for brain disease |
None |
| 2011-03-14 |
New insights into factors affecting adolescent marijuana use |
None |
| 2011-03-14 |
Tamoxifen against breast cancer can save lives and reduce medical costs |
None |
| 2011-03-14 |
New international research project to identify antibiotics against tuberculosis |
None |
| 2011-03-14 |
US District Court rules in favor of Watson in FENTORA patent litigation |
None |
| 2011-03-12 |
Provepharm receives favorable EMA Review of its methylthioninium chloride Proveblue |
None |
| 2011-03-12 |
New drug for Lupus approved |
1.5 |
| 2011-03-11 |
ChromaDex pTeroPure Pterostilbene receives 2010 Most Promising Ingredient of the Year award |
None |
| 2011-03-11 |
Updated NCCN Guidelines for Breast Cancer outline expanded treatment options |
None |
| 2011-03-11 |
Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta |
None |
| 2011-03-11 |
Simcere files IND with SFDA of China for APX003 to treat cancer |
None |
| 2011-03-11 |
PNP reaches several major objectives in cancer therapeutic product development |
None |
| 2011-03-11 |
FDA announces consent decree of permanent injunction against McNeil-PPC |
None |
| 2011-03-11 |
FDA holds Senesco's SNS01-T clinical study due to delay of supplier's DMF updation |
None |
| 2011-03-11 |
OncoVista plans to advance reduced-toxicity targeted cancer treatments |
None |
| 2011-03-11 |
Canadian House of Commons passes bill that could ease access to generic drugs in developing countries |
None |
| 2011-03-11 |
Researchers concerned about use of mercury-based compound in inactivated flu vaccines |
None |
| 2011-03-11 |
Murad launches new powerhouse anti-aging treatment product |
5 |
| 2011-03-11 |
SAMHSA study finds 51.5% drug-related hospital visits by older patients |
None |
| 2011-03-11 |
Infant formulas with fluoridated water increase risk of discolored teeth: HHS |
5 |
| 2011-03-11 |
Eisai, Epizyme partner to develop and commercialize EZH2 epigenetic enzyme |
None |
| 2011-03-10 |
FDA approves Matrix NDA for Zidovudine Tablets |
None |
| 2011-03-10 |
Novartis new MS treatment receives Notice of Compliance in Canada |
None |
| 2011-03-10 |
FDA approves Covidien's LEU-based Mo-99 medical isotope |
None |
| 2011-03-10 |
Medtronic resolves FDA warning letters over Mounds View, Juncos facilities |
None |
| 2011-03-10 |
Despite aspirin therapy, specific inflammatory pathways may influence risk of colorectal cancer |
None |
| 2011-03-10 |
Pepscan signs Research and License Agreement with Crucell to devlop novel vaccines |
None |
| 2011-03-10 |
Scientists identify chemical compound that may lead to cancer-fighting drugs |
1 |
| 2011-03-10 |
AHF unveils new national advertising campaign about AIDS drugs |
None |
| 2011-03-10 |
CRT, ICR sign deal with ZoBio to discover and develop cancer drugs |
None |
| 2011-03-10 |
Opinions: Investing in science, technology; Indian public-private partnership for NTDs; U.S. global food security investments; Clinton's statements on PEPFAR; U.S. foreign aid; primary care |
None |
| 2011-03-10 |
FDA informs additional delay of ARYx's request for naronapride SPA |
None |
| 2011-03-10 |
FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus |
5 |
| 2011-03-10 |
Israel grants patent to Kamada's Transferrin for use in Pharmaceutical Compositions |
None |
| 2011-03-10 |
NCPA encourages patients on safe disposal of unwanted medications |
None |
| 2011-03-10 |
FDA accepts Merck's SAFLUTAN NDA for standard review |
None |
| 2011-03-10 |
Illicit drug users may face increased risk of microbial infections |
None |
| 2011-03-09 |
EDT receives European approval for XEPLION injection to treat schizophrenia |
1.7 |
| 2011-03-09 |
KineMed extends collaboration with BMY to identify and characterize Alzheimer's biomarkers |
None |
| 2011-03-09 |
U.S. FDA approves Hospira's docetaxel to treat variety of cancers |
None |
| 2011-03-09 |
New Australian drug approvals subject to budget cuts |
None |
| 2011-03-09 |
Human Genome Sciences receives FDA approval for Benlysta to treat lupus |
2 |
| 2011-03-09 |
Adamis submits APC-100 IND to FDA for treatment of prostate cancer |
None |
| 2011-03-09 |
MD Solarsciences launches new sunscreen lotion at 2011 AAD meeting |
5 |
| 2011-03-09 |
Oral magnesium oxide is a safe treatment for children with chronic constipation |
None |
| 2011-03-09 |
Variation in exposure to sunlight may affect sensitivity of individuals to drugs |
None |
| 2011-03-09 |
PILMA praises Senate for 2011 Patent Protection Act |
None |
| 2011-03-09 |
Yakult Honsha, AEZS sign agreement to develop, commercialize and license perifosine |
None |
| 2011-03-09 |
Also in global health news: Rights abuses in Myanmar; Indian malnutrition; Mali Global Fund grant; shift in USAID's programs in Afghanistan; Gates Foundation grant for vaccines |
None |
| 2011-03-09 |
Apotex passes Bill C-393 to fix Canada's Access to Medicines Regime |
None |
| 2011-03-09 |
USPTO grants new patent to Intellect's Alzheimer's vaccine |
None |
| 2011-03-09 |
New nitric oxide producing topical products support healing process |
None |
| 2011-03-09 |
Chemist discover new strategy to process certain drugs |
None |
| 2011-03-09 |
FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review |
None |
| 2011-03-08 |
Patrys succeeds in obtaining commercial yields for its anti-cancer antibody therapeutic |
None |
| 2011-03-08 |
New insight into malaria |
None |
| 2011-03-08 |
Mississippi researchers work on drug discovey for poison ivy skin rash |
None |
| 2011-03-08 |
Anacor and iOWH establish research agreement to identify new drugs for shigellosis |
None |
| 2011-03-08 |
Discovery of potent class of anti-cancer compounds by Scripps Research and MIT scientists |
None |
| 2011-03-08 |
URMC research confirms possible use of mifepristone for painful fibroids |
None |
| 2011-03-08 |
Also in global health news: EU-India talks; China's health system funding; water in Ethiopia; nonprofit offering health services abroad to sell off assets; polio in India |
None |
| 2011-03-08 |
UCSF's new pharmacy to focus on direct patient care |
None |
| 2011-03-08 |
Ambry, RainDance enter new collaboration to develop and commercialize ADME screening |
None |
| 2011-03-07 |
New Lupus drug marching towards approval |
None |
| 2011-03-07 |
FDA says no cause for alarm on vaccines for meningitis and pneumonia |
None |
| 2011-03-07 |
5a-reductase inhibitors for male health problems can affect sexual health |
2 |
| 2011-03-07 |
Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product |
None |
| 2011-03-07 |
Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders |
None |
| 2011-03-07 |
Launch Excellence Services provides solutions to new pharma product market entry |
None |
| 2011-03-07 |
FDA's action impacts Elite pharma drugs |
None |
| 2011-03-06 |
New research: Rectal specific microbicides can protect against HIV |
None |
| 2011-03-05 |
FDA approves change to prescribing information for Gilead Sciences' Letairis |
None |
| 2011-03-05 |
Deal Search Online: Pharma is the single most active sector in decade's health care M&A market |
None |
| 2011-03-05 |
New turf battle: Retail pharmacists vs. mail order companies |
None |
| 2011-03-05 |
FDA accepts Lundbeck's clobazam NDA for review |
2 |
| 2011-03-05 |
ADM, Burcon NutraScience enter license agreement to market CLARISOY soy protein |
None |
| 2011-03-05 |
Grifols receives FDA approval for Alphanate to treat vCJD |
None |
| 2011-03-05 |
Scientific symposium to examine new approaches to schizophrenia drug development |
None |
| 2011-03-05 |
Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics |
None |
| 2011-03-05 |
Football player announces release of new pre-workout intensity supplement |
None |
| 2011-03-05 |
Monthly liver enzyme tests not required for PAH patients taking Letairis tablets: FDA |
None |
| 2011-03-05 |
FDA approves Emoquette for prevention of pregnancy in women |
None |
| 2011-03-05 |
Topamax medication during pregnancy can lead to increased risk of oral birth defects in babies |
None |
| 2011-03-05 |
New research into drugs to prevent brain tumours in children wins vital funding |
None |
| 2011-03-04 |
Study: Resveratrol can reduce body fat |
None |
| 2011-03-04 |
Alcohol, marijuana and methamphetamines are common abuse substances |
None |
| 2011-03-04 |
Study: Vaccinated children and adolescents are less prone to infectious diseases |
None |
| 2011-03-04 |
New discovery holds promise for TB treatment |
None |
| 2011-03-04 |
European Commission approves BMY's ONGLYZA to treat type 2 diabetes |
None |
| 2011-03-04 |
Few primary care physicians pay adequate attention to patients taking prescription opioid drugs |
None |
| 2011-03-04 |
Protesters call on Indian government to reject free trade agreement with EU |
None |
| 2011-03-04 |
Shire receives European Commission approval for self-administration of FIRAZYR for HAE |
None |
| 2011-03-04 |
Exercise can reduce cannabis use in persons who don't want to stop |
None |
| 2011-03-03 |
Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies |
None |
| 2011-03-03 |
Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS |
None |
| 2011-03-03 |
FDA approves Amneal's Indomethacin ER capsules |
None |
| 2011-03-03 |
EU's Avastin policy: A stark contrast to the FDA's recent decision |
None |
| 2011-03-03 |
EC grants marketing authorization for InterMune's Esbriet to treat IPF |
None |
| 2011-03-03 |
Roche, OraSure receive FDA 510(k) clearance for Oral Fluid Drug Testing System |
None |
| 2011-03-03 |
Real-life scientists search for new medicinal plants in remote areas |
None |
| 2011-03-03 |
Lancet Infectious Diseases examines how resource gaps are creating barriers to reduce child mortality |
None |
| 2011-03-03 |
New Sanitized MedX 200s active ingredient series to reduce risk of HAI |
None |
| 2011-03-03 |
Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines |
5 |
| 2011-03-03 |
CTI meets officials of FDA's OND to support pixantrone NDA |
None |
| 2011-03-03 |
FDA takes action against companies that manufacture unapproved prescription drugs |
None |
| 2011-03-03 |
Omeros identifies orphan GPCR compounds associated to pancreatic cancer, cognitive disorders |
None |
| 2011-03-03 |
New breakthrough in immunological research |
None |
| 2011-03-03 |
FADD protein discovery can lead to better cancer and autoimmune disease drugs |
None |
| 2011-03-03 |
Study: Men who consume non-steroidals more likely to have erectile dysfunction |
None |
| 2011-03-03 |
Portola, Accumetrics sign agreement to develop and supply VerifyNow System |
None |
| 2011-03-02 |
Ibuprofen may protect against development of Parkinson's disease |
None |
| 2011-03-02 |
IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India |
None |
| 2011-03-02 |
Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte |
None |
| 2011-03-02 |
PreTreat Complete is now available for public to reduce migraine headaches |
None |
| 2011-03-02 |
Ipsen, Gtx terminate collaboration for development and commercialization of toremifene |
None |
| 2011-03-02 |
WARFARIN study to explore impact of genetic testing on individualized dosing |
3 |
| 2011-03-02 |
Study: Medication adherence alone may not benefit employees with chronic conditions |
None |
| 2011-03-02 |
Inter Press Service explores how Kenya's Anti-Counterfeit Act, possible EU-India free trade agreement could scale back access to affordable medications |
None |
| 2011-03-02 |
Trial date set for Teva's generic COPAXONE patent infringement litigation against Momenta |
None |
| 2011-03-02 |
Four pharmaceutical companies partner to create new single-source industry |
None |
| 2011-03-02 |
EMD Serono receives FDA CRL on Cladribine Tablets NDA for relapsing-remitting multiple sclerosis |
None |
| 2011-03-02 |
Baxter announces European rMRP approval of PREFLUCEL seasonal influenza vaccine |
None |
| 2011-03-02 |
U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI |
None |
| 2011-03-02 |
Study: 700,000 drug-related ED visits cost nearly $1.4 billion in 2007 |
None |
| 2011-03-02 |
Study: Pycnogenol- offers natural solution for patients with metabolic syndrome |
None |
| 2011-03-02 |
Research: Tanning bed exposure can lead to serious skin problems |
None |
| 2011-03-02 |
EPO to grant patent for Apricus MycoVa product to treat nail fungus |
3 |
| 2011-03-01 |
VaxInnate receives $196 million BARDA contract to develop novel flu vaccines |
None |
| 2011-03-01 |
European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease |
None |
| 2011-03-01 |
FDA approves roflumilast to treat COPD |
1 |
| 2011-03-01 |
New drug approved for COPD by the FDA |
3 |
| 2011-03-01 |
New therapeutic strategy improves superior renal function after kidney transplantation |
None |
| 2011-03-01 |
FDA approves Forest Labs' Daliresp to treat COPD |
None |
| 2011-03-01 |
Anti-AIDS gel shows promise |
None |
| 2011-03-01 |
Medical experts propose six-point framework for safe production and use of Kava plant |
None |
| 2011-03-01 |
Decision Resources: 52% of surveyed cardiologists identify furosemide as efficacious acute heart failure therapy |
None |
| 2011-03-01 |
Excella achieves SafeBridge Potent Compound Safety Certification |
None |
| 2011-03-01 |
Meda launches Medivir's cold sore treatment Xerese in the U.S. |
None |
| 2011-03-01 |
Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain |
None |
| 2011-03-01 |
Santaris licenses miR-33 from MGH to treat cardiovascular disorders |
None |
| 2011-03-01 |
Novavax announces agreement to license VLP vaccine technology to LGLS |
None |
| 2011-03-01 |
HP announces innovative drug research application for its inkjet technology |
None |
| 2011-03-01 |
AFFiRiS announces significant progress in collaboration with GSK for Alzheimer's vaccine development |
None |
| 2011-03-01 |
Nile plans to develop novel therapeutics for ADHF |
None |
| 2011-02-28 |
HHS awards two contracts to accelerate flu vaccine availability |
None |
| 2011-02-28 |
CellSeed, LA BioMed enter two-year research agreement to study core technology in regenerative medicine |
None |
| 2011-02-28 |
AFFiRiS AG - Alzheimer's vaccines generate further cash flow |
None |
| 2011-02-28 |
UCSF collaborates with Zcube to develop new ways to deliver drugs |
None |
| 2011-02-28 |
TCD announces first patient treated in its TCD-717 Phase I trial |
None |
| 2011-02-28 |
Rexahn's novel anti-cancer quinoxalinyl-piperazine compounds granted European patent |
None |
| 2011-02-28 |
FDA grants 510(k) clearance for Derma Sciences MEDIHONEY Gel Wound and Burn Dressing |
None |
| 2011-02-28 |
FDA approves Matrix Labs generic Neurontin ANDA |
None |
| 2011-02-28 |
Seattle Genetics submits brentuximab vedotin BLA to FDA for treatment of ALCL, Hodgkin lymphoma |
None |
| 2011-02-28 |
Janssen-Cilag, NovAlix enter research services agreement for chemistry to support drug discovery efforts |
None |
| 2011-02-28 |
Researchers to examine thrombolysis for treatment of DVT in leg |
None |
| 2011-02-28 |
Medunik to introduce novel orphan drugs to Canadians with rare diseases |
None |
| 2011-02-28 |
Almac's new North American Headquarters launches schedule I-V controlled capabilities |
None |
| 2011-02-28 |
Despite FDA action, Deston still believes Auralgan as a safe and effective drug product |
None |
| 2011-02-28 |
Pharming, Santarus receive FDA refusal to file letter for RHUCIN BLA |
None |
| 2011-02-28 |
New study identifies recurrent wound botulism among injection drug users |
None |
| 2011-02-28 |
AHRQ: $52.2 billion spent on prescription drugs for treatment of metabolic conditions during 2008 |
None |
| 2011-02-27 |
FDA approves GSK's PROMACTA to treat rare blood disorder |
2 |
| 2011-02-27 |
Experts offer myth-busting advice to fight against spring allergies |
None |
| 2011-02-27 |
Samsung enters strategic partnership with Quintiles to support biopharmaceuticals market |
None |
| 2011-02-27 |
Takeda receives FDA approval for EDARBI to treat hypertension in adults |
None |
| 2011-02-27 |
Vaccine lawsuit rejected by Supreme Court |
5 |
| 2011-02-27 |
Avastin debate spills over until June FDA hearing |
None |
| 2011-02-25 |
Takeda receives Japanese approval for additional indications for NESINA |
None |
| 2011-02-25 |
Savient launches KRYSTEXXA in the U.S. |
None |
| 2011-02-25 |
Symposium examines Bruesewitz vs. Wyeth Supreme Court case |
None |
| 2011-02-25 |
Patients presented to ED with adverse drug events are more costly to health care system |
None |
| 2011-02-25 |
Study: AEG-1 expression predicts erlotinib treatment response in patients with EGFR-mutant lung cancer |
None |
| 2011-02-25 |
Signal files complaint against Med Biogene and Precision Therapeutics in Supreme Court |
None |
| 2011-02-25 |
Salix anticipates receipt of FDA's CRL for XIFAXAN 550 mg sNDA |
None |
| 2011-02-25 |
Unigene accelerates UGP281 anorexigenic peptide to treat obese patients |
None |
| 2011-02-25 |
bioMérieux, Ipsen partner to develop personalized medicine for cancer |
None |
| 2011-02-25 |
Genentech granted FDA hearing on Avastin for metastatic breast cancer |
None |
| 2011-02-25 |
New 'closed-loop' system can provide tightly controlled anesthesia in patients undergoing surgery |
None |
| 2011-02-24 |
Celgene, Elan enter settlement and license agreement for ABRAXANE |
None |
| 2011-02-24 |
FDA approves sBLA for CSL's Hizentra to treat PI |
None |
| 2011-02-24 |
Supreme Court raises the bar for suits against vaccine producers |
None |
| 2011-02-24 |
Steroid administration may impact immune system in children with asthma |
None |
| 2011-02-24 |
Study examines several homicides involving anesthetic drugs, outlines anesthesiologists' experiences |
None |
| 2011-02-24 |
Stamford Hospital to participate in US FDA Expanded Access Treatment IND program for Generex Oral-lyn |
None |
| 2011-02-24 |
Takeda submits NDA to FDA for fixed-dose combination of azilsartan medoxomil plus CLD to treat hypertension |
None |
| 2011-02-24 |
G-CSF treatment improves inadequate endometrium during IVF cycles |
4 |
| 2011-02-24 |
New strategies to improve developing countries' access to low-cost generic drugs needed, experts say |
None |
| 2011-02-24 |
UBC study shows Canadians and Americans receive different drug information online |
None |
| 2011-02-24 |
Scientists find bovine colostrum can massively reduce leaky gut syndrome |
None |
| 2011-02-24 |
Aminothiazoles as therapeutic leads for prion diseases |
None |
| 2011-02-24 |
New vaccine offers hope against Hepatitis C |
5 |
| 2011-02-24 |
FDA approves ONGLYZA to treat type 2 diabetes patients with renal impairment |
None |
| 2011-02-24 |
CST, Astellas Pharma enter commercialization partnership for cancer diagnostic, therapeutic products |
3 |
| 2011-02-24 |
Polio: Myanmar plans vaccination campaign after confirming first new case in three years; India fights disease in rural areas |
None |
| 2011-02-23 |
Novo Nordisk submits rFXIII BLA to FDA for treatment of inherited bleeding disorder |
None |
| 2011-02-23 |
Researchers identify low-dose, two-drug cocktail that reduces noise-induced hearing loss in mice |
None |
| 2011-02-23 |
FDA grants Fast Track designation to Sunesis' vosaroxin for treatment of AML |
None |
| 2011-02-23 |
Multi-national consortium develops new approaches to cure the flu |
None |
| 2011-02-23 |
Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference |
None |
| 2011-02-23 |
Pharmacelsus participates in FLUCURE project to develop novel therapeutics against influenza |
None |
| 2011-02-23 |
Healthcare professionals need evidence-based education, guidance about CAM use in maternity care |
None |
| 2011-02-23 |
USPTO issues patent to Synergy's SP-333 for treatment of IBD |
None |
| 2011-02-23 |
Survey: 67% of pharma and biotech companies outsource more than half of all clinical trials |
None |
| 2011-02-23 |
Omeros announces license agreement with Daiichi Sankyo for PDE7 inhibitors |
5 |
| 2011-02-23 |
MWV announces availability of preservative pharmaceutical spray pumps for sampling |
None |
| 2011-02-23 |
New study: Cannabis ingredient can improve appetites and sense of taste in cancer patients |
None |
| 2011-02-23 |
Study: Cannabis use may negatively impact male sexual performance |
None |
| 2011-02-23 |
Japan MHLW approves Sosei's NorLevo emergency contraceptive pill |
None |
| 2011-02-23 |
Noven claims patent infringement over Vivelle-Dot, files lawsuit against Mylan |
None |
| 2011-02-23 |
Tifacogin administration shows no treatment benefit in patients with severe CAP |
None |
| 2011-02-23 |
Federal anti-drug campaign appears to reduce marijuana use among teenagers |
None |
| 2011-02-23 |
New nanoparticle can help develop vaccines against HIV, malaria |
None |
| 2011-02-23 |
CVS condemns Supreme Court's decision to preempt all vaccine design defect lawsuits |
None |
| 2011-02-23 |
Aspirin for coronary heart prevention is less costly, more effective |
None |
| 2011-02-23 |
Study: Antibody-directed chemotherapy may be effective for majority of younger AML sufferers |
None |
| 2011-02-23 |
Research: Drug developed for controlling cholesterol synthesis can kill human breast cancer cells |
None |
| 2011-02-23 |
USPTO issues Notice of Allowance to Somaxon's Silenor patent application |
None |
| 2011-02-23 |
Prolonged use of osteoporosis drugs may increase risk of unusual fractures in women |
None |
| 2011-02-22 |
Researcher finds antibiotic in Eastern Red Cedar tree effective against MRSA |
None |
| 2011-02-22 |
Novartis FLUAD seasonal flu vaccine for older adults receives Health Canada approval |
None |
| 2011-02-22 |
Health Canada approves Orexo's Abstral to treat chronic cancer pain |
None |
| 2011-02-22 |
Vical extends relationship with U.S. NMRC for emerging disease vaccine platform |
None |
| 2011-02-22 |
Scientists believe plant extracts may have medical benefits to treat herpes |
None |
| 2011-02-22 |
Tropical seaweed's antifungal chemical cues may have promising antimalarial properties for humans |
None |
| 2011-02-22 |
AHFS, PEPID partner to deliver electronic drug information to pharmacists nationwide |
None |
| 2011-02-22 |
Experimental vaccine appears to protect against pneumonia |
None |
| 2011-02-22 |
New research: Fluid retention may explain drugs' risk of strokes and heart attacks |
None |
| 2011-02-22 |
MorphoSys completes technology transfer in strategic antibody alliance |
None |
| 2011-02-22 |
Research: Blood and hormone level in saliva can reveal burnout symptoms |
None |
| 2011-02-21 |
New study: Rapamycin reverses cardiac muscle damage in LEOPARD syndrome mouse model |
None |
| 2011-02-21 |
Sheffield Bio-Science forms strategic alliance with Wockhardt to strengthen cell culture media portfolio |
None |
| 2011-02-21 |
Mouse model could help develop new classes of antidepressant drugs |
None |
| 2011-02-21 |
NCPA, NACDS explain importance of pharmacies in Medicaid program |
5 |
| 2011-02-21 |
Proper wound care may treat skin infections effectively than antibiotics in children with MRSA |
3 |
| 2011-02-20 |
Amphetamines appear to increase risk of developing Parkinson's disease: New research |
None |
| 2011-02-20 |
New study shows low doses of aspirin can significantly reduce risk of cancers |
None |
| 2011-02-20 |
QRxPharma granted FDA pre-NDA meeting, further phase II data released |
4 |
| 2011-02-19 |
PBMI awards CVS Caremark and ArcelorMittal the 2011 Rx Benefit Innovation Award |
None |
| 2011-02-19 |
Upsher-Smith expands voluntary recall of Jantoven Warfarin Sodium, 3 mg Tablets |
None |
| 2011-02-19 |
U.S. scientists assess progress of dengue vaccine at 3-day summit in Puerto Rico |
None |
| 2011-02-18 |
Biocare, HJF sign license agreement to distribute antibody against prostate cancer |
None |
| 2011-02-18 |
Impax' NDA for generic version of Adoxa receives final FDA approval |
None |
| 2011-02-18 |
Scientists investigate natural chemical compound in sea sponges to create novel anti-cancer drugs |
5 |
| 2011-02-18 |
Rinsing technique with betadine may reduce infection rate following total knee, hip arthroplasty |
None |
| 2011-02-18 |
Certain uses of terbutaline could lead to maternal heart problems and death, FDA warns |
None |
| 2011-02-18 |
China-Biotics applies 5 new patents for probiotics supplement, preparation |
None |
| 2011-02-18 |
U.S. FDA approves Corifact to prevent bleeding in people with Factor XIII deficiency |
None |
| 2011-02-17 |
Statin drug may help prevent blindness in diabetics |
None |
| 2011-02-17 |
Astellas' Protopic receives Health Canada approval for prevention of eczema flares |
5 |
| 2011-02-17 |
Iris Pharma announces validation of new EIU model of ocular inflammation |
5 |
| 2011-02-17 |
Researchers develop new pneumococcal vaccine through novel discovery approach |
None |
| 2011-02-17 |
Experts say signs and treatment of bacterial infection often misunderstood |
None |
| 2011-02-17 |
Spirulina Pacifica supplement may improve immune function, anemia in senior citizens |
None |
| 2011-02-17 |
EMA publishes concept paper on pharmaceutical cold storage conditions during transport |
None |
| 2011-02-17 |
HHS unveils new National Vaccine Plan to enhance coordination of immunization activities |
None |
| 2011-02-17 |
ACEA Biosciences receives new U. S. Patent for chemical compound screening |
None |
| 2011-02-17 |
Upcoming Bangladeshi mass cholera vaccine program might shed light on strategy effectiveness |
None |
| 2011-02-17 |
Patients with high blood pressure can benefit from 'adherence therapy' course |
None |
| 2011-02-17 |
MedImmune, PDL BioPharma enter definitive agreement to resolve legal patent disputes |
None |
| 2011-02-17 |
Astellas, AVEO enter development, commercialization agreement for tivozanib |
None |
| 2011-02-17 |
Inexpensive drug therapy shows promise in treating premature infants with childhood blindness |
None |
| 2011-02-16 |
Vical announces issuance of U.S. Patent for cytomegalovirus vaccines |
None |
| 2011-02-16 |
Flu vaccine update |
1 |
| 2011-02-16 |
New treatment using naltrexone implants can reduce heroin dependency: Study |
None |
| 2011-02-16 |
ADVENTRX updates ANX-514 candidate for FDA approval |
None |
| 2011-02-16 |
Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection |
5 |
| 2011-02-16 |
Study: BPS is safe and effective for patients undergoing therapeutic endoscopy |
None |
| 2011-02-16 |
Ecstasy does not impair cognitive performance: Study |
None |
| 2011-02-16 |
CTI's fourth quarter net loss increases to $34.1 million |
None |
| 2011-02-16 |
Also in global health news: Gates Foundation global health head to step down; drug, medical supply shortages in Gaza; food security in N. Korea |
None |
| 2011-02-16 |
Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide |
None |
| 2011-02-16 |
New study confirms effectiveness of inhaled epinephrine to treat croup |
None |
| 2011-02-16 |
NGDI-UBC, CDRD partner for drug development platform to treat neglected global diseases |
None |
| 2011-02-16 |
Aeolus receives BARDA contract for AEOL 10150 drug development against ARS |
None |
| 2011-02-16 |
Mylan launches generic Vfend |
None |
| 2011-02-15 |
Bisphosphonates appear to reduce risk of postmenopausal colorectal cancer by 50% |
None |
| 2011-02-15 |
RPCI offers first FDA-approved cancer treatment vaccine |
None |
| 2011-02-15 |
2007 financial crisis linked to increase in patients seeking treatment for prescription drug and painkiller addiction |
None |
| 2011-02-15 |
FDA requests $4.3 billion to protect and promote health of Americans as part of FY 2012 budget |
None |
| 2011-02-15 |
Study finds GI bleeding rare outside of ICU, regardless of whether or not patients receive medication |
None |
| 2011-02-15 |
PCMA releases statement on President Obama's budget proposal for biotech medications |
None |
| 2011-02-15 |
Study shows lower success rate of FDA drug approval from 2003 to 2010 |
None |
| 2011-02-15 |
Ecstasy users show no signs of cognitive impairment: New study |
None |
| 2011-02-15 |
Apricus Bio awards Neopharm exclusive rights to market and sell Vitaros in Israel and Palestinian Territories |
None |
| 2011-02-15 |
Dabigatran drug helps prevent blood clots in patients with atrial fibrillation |
None |
| 2011-02-15 |
State court jury rules in favor of Merck in FOSAMAX trial |
None |
| 2011-02-14 |
Oral bisphosphonates outweigh the risk associated with jaw disease |
None |
| 2011-02-14 |
AP: Crooks find Medicare Part D an easy target |
None |
| 2011-02-14 |
Huntington Insurance adds HealthWarehouse.com to prescription drug benefit program |
None |
| 2011-02-14 |
FDA accepts King's ACUROX NDA for filing with Priority review classification |
None |
| 2011-02-14 |
Study: Young survivors covered by Medicare Part D often can't afford stroke medications |
None |
| 2011-02-14 |
UH Case Stroke and Cerebrovascular Center increases tPA use for ischemic stroke by 13.5 times |
None |
| 2011-02-14 |
Janssen, Medivir collaborate to discover and develop drugs against dengue virus |
None |
| 2011-02-14 |
Advocates call for follow-through on decade-old pledge to remove tariffs on malaria treatments, prophylactics in Africa |
None |
| 2011-02-14 |
Antimicrobial CPC non alcohol mouth-rinse decreases incidence of preterm birth |
None |
| 2011-02-14 |
Value-based pricing system would benefit NHS: Research |
5 |
| 2011-02-11 |
Scientists develop novel treatment strategy for multiple myeloma |
4 |
| 2011-02-11 |
Times of India examines dengue vaccine trials |
None |
| 2011-02-11 |
Preladenant may offer new supplemental treatment for Parkinson's disease: Study |
None |
| 2011-02-11 |
New findings of drug recently identified to prevent stroke in patients with AF published in NEJM |
None |
| 2011-02-11 |
Intellikine, PKD Foundation to investigate novel therapies for patients with PKD |
3 |
| 2011-02-10 |
Valeant Pharmaceuticals subsidiary acquires Canadian rights to Cholestagel |
None |
| 2011-02-10 |
Global Health Consortium to support development of vaccines to control dengue fever |
None |
| 2011-02-10 |
FDA grants final approval for Hi-Tech Pharmacal's ANDA for levofloxacin ophthalmic solution |
None |
| 2011-02-10 |
Mallinckrodt receives FDA approval for Fentanyl Transdermal System patch ANDA |
None |
| 2011-02-10 |
Alexion fourth quarter net product sales of Soliris increases to $156.0 million |
None |
| 2011-02-10 |
FDLI's new Policy Forum takes close look on emerging health care liability issues |
None |
| 2011-02-10 |
Rhabdomyolysis episode at University of Iowa signals a public health crisis |
None |
| 2011-02-10 |
Avian flu vaccine stockpiled in 2004 still useful |
None |
| 2011-02-10 |
PRA opens new offices in Israel, Ukraine to meet increased demand for services |
None |
| 2011-02-10 |
Florida pain clinic society opposes Gov. Scott's proposal to repeal Prescription Drug Monitoring Program |
None |
| 2011-02-10 |
UCSD: Medication education can help patients with diabetes better stick to drug treatment plans |
None |
| 2011-02-10 |
State and federal efforts to monitor drug prescriptions and payments face challenges |
None |
| 2011-02-10 |
US District Court rules in favor of Watson in generic Mucinex patent infringement suit |
None |
| 2011-02-10 |
Physicist creates technology that may enhance pharma industry's early drug discovery capabilities |
None |
| 2011-02-10 |
Research shows no protective effect of folate intake against spontaneous preterm delivery |
2 |
| 2011-02-10 |
Study: New curcumin-hybrid compound may help protect, regenerate brain cells after stroke |
None |
| 2011-02-09 |
New study: Testosterone administration leads to significant reduction in mind reading |
4 |
| 2011-02-09 |
Genmed announces Suprafen drug registration with Dutch MEB |
None |
| 2011-02-09 |
Zogenix receives 2011 DDP Industry Achievement Award for SUMAVEL DosePro |
None |
| 2011-02-09 |
Protect Pharma completes sale of two patents and patents-applications to Grunenthal |
None |
| 2011-02-09 |
Humira and Enbrel have best overall clinical profile for treatment of moderate to severe psoriasis: Survey |
None |
| 2011-02-09 |
Topical cream used to treat skin diseases activates two distinct neuronal signaling pathways |
4 |
| 2011-02-09 |
Natco Pharma files ANDA with FDA for generic version of Tamiflu |
None |
| 2011-02-09 |
Faster approval times for generic drugs may not drop the price for consumers |
None |
| 2011-02-09 |
New You Magazine about anti-aging management to re-launch in March |
None |
| 2011-02-09 |
Study finds dutasteride not cost-effective in prevention of prostate cancer in men at elevated risk |
None |
| 2011-02-09 |
Momenta receives US patent for methods of developing glatiramer acetate drug |
None |
| 2011-02-09 |
Vical announces issuance of US patent for HSV-2 vaccine |
4 |
| 2011-02-09 |
Babies born to HIV-infected mothers have lower antibody levels against bacterial infections |
5 |
| 2011-02-09 |
Pharmacist-directed anticoagulation service improves quality of care for HIT patients |
None |
| 2011-02-09 |
AMAG receives Health Canada Notice of Non-Compliance for Feraheme NDS |
None |
| 2011-02-09 |
FDA grants Actavis marketing approval for Pantoprazole Sodium Delayed-Release Tablets |
None |
| 2011-02-08 |
NMS Labs launches unique test for Methotrexate |
None |
| 2011-02-08 |
Positron anticipates expanded market opportunity for Attrius PET scanner |
None |
| 2011-02-08 |
ASBP concerned over FDA rejection of Contrave drug |
None |
| 2011-02-08 |
Total flu cover with one shot |
None |
| 2011-02-08 |
Avandia label revised as per FDA directive |
None |
| 2011-02-08 |
ScinoPharm to be Clinical Data's sole API supplier of vilazodone hydrochloride during Viibryd's launch |
None |
| 2011-02-08 |
PDL, UCB enter definitive settlement agreement to resolve all legal patent disputes |
None |
| 2011-02-08 |
Elan 2010 total revenue increases 5% to $1,169.7 million |
None |
| 2011-02-08 |
FDA warning leads to decrease in use of atypical antipsychotics for treatment of dementia |
None |
| 2011-02-08 |
TREK1 activity offers a key target for fluoxetine and other antidepressant drugs |
None |
| 2011-02-08 |
Anthem Blue Cross reminds seniors in Maine to get vaccinated against annual flu, pneumonia |
None |
| 2011-02-08 |
Schizophrenia patients who consume antipsychotics appear to lose small amount of brain tissue |
3 |
| 2011-02-08 |
Particle Sciences announces strategic alliance with HORIBA Instruments |
None |
| 2011-02-08 |
Study on non-surgical approach for treatment of liver hydatidosis |
None |
| 2011-02-08 |
Study reports significant decline in second-generation medication use for dementia |
None |
| 2011-02-08 |
Study: Cannabis use appears to be linked with earlier onset of psychotic illness |
None |
| 2011-02-08 |
Tufts announces public launch of Institute for Biomedical Partnerships, HUB website |
None |
| 2011-02-07 |
Natco Pharma submits ANDA to FDA for generic version of Tamiflu 75 mg capsules |
None |
| 2011-02-07 |
Zeria obtains Japanese regulatory clearance for HemCon products |
None |
| 2011-02-07 |
Progenics, Salix enter exclusive worldwide license agreement for RELISTOR |
None |
| 2011-02-07 |
Reliv International launches new nutritional supplement to address entire fatigue cycle |
None |
| 2011-02-05 |
FDA approves Makena injection to reduce risk of preterm delivery |
None |
| 2011-02-05 |
Vemma donates over 60,000 bottles of Vemma NEXT to K.I.D.S. |
5 |
| 2011-02-05 |
Stiefel introduces BPO Acne Creamy Washes for OTC use in the U.S. |
None |
| 2011-02-05 |
Physicians reaction to FDA decision to rescind breast cancer indication from Avastin |
None |
| 2011-02-05 |
Waismann Method examines link between chronic pain and Opioid-Induced Hyperalgesia |
None |
| 2011-02-05 |
March of Dimes appreciates FDA for approving new drug to prevent preterm births |
None |
| 2011-02-04 |
Jungle Brolly launches new natural line of non alcoholic industrial hand sanitizers |
None |
| 2011-02-04 |
FDA approves ANDA for phentermine HCl 37.5 mg tablets |
None |
| 2011-02-04 |
HPV vaccine can prevent 90% of genital warts in men: Study |
None |
| 2011-02-04 |
ECR launches sleep aid product, Zolpimist Oral Spray in the US |
None |
| 2011-02-04 |
Hologic receives FDA approval for hydroxyprogesterone caproate injection |
None |
| 2011-02-04 |
ECR announces availability of Zolpimist Oral Spray in the U.S. |
None |
| 2011-02-04 |
Bayer HealthCare's regorafenib receives orphan drug status for GIST treatment |
None |
| 2011-02-04 |
Scientists analyze relationship between drug abuse, recognition of basic emotions |
None |
| 2011-02-04 |
Study finds increased prescription drug abuse among teens |
None |
| 2011-02-04 |
AHF urges all AIDS drug manufacturers to reduce medication cost by 20% |
None |
| 2011-02-04 |
Tacere announces reacquisition of HCV compound development, commercialization rights in Asia |
None |
| 2011-02-04 |
AMRI's Burlington facility granted AIFA approval to manufacture octreotide |
None |
| 2011-02-04 |
MedAssurant, UNC to assess relationship between insulin and cancer development |
None |
| 2011-02-04 |
Sodium Thiosulfate Injections recalled |
None |
| 2011-02-04 |
U.S. Patent Office issues Notice of Allowance to Antigen Express AE37 cancer vaccine |
3.5 |
| 2011-02-03 |
FDA approves Hospira's topotecan for SCLC |
None |
| 2011-02-03 |
Genmab reports GBP 9 million net sales for Arzerra in fourth quarter 2010 |
5 |
| 2011-02-03 |
AVEO receives USAN, WHO generic name approval for ficlatuzumab |
None |
| 2011-02-03 |
Public health experts: Improved community engagement needed to prevent pandemic spread |
None |
| 2011-02-03 |
Ta`am Teva Altman, Probi sign agreement to launch dietary supplement for gut health |
None |
| 2011-02-03 |
Losartan improves effectiveness of nanotherapeutics against cancer |
None |
| 2011-02-03 |
New study highlights black box warning inconsistencies on drug's label |
None |
| 2011-02-03 |
FDA disallows obesity drug Contrave pending further large-scale testing |
None |
| 2011-02-03 |
Proper diagnosis and antibiotic treatment are the best way to prevent Lyme arthritis |
None |
| 2011-02-03 |
Largazole appears to be an ideal blueprint for developing new drugs against bone diseases |
None |
| 2011-02-03 |
LSU biochemists develop 5-LOX 3-D model to design effective asthma medication |
None |
| 2011-02-03 |
Malarial drugs may help treat specific form of frontotemporal dementia |
5 |
| 2011-02-02 |
Researchers discover potential vaccine capable of reducing H. pylori colonization |
None |
| 2011-02-02 |
Body weight loss influences prescribing decisions for type 2 diabetes |
None |
| 2011-02-02 |
Shire announces Health Canada's approval of VYVANSE for treatment of ADHD in adolescents and adults |
None |
| 2011-02-02 |
Harbor BioSciences announces publication of newly discovered anti-inflammatory steroids |
3 |
| 2011-02-02 |
New research: Antioxidants in pecans may prevent development of various diseases |
None |
| 2011-02-02 |
FDA issues reminder about safe use of non-sterile alcohol prep pads |
None |
| 2011-02-02 |
Stryker closes sale of OP-1 products used in orthopaedic bone applications |
None |
| 2011-02-02 |
Skinvisible, Novartis enter agreement for technical feasibility study |
None |
| 2011-02-02 |
Swine flu shots linked to narcolepsy: Investigation continues |
None |
| 2011-02-02 |
Study finds treatment-related mortality with bevacizumab in cancer patients |
None |
| 2011-02-02 |
Quebec provides access to new treatment for women with postmenopausal osteoporosis |
None |
| 2011-02-02 |
Daily probiotic may help prevent upper respiratory tract infections in athletes: Research |
5 |
| 2011-02-02 |
Scientists test new dry powder measles vaccine that can be inhaled |
None |
| 2011-02-01 |
New compound appears to prevent pain crises in sickle cell disease: GHSU |
None |
| 2011-02-01 |
FDA, Optivia collaborate to examine effect of dietary supplements in drug-induced liver injury |
None |
| 2011-02-01 |
FDA approves NCI's Sodium Fluoride F18 NDA for use in bone scans |
None |
| 2011-02-01 |
CAM therapies are more pronounced among whites than racial and ethnic minorities |
None |
| 2011-02-01 |
Highly favorable final results from ERGOFLEX initial clinical study for joint pain relief |
None |
| 2011-02-01 |
Yale University scientists synthesize lomaiviticin that appears to destroy cancer stem cells |
None |
| 2011-02-01 |
PCMA finds Ohio's Medicaid program can save $135 million over the next decade |
None |
| 2011-02-01 |
French guy says Parkinson’s drug induced gambling and gay sex addiction, tries to sue GSK for $610,000 |
5 |
| 2011-02-01 |
Easier access to emergency birth control increases sexually-transmitted diseases among teenagers |
None |
| 2011-02-01 |
Johnson & Johnson deal may bring HIV/AIDS drugs to developing countries faster |
None |
| 2011-02-01 |
Generics companies weigh in on biological drugs, the Wall Street Journal reports |
None |
| 2011-02-01 |
Eurogentec, ImaginAb announce collaboration to produce engineered antibody fragments |
None |
| 2011-02-01 |
AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription |
5 |
| 2011-01-31 |
MAP Pharmaceuticals, Allergan collaborate for LEVADEX to treat acute migraine in adults |
None |
| 2011-01-31 |
Baxter launches OLIMEL emulsion for parenteral nutrition |
2 |
| 2011-01-31 |
Empire State Building, NYRR partner with MMRF for new myeloma drugs |
None |
| 2011-01-31 |
Jiangsu Aosaikang Pharmaceutical to take 5% equity position in Living Cell Technologies |
None |
| 2011-01-31 |
Endo Pharmaceutical partners receive Paragraph IV Certification for generic version of LIDODERM |
None |
| 2011-01-31 |
U.S. District Court grants preliminary injunction, clears sale of Dr. Reddy's Allegra D24 tablet |
None |
| 2011-01-29 |
EVP of Advaxis' Science & Operations moderates Live Cancer Vaccines panel discussion |
None |
| 2011-01-29 |
Taxol reduces cell regeneration obstacles after spinal cord injury: Scientists |
None |
| 2011-01-29 |
NexMed presents data on NexACT technology use to improve less permeable, soluable oral drugs |
None |
| 2011-01-29 |
Initiative to eliminate polio in the U.K. |
None |
| 2011-01-29 |
LivDerma founder develops transdermal delivery system for effective pain relief |
None |
| 2011-01-29 |
Etanercept can restore responsiveness to pain-relieving effects of morphine: Study |
None |
| 2011-01-29 |
BGU, PTT sign R&D collaboration agreement for commercial development of green algae strain |
None |
| 2011-01-29 |
King Pharmaceuticals awards payment to Pain Therapeutics for abuse-resistant medications |
None |
| 2011-01-29 |
Nitrous oxide anesthesia may lead to increased risk of myocardial infarction: Study |
5 |
| 2011-01-29 |
FDA approves Mylan's ANDA for ER Tablets |
None |
| 2011-01-29 |
FDA approves GRALISE Tablets for treatment of PHN |
None |
| 2011-01-28 |
Antibiotic may help in development of new anti-cancer agents: Researchers |
4 |
| 2011-01-28 |
Genentech, Biogen announce FDA approval of Rituxan to treat follicular lymphoma |
None |
| 2011-01-28 |
WOUNDS article profiles efficacy of Quick-Med's antimicrobial BIOGUARD dressings |
None |
| 2011-01-28 |
Taxol drug promotes regeneration of nerve cells in CNS after spinal cord injury: Study |
None |
| 2011-01-28 |
FDA schedules fourth orphan drug designation workshop |
None |
| 2011-01-28 |
Bill Gates, crown prince of Abu Dhabi announce $100m pledge for vaccines for Afghan, Pakistani children |
None |
| 2011-01-28 |
Tibotec grants multiple non-exclusive licenses to generic manufacturers for rilpivirine hydrochloride |
None |
| 2011-01-28 |
New research: Retired NFL players more likely to misuse painkillers |
None |
| 2011-01-28 |
Frequency of analgesic drug errors in hospitals is nearly 3 per 1000 prescriptions: Study |
None |
| 2011-01-28 |
Matrix enters licensing agreement with Tibotec for generic Rilpivirine Hydrochloride |
None |
| 2011-01-28 |
CSL Behring receives marketing approval for HAE drug Berinert in Israel |
None |
| 2011-01-28 |
Reuters examines how Russia's 'drug problem' has 'become an AIDS problem' |
None |
| 2011-01-28 |
FDA approves Boca's generic Xodol for relief of moderate to moderately severe pain |
None |
| 2011-01-27 |
FDA accepts Pain Therapeutics NDA resubmission for REMOXY |
None |
| 2011-01-27 |
Medisafe to develop barcoded system to confirm origin of prescription medications |
None |
| 2011-01-27 |
Antibiotic use in first six months of life may result in childhood asthma |
None |
| 2011-01-27 |
Metanx promotes restoration of lost cutaneous sensation in Diabetic Neuropathy patients |
None |
| 2011-01-27 |
FDA, Simulations Plus sign RCA to develop QSAR toxicity models |
None |
| 2011-01-27 |
FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer risk |
None |
| 2011-01-27 |
Quest Diagnostics releases new data on oral fluid testing system |
None |
| 2011-01-27 |
WSJ: Biotech generics battle heats up |
None |
| 2011-01-26 |
Teva, APP enter agreement for launch of generic Gemzar |
None |
| 2011-01-25 |
Pill for multiple sclerosis in the pipeline |
4 |
| 2011-01-25 |
Nordion and Sterigenics sign five year contract for Cobalt-60 supply |
None |
| 2011-01-25 |
Mylan enters settlement agreement with Pfizer for Caduet Tablets litigation |
None |
| 2011-01-25 |
Nordic Naturals launches one-per-day omega-3 fatty acid gels |
None |
| 2011-01-25 |
Triad alcohol prep pads with ARIXTRA Starter Kits not to be used |
None |
| 2011-01-25 |
Kira For Women introduces two new products for menopause, PMS |
None |
| 2011-01-25 |
Sanofi-aventis acquires world-wide license for ADC products |
None |
| 2011-01-25 |
Strong opposition to 'prescription-only' measures for OTC medicines with pseudoephedrine |
None |
| 2011-01-25 |
ASA concerned over non-availability of sodium thiopental |
None |
| 2011-01-25 |
SNM commends FDA Advisory Committee recommendation for florbetapir approval |
None |
| 2011-01-25 |
Researchers find White-Hispanic disparities in receiving immunization against flu, pneumonia |
None |
| 2011-01-25 |
FDA approves Matrix's generic Protonix DR Tablets ANDA |
None |
| 2011-01-24 |
FedEx launches Deep Frozen Shipping Solution for temperature-sensitive healthcare products |
None |
| 2011-01-24 |
PediatRx announces first-ever revenues and successful launch of GRANISOL |
None |
| 2011-01-24 |
FDA accepts Optimer's fidaxomicin NDA for filing |
None |
| 2011-01-24 |
Spectrum submits Post Approval Supplement for removal of bioscan requirement for Indium-111 ZEVALIN |
None |
| 2011-01-24 |
BDSI refutes MonoSol's patent infringement claims relating to BEMA Buprenorphine |
None |
| 2011-01-24 |
FDA approves Clinical Data's Viibryd for major depressive disorder |
None |
| 2011-01-24 |
Bayer's gadobutrol injection for CNS imaging receives FDA Advisory Committee approval |
4 |
| 2011-01-24 |
Rotavirus vaccine significantly cuts child hospitalizations, study says |
None |
| 2011-01-24 |
European CHMP issues positive opinion for retigabine |
None |
| 2011-01-24 |
Eckert & Ziegler receives European Commission's indefinite approval for YTTRIGA |
None |
| 2011-01-24 |
China Shenghuo's Lixuwang product recieves Chinese Well-Known Trademark Honor |
None |
| 2011-01-24 |
Boehringer Ingelheim's Prazaxa receives Japanese approval for stroke prevention in AF patients |
3.5 |
| 2011-01-24 |
Two studies explore relationship between nutrition and asthma |
None |
| 2011-01-24 |
Tamoxifen may reduce individual's risk of death from lung cancer: New study |
None |
| 2011-01-24 |
PGxHealth receives FDA approval for Viibryd tablets to treat major depressive disorder |
None |
| 2011-01-21 |
CVAF completes new investment agreement with Oncovir for production of Hiltonol |
5 |
| 2011-01-21 |
PenTAG research plays pivotal role in NICE decision to extend availability of Alzheimer's disease drugs |
None |
| 2011-01-21 |
VIVUS holds End-of-Review meeting with FDA for QNEXA NDA |
None |
| 2011-01-21 |
GSK, Valeant receive European CHMP positive opinion for Trobalt |
None |
| 2011-01-21 |
EMA CHMP issues negative opinion against Biogen Idec's FAMPYRA for multiple sclerosis |
None |
| 2011-01-21 |
Adopting pharmacy carve-in approach can help 13 states realize over $11 billion savings in Medicaid |
None |
| 2011-01-21 |
WHO executive board meeting addresses agency's policy on counterfeit, substandard medications |
None |
| 2011-01-21 |
Major breakthrough: Genome-based medicine for treatment of alcoholism |
None |
| 2011-01-21 |
Supreme Court considers drug-pricing lawsuit |
None |
| 2011-01-21 |
Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder |
None |
| 2011-01-21 |
New study reveals illicit HGH use among young American male weightlifters |
None |
| 2011-01-20 |
Researchers discover nitroxoline can reduce human breast, bladder cancer cell growth |
None |
| 2011-01-20 |
Genzyme to expand Geel facility to support growth of Myozyme and Lumizyme for Pompe disease |
None |
| 2011-01-20 |
FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA |
None |
| 2011-01-20 |
Rx-Webmasters website offers flexible discounts to customers on high-quality medications |
None |
| 2011-01-20 |
Huanggang Winner receives State Development and Reform Commission's Cotton Processing Certificate |
None |
| 2011-01-20 |
Long-term use of khat drug decreases self-control, leads to undesirable behaviour: Study |
None |
| 2011-01-20 |
Study: Vitamin E supplementation may extend life-span of restricted groups of men |
None |
| 2011-01-20 |
Reducing generic prices will not result in pharmacy shortages: Study |
None |
| 2011-01-20 |
BI refuses to offer increased access to AIDS drugs for low-income Americans |
None |
| 2011-01-20 |
Novo Nordisk to appeal against ruling in repaglinide combination patent case |
3 |
| 2011-01-20 |
Oral contraceptives do not cause weight gain, says new study |
None |
| 2011-01-20 |
Dried blood spot technology finds new role in developing lifesaving medications |
None |
| 2011-01-19 |
USPTO grants KL4 surfactant combination product patent to Discovery Labs |
None |
| 2011-01-19 |
Pisgah to scale-up patent-pending form of hydrocodone |
None |
| 2011-01-19 |
San Diego hospital tests RFID-based drug-management system developed by MEPS Real Time |
None |
| 2011-01-19 |
Study shows risky knowledge gaps, deficits in dietary supplements among pregnant women |
None |
| 2011-01-19 |
Scientists produce tiny molecular 'binder' that may help develop more efficient drugs |
None |
| 2011-01-19 |
Loyola offers new, nonsurgical treatment for Dupuytren's contracture |
3 |
| 2011-01-19 |
FDA announces consent decree of permanent injunction against Deltex |
None |
| 2011-01-19 |
Antidepressant medication reduces frequency and severity of menopausal hot flashes |
None |
| 2011-01-18 |
Study elaborates relationship between obesity and MDD-R, long-term use of ADs |
None |
| 2011-01-18 |
FDA approves Natroba for treatment of head lice infestations |
None |
| 2011-01-18 |
FDA approves ParaPRO's Natroba for topical treatment of head lice |
None |
| 2011-01-18 |
Z-Medica develops new version of QuikClot Combat Gauze |
None |
| 2011-01-18 |
DKMA issues GMP certificate to Cambrex Zenara Indian manufacturing facility |
None |
| 2011-01-18 |
Transcept announces Intermezzo NDA resubmission for treatment of middle of the night awakenings |
None |
| 2011-01-18 |
Cadence launches OFIRMEV pain medication in the U.S. |
None |
| 2011-01-18 |
Mylan receives FDA approval for generic Precose Tablets ANDA |
None |
| 2011-01-18 |
Quebec reimburses VIDAZA for treatment of blood cancer |
None |
| 2011-01-18 |
Seordus recieves Japanese patent for SER100 |
None |
| 2011-01-18 |
PecFent accepted in Scotland for treatment of breakthrough cancer pain |
3 |
| 2011-01-18 |
OMJPI, Sanford-Burnham enter agreement to discover compounds for Alzheimer's disease, psychiatric disorders |
None |
| 2011-01-18 |
T3SS-dependent bacteria may be a suitable point of attack for future antibiotics: Study |
None |
| 2011-01-18 |
McNeil Consumer Healthcare initiates voluntary recall |
1 |
| 2011-01-18 |
Antibiotics with blood pressure medications may cause hypotension |
4.5 |
| 2011-01-18 |
Study reports warfarin users may face risk of death after traumatic injuries |
None |
| 2011-01-18 |
Health Canada approves Eli Lilly's BYETTA for treatment of adults with type 2 diabetes |
2 |
| 2011-01-17 |
Pharmacists can help patients to manage their medication and stop smoking |
1 |
| 2011-01-16 |
Capsules with essential oils reduce symptoms of premenstrual syndrome: Study |
2 |
| 2011-01-14 |
Study: Health advocacy groups don't always disclose drug company funding |
None |
| 2011-01-14 |
Health Canada requests Osiris for additional information in support of Prochymal approval |
None |
| 2011-01-14 |
pH Advantage adds Pyranase to facial skin care line |
None |
| 2011-01-14 |
Unintended direct conflict between pharmaceutical marketing and public health |
None |
| 2011-01-14 |
Covidien announces support for FDA on safe use of acetaminophen |
None |
| 2011-01-14 |
Sleep medications increase risk for nighttime falls and potential injury |
None |
| 2011-01-14 |
ShangPharma opens new multi-purpose pharma development and cGMP manufacturing facility in Fengxian |
None |
| 2011-01-14 |
Orexo, Invida enter exclusive licensing and distribution agreement for Abstral in Asia Pacific |
None |
| 2011-01-14 |
FDA takes new steps to cut risks from use of acetaminophen |
None |
| 2011-01-14 |
FDA asks manufacturers to eliminate higher-dose prescription combination acetaminophen products |
None |
| 2011-01-14 |
T.A. Sciences receives US patent for TA-65 to tackle aging process |
4.8 |
| 2011-01-14 |
CJSM highlights emerging issues in sport medicine |
None |
| 2011-01-14 |
Older adults with recent heart attack, kidney dysfunction lack long-term medication adherence: Study |
None |
| 2011-01-14 |
IDRI receives Bill and Melinda Gates Foundation multi-million dollar grant to identify new leads in TB |
None |
| 2011-01-14 |
ITM scientists to combat tapeworm infection using drugs |
None |
| 2011-01-13 |
FDA approves Cumberland's Acetadote Injection |
None |
| 2011-01-13 |
FDA calls for cuts in Acetaminophen in painkillers |
None |
| 2011-01-13 |
Abuse of legal substances |
None |
| 2011-01-13 |
PPPI-III conference to focus on fundamental research and industrial application of particulate processing |
None |
| 2011-01-13 |
Study supports use of PRX as an anti-cataract agent |
None |
| 2011-01-13 |
BP-lowering medications provide long-term benefit of reducing death risk from cardiovascular disease |
None |
| 2011-01-13 |
Antibiotic treatment may be sufficient to overcome River Blindness |
None |
| 2011-01-13 |
Genomic research could help doctors better target oxaliplatin drug to treat colorectal cancer patients: Study |
None |
| 2011-01-13 |
Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC |
4 |
| 2011-01-12 |
FDA accepts to review Fibrocell Science's azficel-T drug |
None |
| 2011-01-12 |
K-V Pharmaceutical provides update on FDA review of NDA for Gestiva |
None |
| 2011-01-12 |
FDA panel rejects new pancreatic enzyme replacement drug |
None |
| 2011-01-12 |
US most susceptible to brand erosion post patent expiry |
5 |
| 2011-01-12 |
Study highlights importance of independent evaluation of Tamiflu drug |
1 |
| 2011-01-12 |
Study shows delivering cancer drug in hydrophobic nanoparticle is a safe and effective prostate cancer therapy |
None |
| 2011-01-12 |
New research identifies nutrition inadequacy among Americans |
1 |
| 2011-01-12 |
Study: 23% of doctors have negative perceptions on quality, effectiveness of generic drugs |
None |
| 2011-01-12 |
56% of respondents have still not received flu shots |
None |
| 2011-01-12 |
Apixaban drug raises hope for DVT prevention in patients undergoing hip replacement surgery |
None |
| 2011-01-12 |
Herpes zoster vaccine reduces risk of developing shingles by 55% |
None |
| 2011-01-12 |
Coventry Health Care offers new medicare plans for employer group |
None |
| 2011-01-12 |
BPH, hair loss prevention drugs may produce adverse side effects in men |
None |
| 2011-01-12 |
FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes |
None |
| 2011-01-12 |
Patients who consume painkillers may face cardiovascular risk |
None |
| 2011-01-11 |
Zogenix, Desitin receive MAA approval for SUMAVEL DosePro in Germany and the UK |
None |
| 2011-01-11 |
ESHRE Annual Meeting addresses latest breakthroughs in reproductive medicine |
None |
| 2011-01-11 |
Genzyme provides update on discussions with Sanofi-Aventis |
None |
| 2011-01-11 |
Study to identify early warning biomarkers for presence of breast and prostate cancers |
None |
| 2011-01-11 |
Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants |
None |
| 2011-01-11 |
Largest, national long-term study of children's health opens for Cuyahoga County |
None |
| 2011-01-11 |
Nutriceuticals may restore age-related vision loss |
None |
| 2011-01-11 |
Predator microbes may work against antibiotic resistant disease-causing bacteria: Study |
None |
| 2011-01-11 |
Prontosan Wound Management Gel with PHMB now available OTC |
3.5 |
| 2011-01-10 |
PPD announces joint venture with TBL to develop novel biotherapeutics |
None |
| 2011-01-10 |
IGI Laboratories submits second abbreviated new drug application to FDA |
None |
| 2011-01-10 |
Obama administration sides with drug companies in pricing lawsuit; Supreme Court agrees to hear case regarding use of prescription drug data |
None |
| 2011-01-10 |
Shionogi brings KAPVAY ADHD drug to the U.S market |
None |
| 2011-01-10 |
Neomend receives CE Mark for ProGEL PLATINUM Surgical Sealant |
None |
| 2011-01-10 |
EffRx submits EX101 NDA for osteoporosis treatment to FDA |
4 |
| 2011-01-10 |
Manhattan enters settlement and release agreement with Nordic and H Pharmaceuticals |
None |
| 2011-01-10 |
Pennsaid fourth quarter prescriptions increase 20% sequentially |
None |
| 2011-01-10 |
New, paid prescriptions for Questcor's Acthar increase 66% |
None |
| 2011-01-10 |
Watson receives FDA approval for generic Fentora |
None |
| 2011-01-10 |
New study finds extending term of exclusive access can lead to higher drug costs in short term |
None |
| 2011-01-10 |
Endo Pharmaceuticals receives FDA complete response letter for OPANA ER |
None |
| 2011-01-10 |
FDA warns public about extortion scam |
None |
| 2011-01-10 |
FDA approves Abstral drug for treatment of breakthrough pain in cancer patients |
3 |
| 2011-01-10 |
U.S. District Court grants injunction for Sensipar patents |
None |
| 2011-01-09 |
Abstral transmucosal tablets receive FDA approval, may help manage pain in cancer patients |
None |
| 2011-01-09 |
Old flu jabs from pandemic to combat this winter’s peak |
None |
| 2011-01-07 |
Malaria drug makes cancer drug more effective |
None |
| 2011-01-07 |
NovaDel receives $500,000 milestone payment from Akrimax in connection with NitroMist agreement |
None |
| 2011-01-07 |
FDA approved KOMBIGLYZE XR for type 2 diabetes mellitus now available in pharmacies |
None |
| 2011-01-07 |
Dendreon provides U.S. commercialization and European strategy updates for PROVENGE |
None |
| 2011-01-07 |
Intrexon Corporation, ZIOPHARM enter partnership to develop, commercialize DNA-based therapeutics |
None |
| 2011-01-07 |
DARPA grants million dollar to IDRI to develop single dose influenza vaccine |
None |
| 2011-01-07 |
Amgen, Xencor collaborate to develop XmAb5871 for autoimmune disease |
None |
| 2011-01-07 |
Ligand, Chiva Pharmaceuticals enter strategic relationship to develop multiple Ligand assets, technology |
None |
| 2011-01-07 |
Isis Pharmaceuticals announces addition of two new drugs to development pipeline |
None |
| 2011-01-07 |
FDA introduces new Web resource that helps companies to save time, resources |
None |
| 2011-01-06 |
Choosing between EGFR therapeutic options in metastatic colorectal cancer |
None |
| 2011-01-06 |
Lab21 acquires Microgen Bioproducts |
None |
| 2011-01-06 |
Problems reported with Implanon contraceptive implant |
2.3 |
| 2011-01-06 |
Study shows clinical benefits of iniparib in combination with standard chemotherapy for triple-negative breast cancer |
None |
| 2011-01-06 |
Research report on advanced drug delivery market |
None |
| 2011-01-06 |
Medical experts issue warning about common practice of tablet splitting |
None |
| 2011-01-06 |
VEREGEN Ointment added as new therapeutic option in 2010 CDC STD Treatment Guidelines |
3 |
| 2011-01-06 |
Findings of AM095 in various in vitro, in vivo models of fibrotic disease published in JPET |
None |
| 2011-01-06 |
Opexa completes meetings with FDA regarding planned development program for Tovaxin |
4 |
| 2011-01-06 |
J&JPRD submits New Drug Application to FDA for rivaroxaban |
4 |
| 2011-01-06 |
Indian drugmaker seeks to make, sell generic version of Pfizer's HIV drug |
None |
| 2011-01-06 |
FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA |
4 |
| 2011-01-06 |
Avaxia Biologics generates compelling pre-clinical data in animal models of IBD |
None |
| 2011-01-06 |
Water Street Healthcare announces acquisition of OraPharma from Johnson & Johnson |
None |
| 2011-01-06 |
Study: Antibiotics can provide long-lasting relief to patients with irritable bowel syndrome |
None |
| 2011-01-06 |
FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment |
None |
| 2011-01-05 |
Spectrum Pharmaceuticals enters agreement with Viropro to develop biosimilar rituximab |
5 |
| 2011-01-05 |
Tablet splitting leads to inaccurate dosages |
None |
| 2011-01-05 |
EUSA receives FDA Priority Review status for ERWINAZE BLA |
None |
| 2011-01-05 |
Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX |
5 |
| 2011-01-05 |
GLUMETZA tablets are now available to wholesalers and physicians |
None |
| 2011-01-05 |
Men are more willing to receive HPV vaccine, trend may help reduce cancer deaths |
None |
| 2011-01-05 |
Indian government rejects Abbott's patent application for second-line ARV |
None |
| 2011-01-05 |
Elis granted exclusive rights to market Apricus Bio's Vitaros in the Gulf and part of the Middle East |
5 |
| 2011-01-05 |
Researchers create model that predicts drug effects on fetal development |
4 |
| 2011-01-05 |
Dongsheng obtains exclusive sales rights of Thymosin Alpha 1 Injection in China |
None |
| 2011-01-05 |
Fruit fly faeces provides answers to pregnant women's bloating and constipation |
5 |
| 2011-01-05 |
Two doses of varicella vaccine provide higher antibody levels than one |
4 |
| 2011-01-05 |
Researchers develop unique vaccine that produces long-lasting anti-cocaine immunity in mice |
None |
| 2011-01-05 |
Study suggests new experimental drug is better than standard morphine |
None |
| 2011-01-05 |
Kiadis Pharma, Hospira sign license agreement to develop and commercialize ATIR hematology product |
5 |
| 2011-01-05 |
Opinions: U.S. International Affairs Budget; Health impacts of climate change; Role of U.N.; Drug development, free trade |
None |
| 2011-01-04 |
New USP standards to improve health literacy, proper medication usage among patients |
None |
| 2011-01-04 |
BNA announces publication of Second Edition of Pharmaceutical Patent Law |
None |
| 2011-01-04 |
Bupropion and varenicline help curb cigarette craving |
None |
| 2011-01-04 |
Meda acquires two additional OTC products from GSK |
None |
| 2011-01-04 |
Mediterranean diet appears to slow cognitive decline in older adults |
None |
| 2011-01-04 |
Senator eyes plan to ease prescription drug shortages |
None |
| 2011-01-04 |
Risk-adjusted TTR appears to improve anticoagulation control |
None |
| 2011-01-04 |
The Scientist examines how nonprofit, for-profit pharma groups are working together to make drugs more affordable for developing countries |
None |
| 2011-01-03 |
Mothers can play a key role in convincing college-aged women to receive HPV vaccine |
None |
| 2011-01-03 |
SinoFresh, Green Valley Drug enter marketing relationship for Homeopathic Antiseptic Nasal Spray |
None |
| 2011-01-03 |
FDA approves 200 mg formulation of INTELENCE for HIV-1 |
None |
| 2011-01-03 |
FDA grants orphan drug status for Senesco's SNS01-T in treatment of multiple myeloma |
5 |
| 2011-01-03 |
Labopharm monetizes future royalty payment stream for RYZOLT through subsidiary |
None |